{"meta":{"query_hash":"56e7e383c846","filters":{"venue":"Pharmacology & Therapeutics"},"cohort_total":138,"direct_labels_cover":0,"predictions_cover":138,"exported":138,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/56e7e383c846","api":"https://metacan.xera.ac/api/v1/cohort?venue=Pharmacology+%26+Therapeutics"},"results":[{"id":"W1466412209","doi":"10.1016/j.pharmthera.2015.07.005","title":"Changes in mu-opioid receptor expression and function in the mesolimbic system after long-term access to a palatable diet","year":2015,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Neuroendocrine regulation and behavior","field":"Psychology","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Calgary","funders":"","keywords":"μ-opioid receptor; Receptor; Opioid; Offspring; Mesolimbic pathway; Nucleus accumbens; Opioid receptor; Obesity; Endocrinology; Reward system; Brain stimulation reward; Internal medicine; Biology; Psychology; Neuroscience; Medicine; Ventral tegmental area; Dopamine; Pregnancy","score_opus":0.1553380522545795,"score_gpt":0.45152101331341454,"score_spread":0.296182961058835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1466412209","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.026233474,0.96593136,0.000008327254,0.00087958976,0.0033967183,0.0032787286,0.00006020532,0.00007706343,0.00013452565],"genre_scores_gemma":[0.017524738,0.96902734,0.000013219889,0.0045699505,0.0008204122,0.0060388367,0.00015216475,0.00014291024,0.0017104285],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.996629,0.0014627114,0.0005400381,0.0006287066,0.00020944596,0.0005301087],"domain_scores_gemma":[0.99897814,0.00019846184,0.00025194662,0.000405196,0.000053341555,0.00011294309],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042955446,0.00046351514,0.0009899917,0.0004831332,0.000056191617,0.000073751646,0.0005246667,0.00026276644,0.0006981944],"category_scores_gemma":[0.0000014124955,0.00032027913,0.00010269444,0.0005314615,0.00006786443,0.000101294165,0.000210391,0.0006620514,0.00015862621],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014934404,0.0008777076,0.011761206,0.005509472,0.0002998301,0.00044846098,0.0021177912,0.0000010498466,0.00040929118,0.000018737273,0.010736579,0.9663264],"study_design_scores_gemma":[0.001043183,0.0003020247,0.0064259437,0.0011741457,0.0012155352,0.000105368825,0.000093020775,0.0000016782174,0.0000316932,0.000002459209,0.98928416,0.00032080262],"about_ca_topic_score_codex":0.000012029114,"about_ca_topic_score_gemma":0.00010527107,"teacher_disagreement_score":0.9785476,"about_ca_system_score_codex":0.00017288003,"about_ca_system_score_gemma":0.00006784698,"threshold_uncertainty_score":0.9999249},"labels":[],"label_agreement":null},{"id":"W1963777356","doi":"10.1016/j.pharmthera.2012.03.004","title":"Novel HDL-based therapeutic agents","year":2012,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Cholesterylester transfer protein; Apolipoprotein B; Cholesterol; Pharmacology; Medicine; Mechanism of action; Lipoprotein; Therapeutic approach; Reverse cholesterol transport; High-density lipoprotein; Mechanism (biology); Disease; Bioinformatics; Internal medicine; Chemistry; Biology; Biochemistry","score_opus":0.20972457457453705,"score_gpt":0.4332547411128237,"score_spread":0.22353016653828664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963777356","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000010215954,0.9920882,0.0011533244,0.00046511032,0.0023225874,0.0030095004,0.00006110323,0.00019709783,0.0006928659],"genre_scores_gemma":[0.00018742979,0.9749477,0.00048400112,0.020604648,0.0023243197,0.0005255781,0.00020469846,0.00025732073,0.00046431285],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99637145,0.00047980904,0.00083420996,0.00063965644,0.0006190405,0.0010558652],"domain_scores_gemma":[0.997872,0.00017316893,0.00042568808,0.00094280107,0.00014850336,0.00043783776],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009245043,0.0008419403,0.0028782848,0.0003164344,0.00017655217,0.000022845476,0.00040799828,0.0008558884,0.0010450287],"category_scores_gemma":[0.0000020960185,0.0006349901,0.0018636457,0.000483778,0.00019664102,0.00005496971,0.00008499197,0.0013969349,0.00054903823],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052103554,0.0007722275,0.000010373107,0.011267279,0.0066445027,0.00003519149,0.000036688212,8.1541e-7,0.00006383183,0.000016459877,0.0002549257,0.98084563],"study_design_scores_gemma":[0.0021222797,0.00018942944,0.000035435143,0.0010957905,0.04987362,0.0003804774,0.0000050828085,0.00004529093,0.000057918907,0.0000042187235,0.94569314,0.00049730926],"about_ca_topic_score_codex":0.000023737348,"about_ca_topic_score_gemma":0.0000015093057,"teacher_disagreement_score":0.9803483,"about_ca_system_score_codex":0.00043933652,"about_ca_system_score_gemma":0.0013178047,"threshold_uncertainty_score":0.99986815},"labels":[],"label_agreement":null},{"id":"W1964911738","doi":"10.1016/j.pharmthera.2011.11.004","title":"The cellular and molecular origin of reactive oxygen species generation during myocardial ischemia and reperfusion","year":2011,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Cardiac Ischemia and Reperfusion","field":"Medicine","cited_by":382,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of British Columbia Hospital","funders":"Canadian Institutes of Health Research","keywords":"Ischemia; Reactive oxygen species; Reperfusion injury; Medicine; Oxidative stress; Cardiology; Myocardial ischemia; Internal medicine; Cell biology; Biology","score_opus":0.05527757451575596,"score_gpt":0.33430661525336186,"score_spread":0.2790290407376059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964911738","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21100172,0.787023,0.000007981535,0.000105304556,0.0005124281,0.00074760756,0.000009863196,0.000020181911,0.00057189725],"genre_scores_gemma":[0.0050960863,0.9933773,0.000074814256,0.00017150682,0.00069187843,0.000053616033,0.00005665572,0.000058248723,0.00041986763],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984438,0.00021697831,0.0004721627,0.00042347738,0.00018093258,0.00026265028],"domain_scores_gemma":[0.9990185,0.00012782494,0.00032866138,0.00030284244,0.00012336961,0.000098783465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003182995,0.00037098318,0.0010917416,0.00010083076,0.00022361698,0.000015662048,0.0000968277,0.00042768923,0.000026544469],"category_scores_gemma":[0.0000072187217,0.00023802786,0.0003311414,0.0001260181,0.0003554834,0.000036171823,0.00017190269,0.0005699427,0.0000028308896],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011685897,0.000041499294,0.000027783164,0.0015637209,0.0013535637,0.000040833515,0.00029376353,8.538045e-8,0.9002674,0.00004070775,0.00016511361,0.09608863],"study_design_scores_gemma":[0.00057921855,0.00007217747,0.000008670078,0.00036125968,0.0067484267,0.00016712023,0.000028442453,0.000010749422,0.32399568,0.0000048685906,0.6678515,0.00017186464],"about_ca_topic_score_codex":0.0000059921467,"about_ca_topic_score_gemma":3.2119027e-7,"teacher_disagreement_score":0.6676864,"about_ca_system_score_codex":0.00008491793,"about_ca_system_score_gemma":0.00018316458,"threshold_uncertainty_score":0.9706495},"labels":[],"label_agreement":null},{"id":"W1967586503","doi":"10.1016/j.pharmthera.2015.04.001","title":"Epigenetic targets and drug discovery Part 2: Histone demethylation and DNA methylation","year":2015,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Structural Genomics Consortium; University of Toronto","funders":"Canadian Institutes of Health Research; Wellcome Trust; Ontario Ministry of Economic Development and Innovation; Ontario Genomics Institute; Genome Canada","keywords":"Histone methyltransferase; DNA demethylation; Histone methylation; Epigenomics; Epigenetics; Methyltransferase; Histone; Chromatin; Cancer epigenetics; Biology; DNA methylation; Histone code; Genetics; Computational biology; DNA; Methylation; Nucleosome; Gene; Gene expression","score_opus":0.05933012450344433,"score_gpt":0.38541104618012767,"score_spread":0.32608092167668334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967586503","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004821285,0.9918884,0.0010554177,0.000116638555,0.0011071479,0.0007993842,0.00007275092,0.000021262927,0.000117685086],"genre_scores_gemma":[0.001566053,0.99536204,0.0004271103,0.00028867464,0.00067788985,0.00010987164,0.000671157,0.000095133,0.00080208323],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973894,0.0007055639,0.0006160159,0.0007341398,0.00019104511,0.00036388315],"domain_scores_gemma":[0.9988055,0.00011890139,0.0004621723,0.00030211933,0.00014356294,0.00016769538],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008381638,0.00052136154,0.00086407893,0.00015394327,0.0001513409,0.000058789014,0.00018092847,0.0005378787,0.00001524908],"category_scores_gemma":[0.000016247392,0.00048330138,0.00015583695,0.00014402687,0.00024112553,0.000015538611,0.00020333727,0.00030136644,0.000007501373],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043546945,0.00008634574,0.000047279085,0.0010820475,0.0008250225,0.0000034488476,0.00012775726,0.00001474975,0.025566164,0.00001933793,0.0006407496,0.97154355],"study_design_scores_gemma":[0.00047918124,0.00016442008,0.000027421129,0.000111816466,0.0026132616,0.000008853684,0.000010854669,0.0000391592,0.008340302,0.0003213769,0.9873954,0.00048795473],"about_ca_topic_score_codex":0.0000060973252,"about_ca_topic_score_gemma":0.0000109622915,"teacher_disagreement_score":0.98675466,"about_ca_system_score_codex":0.00006739758,"about_ca_system_score_gemma":0.00024460847,"threshold_uncertainty_score":0.9997619},"labels":[],"label_agreement":null},{"id":"W1968413700","doi":"10.1016/s0163-7258(03)00086-x","title":"cDNA microarray and proteomic approaches in the study of brain diseases: focus on schizophrenia and Alzheimer's disease","year":2003,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Advanced Biosensing Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":75,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Institutes of Health Research; Institute of Neurosciences, Mental Health and Addiction; Douglas Mental Health University Institute; McGill University","funders":"","keywords":"Proteomics; Computational biology; Neuroscience; Schizophrenia (object-oriented programming); Genomics; Biology; DNA microarray; Disease; Alzheimer's disease; Microarray; Bioinformatics; Data science; Computer science; Genetics; Gene; Psychology; Medicine; Gene expression; Genome; Pathology; Psychiatry","score_opus":0.08297676102349129,"score_gpt":0.37324481441169166,"score_spread":0.2902680533882004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968413700","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011973565,0.9844337,0.00004752942,0.00031081057,0.000028687975,0.0030830388,0.00006227585,0.000013418867,0.000046952522],"genre_scores_gemma":[0.042181876,0.95592326,0.0004200564,0.00065537693,0.00007760499,0.00059838756,0.000044936245,0.00006689255,0.00003161599],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986431,0.0003965638,0.00026831962,0.00045396565,0.00006457365,0.0001734527],"domain_scores_gemma":[0.99932975,0.000056603465,0.00019569235,0.0003447113,0.000013311494,0.000059913127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014165427,0.0002955483,0.00043745656,0.00007011749,0.000069923786,0.000011973985,0.00021712611,0.00014545493,0.0000021618118],"category_scores_gemma":[0.0000032587795,0.00020493426,0.0000774639,0.00011453528,0.00021765882,0.0000017552844,0.00007972109,0.00021091671,6.7784174e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034168334,0.002435131,0.00017407707,0.0008017549,0.0013187442,0.000015167991,0.00016529864,0.0000028787329,0.0058403364,0.0003133477,0.0006841858,0.9879074],"study_design_scores_gemma":[0.001733879,0.0009103221,0.00026851185,0.00028830924,0.0052915197,0.000032243395,0.00010829633,0.000014096125,0.0012372417,0.0005313081,0.98897207,0.0006122291],"about_ca_topic_score_codex":0.0000019026369,"about_ca_topic_score_gemma":0.0000034323623,"teacher_disagreement_score":0.98828787,"about_ca_system_score_codex":0.000007785316,"about_ca_system_score_gemma":0.000067433204,"threshold_uncertainty_score":0.83569765},"labels":[],"label_agreement":null},{"id":"W197294569","doi":"10.1016/j.pharmthera.2014.03.007","title":"Epigenetic targets and drug discovery","year":2014,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Structural Genomics Consortium","funders":"Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Wellcome Trust; Ontario Ministry of Economic Development and Innovation; Ontario Genomics Institute; Canadian Institutes of Health Research; Genome Canada","keywords":"Epigenetics; Histone; Methyltransferase; Drug discovery; Chromatin; Methylation; Histone methyltransferase; Acetylation; Computational biology; EZH2; Biology; Histone-modifying enzymes; Chemical biology; Histone methylation; DNA methylation; Genetics; Bioinformatics; DNA; Gene; Gene expression","score_opus":0.033937595675370004,"score_gpt":0.3629949173679335,"score_spread":0.32905732169256346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W197294569","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00062392355,0.9962994,0.0012278699,0.00008297058,0.0009040982,0.00055703963,0.000045501667,0.000017565437,0.00024163269],"genre_scores_gemma":[0.0008809004,0.9954222,0.00023648122,0.0008373634,0.000919664,0.000099723016,0.00031690483,0.00010571266,0.0011810382],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978399,0.00049596844,0.000488901,0.00065273937,0.00012039472,0.00040206205],"domain_scores_gemma":[0.99904686,0.00010249389,0.00031253262,0.00036453898,0.000058168134,0.0001154185],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036429506,0.0004959539,0.0008873531,0.000098955585,0.00012279201,0.00005132474,0.00032083338,0.00046086594,0.000025088048],"category_scores_gemma":[0.0000062190793,0.00043344416,0.0002819277,0.000094372874,0.000196147,0.0000038577905,0.00022481203,0.00030505075,0.000026500966],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002256628,0.00009930249,0.000039254257,0.0023805473,0.0011738917,0.0000049106366,0.00004075882,0.000009339922,0.011104877,0.00002753426,0.0008668008,0.9842302],"study_design_scores_gemma":[0.00029140728,0.0001292232,0.0000070639417,0.0001465021,0.0020725883,0.000008721326,0.000003099254,0.00001346046,0.0054715965,0.0000959952,0.99131197,0.0004483579],"about_ca_topic_score_codex":0.0000032082908,"about_ca_topic_score_gemma":0.00000568291,"teacher_disagreement_score":0.9904452,"about_ca_system_score_codex":0.000023710323,"about_ca_system_score_gemma":0.00015936016,"threshold_uncertainty_score":0.9998117},"labels":[],"label_agreement":null},{"id":"W1974041902","doi":"10.1016/j.pharmthera.2012.04.002","title":"Impact of kinins in the treatment of cardiovascular diseases","year":2012,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Bradykinin; Angiotensin II receptor type 1; Heart failure; Myocardial infarction; Angiotensin II; Blood pressure; Diabetes mellitus; Renin–angiotensin system; Valsartan; Pharmacology; Kinin; Internal medicine; Cardiology; Endocrinology; Receptor","score_opus":0.14509657683906985,"score_gpt":0.43665090819518965,"score_spread":0.2915543313561198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974041902","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004949139,0.9931427,0.000004159138,0.00003721215,0.00032858714,0.0012937832,0.00013496696,0.000016344418,0.000093097224],"genre_scores_gemma":[0.029685335,0.9693647,0.0000131558945,0.00010947422,0.00047839616,0.00012259664,0.00013336551,0.000047023837,0.000045939665],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998091,0.00042031857,0.0006563554,0.0002325016,0.00025554883,0.00034428106],"domain_scores_gemma":[0.9985858,0.00042099218,0.0003435441,0.00048724434,0.00007177783,0.00009062892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021337294,0.0004033,0.0023650653,0.00021194368,0.000032437983,0.000003606376,0.00020514007,0.00021839708,0.00020615362],"category_scores_gemma":[0.0000022257677,0.00022335071,0.0025887883,0.00035815436,0.00020571201,0.00003270485,0.000017639031,0.0001558732,0.000009406049],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009080606,0.0024983692,0.0064730598,0.002252759,0.01632588,0.000024235645,0.001055976,0.000013795348,0.000008740363,0.0000128690335,0.00006260854,0.9711809],"study_design_scores_gemma":[0.0015474473,0.0009304737,0.0067560524,0.0004742916,0.06328416,0.000054216314,0.000020999387,0.0000125906,0.000028305683,0.000009727803,0.92671263,0.00016913257],"about_ca_topic_score_codex":0.00010763074,"about_ca_topic_score_gemma":0.0000022825907,"teacher_disagreement_score":0.97101176,"about_ca_system_score_codex":0.00020191603,"about_ca_system_score_gemma":0.0004349049,"threshold_uncertainty_score":0.9107978},"labels":[],"label_agreement":null},{"id":"W1976325881","doi":"10.1016/j.pharmthera.2013.07.009","title":"Mechanisms and therapeutic implications of the placebo effect in neurological and psychiatric conditions","year":2013,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Pain Management and Placebo Effect","field":"Neuroscience","cited_by":65,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Placebo; Nocebo Effect; Nocebo; Schizophrenia (object-oriented programming); Psychology; Disease; Anticipation (artificial intelligence); Medicine; Psychiatry; Neuroscience; Internal medicine","score_opus":0.07334616814695034,"score_gpt":0.3787146527487164,"score_spread":0.3053684846017661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976325881","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0029747223,0.9894749,0.00012908818,0.0013662486,0.0006263114,0.004959334,0.000059118538,0.000059527254,0.00035077133],"genre_scores_gemma":[0.014581863,0.97941846,0.000026811264,0.0050266758,0.000034514516,0.0007968241,0.0000038041908,0.000036199093,0.00007483417],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9935004,0.005072067,0.00042441522,0.0005306797,0.0001262445,0.00034617295],"domain_scores_gemma":[0.99152094,0.0077663055,0.00033973897,0.00030131877,0.000013126228,0.000058559],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010292201,0.0003961663,0.0008396066,0.0002508795,0.00020691955,0.00003218113,0.00053446606,0.00027319312,0.00009435601],"category_scores_gemma":[0.000044492575,0.00024593342,0.00017767004,0.00059168565,0.0004083182,0.000045389635,0.00021862121,0.00069038477,0.000019505576],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008067333,0.000283679,0.0009607981,0.0041850475,0.00035833463,0.000007210742,0.00008743564,0.000010058366,0.01201856,0.0076135527,0.00058074587,0.9738139],"study_design_scores_gemma":[0.003001891,0.00094322726,0.0033738115,0.00063172827,0.011342202,0.00018114908,0.0000075908006,0.0027644977,0.0008382127,0.019724028,0.956006,0.0011856816],"about_ca_topic_score_codex":0.0000023787054,"about_ca_topic_score_gemma":0.0000017928867,"teacher_disagreement_score":0.97262824,"about_ca_system_score_codex":0.000017529606,"about_ca_system_score_gemma":0.000050302413,"threshold_uncertainty_score":0.9999993},"labels":[],"label_agreement":null},{"id":"W1978096952","doi":"10.1016/j.pharmthera.2009.03.014","title":"Therapeutic role of sirolimus in non-transplant kidney disease","year":2009,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Renal Diseases and Glomerulopathies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital","funders":"","keywords":"Sirolimus; Medicine; Polycystic kidney disease; Kidney; Kidney disease; Renal function; Nephrology; Internal medicine; Endocrinology; Cancer research","score_opus":0.03601013233090485,"score_gpt":0.36654445764105004,"score_spread":0.3305343253101452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978096952","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027654512,0.99656034,0.0000070687906,0.0004166601,0.00033434856,0.001562688,0.00031608093,0.00004882837,0.00047742215],"genre_scores_gemma":[0.005833677,0.9863083,0.000023035473,0.0068825777,0.00028998763,0.00014668406,0.00028435534,0.000090600595,0.00014080433],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973002,0.0002918109,0.0009609393,0.0005220031,0.00032509543,0.00059996214],"domain_scores_gemma":[0.9983807,0.00017496372,0.00037364184,0.00043143868,0.000082607636,0.0005566568],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019769056,0.0006584259,0.0023747578,0.00048441268,0.000046673853,0.000010826143,0.00033287593,0.000366459,0.00026112015],"category_scores_gemma":[0.000004058051,0.00050373626,0.00090766745,0.000506161,0.00021776768,0.000049388414,0.00003930951,0.00077686185,0.000055789835],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087046105,0.0015422346,0.00048013905,0.023005357,0.0018752586,0.0004906055,0.00021378978,0.0000038279395,0.00052028114,0.000041814204,0.00020377032,0.9707525],"study_design_scores_gemma":[0.0017634988,0.00034869948,0.0011060049,0.0075309104,0.022523295,0.000064642074,0.00001500666,0.000121035366,0.00005842734,0.00027720004,0.9657368,0.0004544832],"about_ca_topic_score_codex":0.000009879744,"about_ca_topic_score_gemma":8.291057e-7,"teacher_disagreement_score":0.970298,"about_ca_system_score_codex":0.00012225447,"about_ca_system_score_gemma":0.0010239008,"threshold_uncertainty_score":0.99974144},"labels":[],"label_agreement":null},{"id":"W1980938039","doi":"10.1016/j.pharmthera.2005.03.011","title":"Would modulation of intracellular Ca2+ be antiarrhythmic?","year":2005,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Cardiac electrophysiology and arrhythmias","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Heart, Lung, and Blood Institute","keywords":"Intracellular; Biophysics; Contraction (grammar); Membrane potential; Chemistry; Ion channel; Electrophysiology; Coupling (piping); Cell biology; Internal medicine; Neuroscience; Biology; Receptor; Medicine; Biochemistry; Materials science","score_opus":0.07095231622432768,"score_gpt":0.390937535839284,"score_spread":0.3199852196149563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980938039","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014633675,0.9951987,0.00007559686,0.0008354973,0.0008921886,0.0011143187,0.000051252817,0.00007977977,0.0002892581],"genre_scores_gemma":[0.0021585755,0.9916502,0.00023975415,0.0029995348,0.002021981,0.00007172445,0.0002658604,0.000098894125,0.00049342716],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976949,0.00034329225,0.0008003496,0.00048018145,0.00020067686,0.0004805824],"domain_scores_gemma":[0.99859023,0.00021625566,0.000533264,0.0004100624,0.00014093168,0.00010922607],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00023600143,0.00051673455,0.0023713643,0.00028814614,0.00007938022,0.0000047307303,0.00015652987,0.0013350155,0.0004608002],"category_scores_gemma":[0.000004620948,0.00043953597,0.00088479253,0.00034954073,0.00029541604,0.000049486836,0.00006603426,0.0017821526,0.000074278876],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001507127,0.00019936061,0.000002935227,0.0030213464,0.003573941,0.00021511703,0.000077263714,0.0000390212,0.007531159,0.000059224545,0.00076673774,0.9843632],"study_design_scores_gemma":[0.0007829196,0.00024310808,0.000010699497,0.0005149613,0.015116834,0.0008656485,0.0000038140413,0.00022728118,0.0010772297,0.0000245613,0.9808215,0.0003114314],"about_ca_topic_score_codex":0.0000024625604,"about_ca_topic_score_gemma":4.403538e-7,"teacher_disagreement_score":0.98405176,"about_ca_system_score_codex":0.0001575878,"about_ca_system_score_gemma":0.00047427494,"threshold_uncertainty_score":0.99996144},"labels":[],"label_agreement":null},{"id":"W1984441096","doi":"10.1016/s0163-7258(01)00165-6","title":"Alteration of drug biotransformation and elimination during infection and inflammation","year":2001,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":201,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Canadian Institutes of Health Research","keywords":"Inflammation; Mediator; Cytochrome P450; Biotransformation; Endogeny; Signal transduction; Biology; Drug; Drug metabolism; Immunology; Pharmacology; Cell biology; Enzyme; Endocrinology; Biochemistry","score_opus":0.14086341103683375,"score_gpt":0.46719198610173945,"score_spread":0.3263285750649057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984441096","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.061535433,0.93437177,0.00015988735,0.00029308847,0.0016357986,0.0015020717,0.00008940794,0.0000923257,0.00032019312],"genre_scores_gemma":[0.014186265,0.98419493,0.000098912074,0.00033941967,0.0006434495,0.00018039193,0.00018483728,0.00006727386,0.000104530736],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99663556,0.0011267086,0.0011320998,0.00047355067,0.0002004276,0.0004316314],"domain_scores_gemma":[0.9982628,0.00035965935,0.0008474007,0.00015458759,0.00019360824,0.000181894],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00089749834,0.00058110803,0.0011129605,0.0006391429,0.0003390462,0.000038102327,0.00016794416,0.0007183955,0.00018604484],"category_scores_gemma":[0.0000077344885,0.0005644452,0.00018874725,0.0004630316,0.0003419674,0.00033404338,0.000100760015,0.0010120961,0.000018752398],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010832581,0.00013208312,0.00009439167,0.0065874406,0.00092016376,0.000005970658,0.001097388,0.000046576377,0.013622192,0.00022351155,0.000049405382,0.97711253],"study_design_scores_gemma":[0.0018976944,0.00006770164,0.00020293023,0.0003688138,0.008504823,0.00014551672,0.000022123426,0.0018525898,0.016312376,0.0002097579,0.9698848,0.0005308821],"about_ca_topic_score_codex":0.000014337824,"about_ca_topic_score_gemma":0.000007039858,"teacher_disagreement_score":0.9765817,"about_ca_system_score_codex":0.00010249523,"about_ca_system_score_gemma":0.00011649152,"threshold_uncertainty_score":0.9996807},"labels":[],"label_agreement":null},{"id":"W1985410301","doi":"10.1016/j.pharmthera.2004.10.013","title":"UDP-glucuronosyltransferases and clinical drug-drug interactions","year":2005,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":546,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of British Columbia","funders":"","keywords":"Glucuronidation; Diflunisal; Glucuronosyltransferase; Temazepam; Enzyme; Drug; Chemistry; Pharmacology; CYP2B6; Drug metabolism; Xenobiotic; Biochemistry; Cytochrome P450; Biology; Microsome; CYP1A2; Receptor","score_opus":0.3361456151830802,"score_gpt":0.5765719802520972,"score_spread":0.240426365069017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985410301","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010026108,0.97701705,0.000035521007,0.0017990038,0.0144477375,0.0021811603,0.0007416372,0.000357395,0.0024178901],"genre_scores_gemma":[0.0005654811,0.97152436,0.000274229,0.017367357,0.005722101,0.00043868995,0.00021982861,0.00030228824,0.0035856862],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9892006,0.004719939,0.0025892574,0.001609726,0.00033735935,0.0015431058],"domain_scores_gemma":[0.993311,0.0039015792,0.00090300775,0.00060437864,0.00022925113,0.0010508165],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.0020830913,0.0016503303,0.0035182356,0.00063618436,0.0007276375,0.00009480973,0.0013352028,0.00094780495,0.0045687687],"category_scores_gemma":[0.000018916215,0.0015141334,0.0014500354,0.0005937699,0.0012954538,0.00025552366,0.00046823325,0.0061781113,0.0010727143],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001528717,0.0012835461,0.00009237011,0.001238696,0.0058620223,0.000088964436,0.00033634552,0.000012752026,0.00012063143,0.000101405625,0.019648666,0.9710617],"study_design_scores_gemma":[0.002467937,0.00006218804,0.00001316673,0.00032197448,0.033234812,0.0002559539,0.000041407216,0.0003865389,0.00026770157,0.00006561581,0.96156746,0.0013152148],"about_ca_topic_score_codex":0.000016457918,"about_ca_topic_score_gemma":0.000046345638,"teacher_disagreement_score":0.96974653,"about_ca_system_score_codex":0.0002079876,"about_ca_system_score_gemma":0.00075538276,"threshold_uncertainty_score":0.9997051},"labels":[],"label_agreement":null},{"id":"W1989289560","doi":"10.1016/j.pharmthera.2009.12.005","title":"Cannabinoids and the gut: New developments and emerging concepts","year":2010,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":414,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity; University of Calgary","funders":"Canadian Institutes of Health Research","keywords":"Endocannabinoid system; Cannabinoid receptor; Cannabinoid; Receptor; Biology; Cannabinoid receptor type 2; Lipid signaling; Pharmacology; G protein-coupled receptor; Biochemistry; Agonist","score_opus":0.05962863535081658,"score_gpt":0.43973107332664507,"score_spread":0.3801024379758285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989289560","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019986214,0.97917557,0.000007086054,0.017196009,0.00084905955,0.0017851287,0.000013987301,0.000042538988,0.00073074014],"genre_scores_gemma":[0.000029453111,0.96956295,0.00009336879,0.0065585724,0.0006851957,0.00022786422,0.00002645626,0.00008514119,0.022730991],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977044,0.00030777196,0.000540799,0.0005193271,0.00032115227,0.00060657616],"domain_scores_gemma":[0.9988745,0.00010082397,0.00021946158,0.0002914215,0.000132186,0.00038163154],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006498501,0.00050452945,0.0015428226,0.00019440624,0.0002829792,0.000063211475,0.00027886304,0.00048812272,0.00040515716],"category_scores_gemma":[0.000015617417,0.0003042747,0.00022310959,0.00028664418,0.0011070346,0.00004223935,0.00028609956,0.0018388304,0.000021379854],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011153552,0.000035331435,0.000021013788,0.0018217087,0.00094778085,0.000033511293,0.00052645337,2.0312555e-8,0.000091732276,0.000115144925,0.022935208,0.97336054],"study_design_scores_gemma":[0.0034431235,0.000077171855,0.00005414353,0.0004452726,0.004723917,0.0004918871,0.000043194395,0.000014374566,0.000026470216,0.00006046309,0.9903336,0.00028636583],"about_ca_topic_score_codex":0.000059272526,"about_ca_topic_score_gemma":0.0000151073955,"teacher_disagreement_score":0.9730742,"about_ca_system_score_codex":0.00009781595,"about_ca_system_score_gemma":0.0016801873,"threshold_uncertainty_score":0.99994093},"labels":[],"label_agreement":null},{"id":"W1990867939","doi":"10.1016/s0163-7258(01)00152-8","title":"Pharmacology of adenosine receptors in the vasculature","year":2001,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":187,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Adenosine; Adenosine receptor; Purinergic signalling; Receptor; Adenosine A1 receptor; Internal medicine; Adenosine A3 receptor; Stimulation; Biology; Endocrinology; Pharmacology; Chemistry; Cell biology; Medicine; Agonist","score_opus":0.05805417729074272,"score_gpt":0.38134525874539593,"score_spread":0.32329108145465324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990867939","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00048636406,0.99657214,0.000034550696,0.0003101444,0.0012984782,0.0008432225,0.000027947504,0.000012631912,0.00041453567],"genre_scores_gemma":[0.00053224724,0.99320936,0.00006391463,0.0033488101,0.001859846,0.00016676214,0.0003482373,0.000077955694,0.00039283803],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970971,0.00095433864,0.00073556724,0.00052511547,0.00018908287,0.00049879716],"domain_scores_gemma":[0.99885076,0.00016793625,0.0004486806,0.00038168186,0.00009478367,0.00005616796],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00052048906,0.00053198624,0.0011079786,0.0001873127,0.00007191492,0.000011311814,0.0009996162,0.0008222602,0.00038224884],"category_scores_gemma":[0.000004923411,0.00037297278,0.00053777767,0.00059248373,0.00025782015,0.0000042946954,0.00015812858,0.0008387552,0.000017056029],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037879308,0.0016560658,0.00014879777,0.0059263026,0.008338605,0.00022380735,0.00063417875,0.00020078072,0.011822813,0.00007314145,0.37273303,0.5978637],"study_design_scores_gemma":[0.0007213324,0.00020627063,0.0000023406676,0.00018553346,0.0033685248,0.00016040303,0.00003280562,0.0000052760056,0.0012770848,0.000012267195,0.9936859,0.00034228945],"about_ca_topic_score_codex":0.000008179128,"about_ca_topic_score_gemma":0.0000021379983,"teacher_disagreement_score":0.62095284,"about_ca_system_score_codex":0.000034540928,"about_ca_system_score_gemma":0.00025425822,"threshold_uncertainty_score":0.9998722},"labels":[],"label_agreement":null},{"id":"W1992527377","doi":"10.1016/j.pharmthera.2004.10.005","title":"Emerging role of cyclic ADP-ribose (cADPR) in smooth muscle","year":2004,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Calcium signaling and nucleotide metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institutes of Health; Heart and Stroke Foundation of British Columbia and Yukon; National Institute of General Medical Sciences; Natural Sciences and Engineering Research Council of Canada; Heart and Stroke Foundation of Canada","keywords":"Ryanodine receptor; Cyclic ADP-ribose; Second messenger system; Intracellular; Inositol; Cell biology; Inositol trisphosphate; Cyclic adenosine monophosphate; Inositol trisphosphate receptor; Receptor; Signal transduction; Biology; Chemistry; Biochemistry; CD38","score_opus":0.03067189346650085,"score_gpt":0.35901000196865807,"score_spread":0.3283381085021572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992527377","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005724785,0.9926773,0.00002507528,0.000054247983,0.00075454573,0.00048091184,0.00006395987,0.000021950875,0.00019723245],"genre_scores_gemma":[0.005310821,0.99294823,0.00012447074,0.0004990864,0.0006858027,0.00007691271,0.00015438162,0.00011259294,0.00008768764],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99768287,0.00034212088,0.00075099774,0.0005695814,0.00015088377,0.0005035225],"domain_scores_gemma":[0.9989757,0.000051443494,0.00041973166,0.0003944715,0.000066139284,0.0000925485],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035337848,0.00048622186,0.0011957554,0.00024207616,0.000054743145,0.000010480987,0.000528471,0.0005828924,0.00009165453],"category_scores_gemma":[0.0000069129765,0.00046190896,0.0005232826,0.00031049567,0.00017671457,0.0000036599943,0.00018496743,0.0005283903,0.000023219915],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047553505,0.0003258712,0.000014989938,0.001874326,0.0006506399,0.0000131575025,0.00013324132,0.000072031704,0.16102251,0.000029635972,0.0001330666,0.835683],"study_design_scores_gemma":[0.00078040024,0.0000989923,0.00001837155,0.00060585054,0.0015596341,0.000011791252,0.000022621849,0.000010969027,0.010159246,0.00008092627,0.9862464,0.00040480657],"about_ca_topic_score_codex":0.000036736605,"about_ca_topic_score_gemma":0.000009147406,"teacher_disagreement_score":0.9861133,"about_ca_system_score_codex":0.000055448487,"about_ca_system_score_gemma":0.00036152752,"threshold_uncertainty_score":0.9997833},"labels":[],"label_agreement":null},{"id":"W1994139492","doi":"10.1016/s0163-7258(02)00233-4","title":"Anti-allergic therapies: effects on eosinophil progenitors","year":2002,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Eosinophil; Immunology; Allergic inflammation; Basophil; Medicine; Inflammation; Haematopoiesis; Interleukin 5; Progenitor cell; Cytokine; Immunoglobulin E; Interleukin; Asthma; Stem cell; Biology; Antibody","score_opus":0.07271063841581583,"score_gpt":0.38699497052268644,"score_spread":0.3142843321068706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994139492","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00090807775,0.9929859,0.0000020456116,0.00038494542,0.0021549906,0.002657086,0.00003254158,0.00026681472,0.00060761574],"genre_scores_gemma":[0.00044269633,0.9848657,0.00002458412,0.01048562,0.0025565072,0.000424548,0.00005530482,0.00022472168,0.00092029787],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969136,0.00062249234,0.00064676197,0.00072059577,0.00040133842,0.00069519953],"domain_scores_gemma":[0.9981794,0.0004793799,0.00038712536,0.00051265355,0.000098445795,0.00034300168],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013647227,0.0009325187,0.0024963445,0.00038466702,0.00020465517,0.000025533598,0.0003777626,0.00071985455,0.00072301645],"category_scores_gemma":[0.0000047974468,0.000643114,0.0010696374,0.00042870795,0.0002717806,0.000039196642,0.000065325556,0.0010870602,0.0010133492],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000069157235,0.0009486261,0.000034245728,0.010327397,0.0034896878,0.0005904525,0.00008830783,5.083062e-7,0.00011089843,0.0000055105183,0.003748268,0.98058695],"study_design_scores_gemma":[0.001468151,0.000975044,0.000022989374,0.003152098,0.013550448,0.00014288619,0.000008990692,0.000007387439,0.00022126223,0.000005782628,0.9799128,0.00053211965],"about_ca_topic_score_codex":5.2418784e-7,"about_ca_topic_score_gemma":7.262332e-8,"teacher_disagreement_score":0.9800548,"about_ca_system_score_codex":0.00019644278,"about_ca_system_score_gemma":0.0003921147,"threshold_uncertainty_score":0.9997645},"labels":[],"label_agreement":null},{"id":"W1995430571","doi":"10.1016/j.pharmthera.2006.05.011","title":"Aspirin resistance: Truth or dare","year":2006,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Aspirin; Medicine; Resistance (ecology); Intensive care medicine; Disease; Population; Internal medicine; Biology; Environmental health","score_opus":0.11914217465125228,"score_gpt":0.4287936914252627,"score_spread":0.3096515167740104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995430571","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000028516917,0.9938517,0.00006112854,0.0001263152,0.0011549649,0.0013670705,0.0001597049,0.00023079908,0.0030197685],"genre_scores_gemma":[0.000024858067,0.9850032,0.00013260514,0.003116674,0.0014916968,0.00023005749,0.0005309792,0.00018722579,0.009282723],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971123,0.00047358245,0.0007249029,0.00067449006,0.00039676824,0.0006179982],"domain_scores_gemma":[0.9984771,0.00029115772,0.00031185866,0.0006058389,0.00011792244,0.00019614658],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00028302366,0.0007304037,0.002730464,0.00022412997,0.00016313084,0.00002731598,0.00035906734,0.0006408476,0.0011041785],"category_scores_gemma":[0.000003899969,0.00050930487,0.001790051,0.00047594018,0.0002713773,0.000049654773,0.00006587626,0.000852914,0.00024047167],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065390795,0.00039543436,0.0000061910055,0.014500836,0.010656029,0.0011766576,0.000021817019,6.4014495e-7,0.0000090782305,0.00003941729,0.010540957,0.96199906],"study_design_scores_gemma":[0.0020943917,0.0001458464,0.000008046614,0.0024939666,0.03820064,0.00036318268,0.000011425413,0.0000015439848,0.000030757492,0.000028234816,0.9561348,0.00048719507],"about_ca_topic_score_codex":0.0000016503668,"about_ca_topic_score_gemma":0.0000022416782,"teacher_disagreement_score":0.96151185,"about_ca_system_score_codex":0.00020438123,"about_ca_system_score_gemma":0.0009386629,"threshold_uncertainty_score":0.99980897},"labels":[],"label_agreement":null},{"id":"W1996151753","doi":"10.1016/j.pharmthera.2005.03.008","title":"The role of Rho GTPases and SNAREs in mediator release from granulocytes","year":2005,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Cellular transport and secretion","field":"Biochemistry, Genetics and Molecular Biology","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Cell biology; GTPase; Exocytosis; Biology; Mediator; Receptor; Inflammation; Intracellular; Signal transduction; Chemistry; Immunology; Biochemistry; Secretion","score_opus":0.02159008645620483,"score_gpt":0.3160386748147415,"score_spread":0.2944485883585367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996151753","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012790562,0.9864232,0.000011565007,0.00006232976,0.0001964625,0.0003509369,0.00011922621,0.0000066601015,0.000039079972],"genre_scores_gemma":[0.006162465,0.99159294,0.000029585477,0.00018655673,0.00038415595,0.00006191622,0.0015106759,0.000035913767,0.000035759775],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987423,0.00019920012,0.0004297021,0.00030906886,0.0000918547,0.00022789075],"domain_scores_gemma":[0.9993509,0.00013649672,0.00020889554,0.00021092047,0.000036615096,0.000056162895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015644578,0.00027068754,0.0005412064,0.000053953365,0.00006514281,0.000009581036,0.0002596373,0.00035569957,0.00004362719],"category_scores_gemma":[0.000003743519,0.00019668789,0.00018489451,0.00007593035,0.00024060805,0.0000024677483,0.000052714287,0.00024556913,0.0000030628564],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013987596,0.00010899929,0.00040295182,0.0003024973,0.0006334037,0.000006595767,0.0000912356,0.0000015561337,0.045934964,0.000014319653,0.00004423706,0.9523194],"study_design_scores_gemma":[0.00037767834,0.00007003295,0.000025952237,0.00012429731,0.0011581677,0.000004316172,0.000035829064,0.000021226817,0.009224226,0.00005699968,0.9887157,0.000185544],"about_ca_topic_score_codex":0.00003122094,"about_ca_topic_score_gemma":0.0001293434,"teacher_disagreement_score":0.9886715,"about_ca_system_score_codex":0.000015116082,"about_ca_system_score_gemma":0.00013455031,"threshold_uncertainty_score":0.80206996},"labels":[],"label_agreement":null},{"id":"W1999142637","doi":"10.1016/s0163-7258(02)00197-3","title":"Protein kinase inhibitors and antibiotic resistance","year":2002,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"RNA and protein synthesis mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Aminoglycoside; Kinase; Biochemistry; Kinome; Enzyme; Biology; Antibiotics; Binding site; Ribosome; Chemistry; Microbiology; RNA","score_opus":0.045188724426326175,"score_gpt":0.32792874014464307,"score_spread":0.2827400157183169,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999142637","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00030093425,0.9971269,0.000052233994,0.0001408611,0.00047785966,0.0013466773,0.000045531713,0.000032588578,0.0004764278],"genre_scores_gemma":[0.00033490648,0.9936437,0.00052474305,0.0007099805,0.00064887304,0.00015603282,0.00005095886,0.000115933944,0.0038148894],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99772996,0.000488919,0.00046870392,0.0007155437,0.00013885587,0.0004580434],"domain_scores_gemma":[0.9990463,0.000041006104,0.0003292841,0.0004038719,0.000052458778,0.00012707131],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002675053,0.00056014094,0.00088212115,0.000103620296,0.0001521424,0.000036380225,0.0003699629,0.00072042196,0.00008007725],"category_scores_gemma":[0.0000072659923,0.00049043074,0.00027225955,0.0001454059,0.00021142325,0.000003884257,0.00016596387,0.0003327255,0.000053921627],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043417836,0.00013067854,0.0000011888833,0.003976813,0.0008767465,0.000038251022,0.000021775073,1.1184023e-7,0.11917806,0.00005014893,0.0018775779,0.8738052],"study_design_scores_gemma":[0.00027285886,0.00014389318,1.9405088e-7,0.00093050767,0.0013073046,0.000030130152,0.000003968513,0.0000011009759,0.05376837,0.00003768432,0.9430268,0.0004772347],"about_ca_topic_score_codex":0.0000011043288,"about_ca_topic_score_gemma":0.0000026097314,"teacher_disagreement_score":0.9411492,"about_ca_system_score_codex":0.000030337435,"about_ca_system_score_gemma":0.0001091934,"threshold_uncertainty_score":0.9997547},"labels":[],"label_agreement":null},{"id":"W1999877293","doi":"10.1016/j.pharmthera.2013.04.008","title":"The Lambeth Conventions (II): Guidelines for the study of animal and human ventricular and supraventricular arrhythmias","year":2013,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Cardiac electrophysiology and arrhythmias","field":"Medicine","cited_by":288,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Supraventricular arrhythmia; Bridge (graph theory); Myocardial infarction; Cardiology; Internal medicine; Atrial fibrillation","score_opus":0.1333543715164267,"score_gpt":0.44262902718197017,"score_spread":0.30927465566554346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999877293","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.030189103,0.9625528,0.000016144673,0.0017728243,0.00032812613,0.0050842175,0.000025045072,0.000023816947,0.000007919034],"genre_scores_gemma":[0.0051559038,0.99205095,0.00003654276,0.0006854425,0.00081447064,0.00089625537,0.000031319534,0.0000496489,0.00027948344],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978987,0.0004204108,0.0007537044,0.00038494042,0.00015954945,0.00038267125],"domain_scores_gemma":[0.9976058,0.0011217804,0.00045560268,0.00034723207,0.0003926851,0.00007687929],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060562877,0.00039323524,0.0013415611,0.00009654612,0.0009247862,0.000020737642,0.00016750803,0.00025541373,0.000026991678],"category_scores_gemma":[0.000025738496,0.00020106789,0.00044029686,0.00020680993,0.00047196224,0.000027072852,0.0001731218,0.00056438934,0.000002743409],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062564167,0.0013345758,0.000103187725,0.005541028,0.03425147,0.00043120564,0.0006204821,0.0000065432923,0.0017007529,0.0015524771,0.011876315,0.94195634],"study_design_scores_gemma":[0.0018467453,0.0022291108,0.0000838657,0.0002291374,0.024859363,0.0008410412,0.00018613387,0.00006562949,0.00005890321,0.00008708827,0.96932054,0.00019244716],"about_ca_topic_score_codex":0.000012770257,"about_ca_topic_score_gemma":0.000002856574,"teacher_disagreement_score":0.9574442,"about_ca_system_score_codex":0.000033893037,"about_ca_system_score_gemma":0.00012955967,"threshold_uncertainty_score":0.8199311},"labels":[],"label_agreement":null},{"id":"W2002684710","doi":"10.1016/j.pharmthera.2014.12.005","title":"Virus-induced modulation of lower airway diseases: Pathogenesis and pharmacologic approaches to treatment","year":2014,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Respiratory viral infections research","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Institute of Allergy and Infectious Diseases; Canadian Institutes of Health Research; National Institutes of Health; Canadian HIV Trials Network, Canadian Institutes of Health Research; GlaxoSmithKline","keywords":"Medicine; Asthma; COPD; Airway; Respiratory tract infections; Immunology; Rhinovirus; Cystic fibrosis; Virus; Respiratory system; Intensive care medicine; Respiratory tract; Internal medicine","score_opus":0.37682763093767613,"score_gpt":0.46271005544539945,"score_spread":0.08588242450772332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002684710","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022784501,0.9717795,0.00012802478,0.00021667067,0.000546576,0.004178703,0.00012245242,0.00009187476,0.00015167645],"genre_scores_gemma":[0.018815603,0.97784173,0.00011285722,0.0011831175,0.00049307133,0.0011555529,0.00006552127,0.00010634161,0.00022618848],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99693304,0.0008835458,0.00075899146,0.00067895115,0.00028547153,0.00046000976],"domain_scores_gemma":[0.9984155,0.00036627465,0.0003265643,0.00041238224,0.0001250432,0.0003542258],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033314156,0.0005916538,0.002044269,0.0005966853,0.0001295447,0.000019590641,0.00019557762,0.00041363624,0.00028350652],"category_scores_gemma":[0.000011299277,0.0004328093,0.00046340376,0.00056318444,0.00023402616,0.00005781933,0.00012095485,0.00036282963,0.00009181535],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030083867,0.0011523024,0.000080197846,0.0035929084,0.0023522263,0.000032214062,0.000053691474,0.000019640253,0.026598494,0.0000113699625,0.000098215874,0.9657079],"study_design_scores_gemma":[0.001573192,0.0036355597,0.00014694806,0.00040309617,0.014335192,0.00004600536,0.000007234705,0.00044341933,0.002723613,0.000009214028,0.9762821,0.0003944194],"about_ca_topic_score_codex":0.000008997741,"about_ca_topic_score_gemma":0.0000019851877,"teacher_disagreement_score":0.9761839,"about_ca_system_score_codex":0.00045605446,"about_ca_system_score_gemma":0.00043287955,"threshold_uncertainty_score":0.99981236},"labels":[],"label_agreement":null},{"id":"W2003055862","doi":"10.1016/s0163-7258(02)00235-8","title":"Function of the endothelinB receptor in cardiovascular physiology and pathophysiology","year":2002,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Nitric Oxide and Endothelin Effects","field":"Medicine","cited_by":144,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Receptor; Endothelin receptor; Prostacyclin; Receptor tyrosine kinase; Biology; Pharmacology; Endocrinology; Endothelium; Internal medicine; Cell biology; Medicine","score_opus":0.05227335557625507,"score_gpt":0.325937846604017,"score_spread":0.2736644910277619,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003055862","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026856663,0.9944401,0.000005697589,0.00009347588,0.0013063377,0.0012993892,0.00002779559,0.000026797095,0.000114779185],"genre_scores_gemma":[0.0011566634,0.9960575,0.000042216252,0.0018049146,0.0004983154,0.00016483225,0.00001756588,0.0000645669,0.00019340712],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973933,0.0010472471,0.0005784343,0.00046242884,0.00014916778,0.00036941466],"domain_scores_gemma":[0.9986226,0.00048554328,0.00028827717,0.00048394554,0.000060517126,0.000059136593],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003328486,0.00040309268,0.0023660352,0.00021362749,0.00004887652,0.0000023338648,0.00020309184,0.00054816087,0.00021679327],"category_scores_gemma":[0.000011639483,0.00025314564,0.00084980024,0.00040066487,0.00032495585,0.000021907497,0.00011558326,0.00087747554,0.000047142574],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014199212,0.00024274341,0.000040707375,0.0071580987,0.0036987418,0.000014381138,0.00007665448,0.000004703885,0.01390582,0.000011460328,0.0002467395,0.974458],"study_design_scores_gemma":[0.0016441663,0.00029293596,0.00010783926,0.0008330099,0.011236443,0.00007400555,0.000008456419,0.000026721716,0.00040689195,0.000087746776,0.98507804,0.00020377201],"about_ca_topic_score_codex":0.000008244194,"about_ca_topic_score_gemma":5.177064e-7,"teacher_disagreement_score":0.9848313,"about_ca_system_score_codex":0.00008349079,"about_ca_system_score_gemma":0.00012974042,"threshold_uncertainty_score":0.9999921},"labels":[],"label_agreement":null},{"id":"W2003471223","doi":"10.1016/j.pharmthera.2011.07.002","title":"Sensing sterile injury: Opportunities for pharmacological control","year":2011,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Immune Response and Inflammation","field":"Immunology and Microbiology","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity; University of Calgary","funders":"","keywords":"Pathogenesis; Rheumatoid arthritis; Inflammation; Medicine; Fibrosis; Immunology; Necrosis; Inflammatory response; Liver injury; Pathology; Pharmacology","score_opus":0.23553267566433983,"score_gpt":0.396913975964576,"score_spread":0.16138130030023617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003471223","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008007635,0.9905823,0.00059460977,0.0002464502,0.0050986605,0.002425634,0.00029319077,0.00022327402,0.00045583188],"genre_scores_gemma":[0.00019999556,0.9917097,0.00006927812,0.0035718542,0.00036131163,0.00042118432,0.00051861623,0.00011323062,0.0030348485],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99585974,0.0017059707,0.0010254711,0.0005270265,0.000037979586,0.0008437834],"domain_scores_gemma":[0.99774414,0.0009959609,0.00074221904,0.0002778521,0.00019332032,0.000046488043],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00072606903,0.0007424059,0.0020472638,0.0003345406,0.00038084967,0.000026831915,0.00052989466,0.0012527055,0.001599277],"category_scores_gemma":[0.000008873148,0.0006049765,0.0007502189,0.00012624718,0.00048861577,0.000121253455,0.000116670104,0.0008911681,0.00048277085],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010877762,0.00014082,1.5542459e-7,0.0011294273,0.006038679,0.000015374624,0.00013258362,1.4081624e-7,0.014508847,0.00012665856,0.010563351,0.9662562],"study_design_scores_gemma":[0.0019005843,0.0005002164,2.3326263e-7,0.00033956455,0.01411659,0.00015227047,0.000054191336,0.000009377572,0.005859939,0.000045156437,0.976434,0.00058790634],"about_ca_topic_score_codex":0.0000032720034,"about_ca_topic_score_gemma":3.9240578e-7,"teacher_disagreement_score":0.9658706,"about_ca_system_score_codex":0.00013592755,"about_ca_system_score_gemma":0.00047992528,"threshold_uncertainty_score":0.99964017},"labels":[],"label_agreement":null},{"id":"W2008427683","doi":"10.1016/j.pharmthera.2012.05.009","title":"Targeting the glucagon receptor family for diabetes and obesity therapy","year":2012,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":142,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Endocrinology; Internal medicine; Glucagon; Receptor; Glucagon receptor; Insulin; Glucagon-like peptide-1; Diabetes mellitus; Medicine; Gastric inhibitory polypeptide; Type 2 diabetes","score_opus":0.11326458060631459,"score_gpt":0.3808651345988934,"score_spread":0.26760055399257876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008427683","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015254891,0.99177086,0.000020565269,0.0007686768,0.0013567733,0.004242774,0.00004151032,0.00009394947,0.00017940589],"genre_scores_gemma":[0.00012009576,0.9874002,0.0003202835,0.008806542,0.0010796784,0.0011567462,0.00023749213,0.00010369788,0.0007752605],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981792,0.00023387844,0.00041138433,0.0003855142,0.0001424155,0.00064763613],"domain_scores_gemma":[0.99868375,0.00058587966,0.00028499248,0.00025636406,0.00007066899,0.00011831524],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005830089,0.00052603695,0.0012836964,0.00010453741,0.00023435343,0.000032066986,0.00022478313,0.00026300034,0.000112922724],"category_scores_gemma":[0.0000029162343,0.00030431073,0.0003780837,0.00014796811,0.0001852626,0.000058102694,0.00010299642,0.00036535732,0.00005145373],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004209888,0.00039084605,0.0001884126,0.0035374332,0.0056397542,9.899213e-7,0.00014301148,6.066187e-8,0.00042997373,0.000045398156,0.0049339645,0.98464805],"study_design_scores_gemma":[0.0013032163,0.0003266426,0.00002401318,0.0003452282,0.017532194,0.0000011814925,0.000025935673,0.000016799022,0.00017445318,0.000028191904,0.97995496,0.00026716554],"about_ca_topic_score_codex":8.9435974e-7,"about_ca_topic_score_gemma":1.17505365e-7,"teacher_disagreement_score":0.9843809,"about_ca_system_score_codex":0.00010898061,"about_ca_system_score_gemma":0.00008495054,"threshold_uncertainty_score":0.9999409},"labels":[],"label_agreement":null},{"id":"W2008915773","doi":"10.1016/j.pharmthera.2004.11.006","title":"Modulation of apoptosis by nitric oxide: implications in myocardial ischemia and heart failure","year":2005,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Nitric Oxide and Endothelin Effects","field":"Medicine","cited_by":184,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Lawson Health Research Institute; London Health Sciences Centre","funders":"","keywords":"Nitric oxide; Apoptosis; Enos; Heart failure; Ischemia; Nitric oxide synthase; Regulator; Internal medicine; Pharmacology; Medicine; Cell biology; Cardiology; Biology; Biochemistry","score_opus":0.04718584277468236,"score_gpt":0.3836316956810957,"score_spread":0.3364458529064133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008915773","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019106463,0.97846514,0.00003761562,0.0008866297,0.00008925364,0.0012147643,0.00006992758,0.000038277678,0.00009193067],"genre_scores_gemma":[0.011168441,0.9859722,0.0005549651,0.0015547392,0.0002721981,0.00020242679,0.00013586943,0.00005868987,0.00008045764],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984415,0.0002021958,0.00058525207,0.00034420352,0.00013113796,0.00029569183],"domain_scores_gemma":[0.9989324,0.00041901149,0.00024364071,0.00023518127,0.00006871102,0.000101029655],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024270524,0.0003265499,0.0013837102,0.00032819388,0.000038312035,0.0000060834554,0.00011178751,0.00045407462,0.000050397844],"category_scores_gemma":[0.000007994408,0.00028685603,0.0002467309,0.0005471245,0.00010546102,0.000049726696,0.00004584128,0.0005855206,0.000019724923],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055786826,0.00039372538,0.0008943941,0.003441091,0.0013722093,0.0000016192399,0.00004490196,0.0000038123069,0.07834921,0.000018104887,0.010073587,0.9053516],"study_design_scores_gemma":[0.0012531388,0.000060759172,0.00036613518,0.00042739318,0.00501442,0.000057477657,0.00000552427,0.000048160986,0.0016260465,0.000015498974,0.99090916,0.00021628983],"about_ca_topic_score_codex":0.0000115962675,"about_ca_topic_score_gemma":6.4826594e-7,"teacher_disagreement_score":0.98083556,"about_ca_system_score_codex":0.00013459822,"about_ca_system_score_gemma":0.0001932384,"threshold_uncertainty_score":0.99995834},"labels":[],"label_agreement":null},{"id":"W2010304921","doi":"10.1016/s0163-7258(02)00183-3","title":"Cyclin-dependent kinases as potential targets to improve stroke outcome","year":2002,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Canadian Stroke Network","keywords":"Cyclin-dependent kinase; Neuroprotection; Kinase; Cyclin; Cell cycle progression; Stroke (engine); Neuroscience; Cell cycle; Cyclin-dependent kinase 5; Cell biology; Biology; Cancer research; Medicine; Cyclin-dependent kinase 2; Apoptosis; Protein kinase A; Biochemistry; Engineering","score_opus":0.07432070612785109,"score_gpt":0.4064105527928755,"score_spread":0.33208984666502445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010304921","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012747095,0.98614395,0.00027246916,0.0009378571,0.0070002573,0.0037015441,0.00037481976,0.0002599072,0.0011817293],"genre_scores_gemma":[0.00040498932,0.9783452,0.0002781939,0.012288187,0.0016231869,0.00048554328,0.00014529262,0.00030813893,0.006121278],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955295,0.0003574085,0.0013110642,0.0011071834,0.0006422126,0.0010526783],"domain_scores_gemma":[0.9977475,0.00015370523,0.0005571278,0.00076946506,0.0002020718,0.0005701705],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00029671277,0.0010228575,0.0028039233,0.00054825784,0.00014798863,0.000038293194,0.00057919684,0.0010167885,0.0023283311],"category_scores_gemma":[0.000019807945,0.00090865494,0.0012459233,0.00035668426,0.00015291368,0.000047117588,0.00030103282,0.0020317687,0.0025866763],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023204993,0.0007771646,0.0000057428842,0.0036658535,0.0060437676,0.001919627,0.000086458145,0.000018375995,0.010892619,0.000011013293,0.002881238,0.9734661],"study_design_scores_gemma":[0.0022887222,0.0008691916,0.0000021087517,0.00064604124,0.0255932,0.000728939,0.000010811764,0.000038551978,0.0021975967,0.000008981622,0.9669151,0.0007007659],"about_ca_topic_score_codex":0.000022542456,"about_ca_topic_score_gemma":0.0000037919308,"teacher_disagreement_score":0.9727653,"about_ca_system_score_codex":0.0008053099,"about_ca_system_score_gemma":0.00058109744,"threshold_uncertainty_score":0.9993364},"labels":[],"label_agreement":null},{"id":"W2013655951","doi":"10.1016/j.pharmthera.2009.12.006","title":"Role of apoptosis in pulmonary hypertension: From experimental models to clinical trials","year":2010,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":126,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital; University of Toronto; St. Michael's Hospital","funders":"","keywords":"BMPR2; Medicine; Lung; Pulmonary hypertension; Endothelial dysfunction; Apoptosis; Pathology; Cancer research; Endothelium; Internal medicine; Biology; Bone morphogenetic protein","score_opus":0.42030613123000643,"score_gpt":0.5270407692677532,"score_spread":0.1067346380377468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013655951","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016296469,0.97889316,0.0000023892428,0.00037894296,0.0009758255,0.002883526,0.00023111535,0.000039571638,0.00029897294],"genre_scores_gemma":[0.010061413,0.98463553,0.0006286279,0.0030791084,0.0006328577,0.00045910152,0.00028218422,0.00010192269,0.00011926332],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9940609,0.0019408548,0.0021483628,0.0008201741,0.00045669504,0.0005730139],"domain_scores_gemma":[0.9960049,0.0021822937,0.0004923763,0.00060088444,0.00016162274,0.00055794406],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015017787,0.000590605,0.005252997,0.0004716407,0.000054065993,0.00000892877,0.00041068773,0.0009838812,0.0005634938],"category_scores_gemma":[0.000046333906,0.0004185546,0.0011652326,0.00038831885,0.00020977802,0.00006859741,0.00026213506,0.0015021833,0.00015412271],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013731561,0.00605987,0.000121026904,0.00036816308,0.0029104247,0.0008389292,0.00004508239,9.288799e-7,0.02371053,0.000003880215,0.00040458675,0.9641634],"study_design_scores_gemma":[0.003484239,0.00093643094,0.000055659373,0.0017868971,0.008905659,0.00025671916,0.00009105139,0.0007066227,0.00415212,0.00014733085,0.9790419,0.00043539246],"about_ca_topic_score_codex":0.00008917881,"about_ca_topic_score_gemma":0.0000023061457,"teacher_disagreement_score":0.9786373,"about_ca_system_score_codex":0.000119396995,"about_ca_system_score_gemma":0.0006409865,"threshold_uncertainty_score":0.9998266},"labels":[],"label_agreement":null},{"id":"W2014031830","doi":"10.1016/j.pharmthera.2010.04.012","title":"A survey of yeast genomic assays for drug and target discovery","year":2010,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Fungal and yeast genetics research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":135,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto","funders":"National Human Genome Research Institute","keywords":"Drug discovery; Computational biology; Saccharomyces cerevisiae; Yeast; Model organism; Biology; Drug; Drug action; Mechanism (biology); Organism; Mechanism of action; Chemical genetics; Drug development; Drug target; Small molecule; Gene; Genetics; Bioinformatics; Pharmacology; In vitro","score_opus":0.07308881779659836,"score_gpt":0.3957121651428354,"score_spread":0.32262334734623704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014031830","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004230367,0.99224985,0.00020127575,0.00003316661,0.0005855296,0.000917025,0.0017200494,0.0000053386675,0.000057386846],"genre_scores_gemma":[0.0018930888,0.9950353,0.00035165902,0.0002151719,0.00037163572,0.0001572105,0.0009154091,0.000085271095,0.00097524445],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982345,0.00036702544,0.00040962882,0.0004873496,0.00011270552,0.0003888063],"domain_scores_gemma":[0.9990253,0.00016092011,0.00024127576,0.0002973851,0.0001766279,0.00009849208],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00065551535,0.00035003145,0.0008212069,0.00009026617,0.00007243656,0.000025642265,0.00044571795,0.00046973495,0.000021627799],"category_scores_gemma":[0.000012628478,0.0002940801,0.00024791717,0.000098450284,0.00029372596,0.000002915263,0.00028842565,0.00040563144,0.000005662909],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003567894,0.00036717064,0.00041522176,0.0063865185,0.0027203949,0.00000346544,0.00006317118,0.0000049313608,0.4482177,0.000015234562,0.0034727633,0.5379766],"study_design_scores_gemma":[0.00047906095,0.00018464813,0.000115147865,0.00007963677,0.0007624229,0.000013058806,0.0000028977927,0.000035191966,0.012389806,0.000018178456,0.9856223,0.00029763533],"about_ca_topic_score_codex":0.000018333621,"about_ca_topic_score_gemma":0.000040894738,"teacher_disagreement_score":0.98214954,"about_ca_system_score_codex":0.000014961093,"about_ca_system_score_gemma":0.00049612205,"threshold_uncertainty_score":0.9999511},"labels":[],"label_agreement":null},{"id":"W2014142027","doi":"10.1016/s0163-7258(02)00192-4","title":"Integrin-linked kinase, a promising cancer therapeutic target: biochemical and biological properties","year":2002,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Integrin-linked kinase; Cancer research; Protein kinase B; GSK-3; Integrin; Cell biology; Biology; Kinase; GSK3B; Carcinogenesis; Signal transduction; Chemistry; Cell; Protein kinase A; Cancer; Cyclin-dependent kinase 2; Biochemistry","score_opus":0.247982091960001,"score_gpt":0.4333687968003416,"score_spread":0.18538670484034062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014142027","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021552232,0.9930573,0.000017718381,0.0011782452,0.0003767811,0.0028309433,0.000027353184,0.00015865972,0.00019778633],"genre_scores_gemma":[0.001116082,0.9928695,0.00029689478,0.003005579,0.00055693823,0.00075909286,0.00005159561,0.00015989684,0.001184412],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962765,0.0006411988,0.0008049288,0.0009800019,0.00039500298,0.00090239244],"domain_scores_gemma":[0.9984844,0.00030160462,0.00026686702,0.00039152327,0.00020701828,0.00034862797],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003372264,0.00082713465,0.0022487044,0.00035744044,0.00016466538,0.000052475003,0.00042384432,0.0010019152,0.0016228212],"category_scores_gemma":[0.000018808294,0.00052618294,0.00046994674,0.00048626252,0.0009223159,0.000039056773,0.00024800457,0.0022212388,0.00012908108],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027539986,0.0006297574,0.000060637925,0.00814569,0.0026964291,0.00018922462,0.00018917247,1.9154552e-7,0.0747757,0.000007697869,0.0009188051,0.9121113],"study_design_scores_gemma":[0.001210719,0.00041512446,0.000013065223,0.002532699,0.0043962067,0.00032320438,0.00002167623,0.00023433295,0.004850341,0.000020490255,0.9854385,0.00054360175],"about_ca_topic_score_codex":0.000009862258,"about_ca_topic_score_gemma":4.100855e-7,"teacher_disagreement_score":0.9845197,"about_ca_system_score_codex":0.0003857301,"about_ca_system_score_gemma":0.00052773504,"threshold_uncertainty_score":0.99971896},"labels":[],"label_agreement":null},{"id":"W2022413279","doi":"10.1016/j.pharmthera.2013.07.001","title":"Targeted therapy of bronchitis in obstructive airway diseases","year":2013,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University","funders":"","keywords":"Sputum; Medicine; Bronchitis; Immunology; Chronic bronchitis; Eosinophilia; Eosinophilic; Asthma; Airway; Disease; COPD; Internal medicine; Pathology; Tuberculosis; Surgery","score_opus":0.06302447195237046,"score_gpt":0.38790834750670194,"score_spread":0.3248838755543315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022413279","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0029306423,0.99374366,0.0000040896316,0.00007908884,0.0006504893,0.0021232709,0.00021807881,0.00006169814,0.0001889754],"genre_scores_gemma":[0.0009048986,0.99621415,0.00005764618,0.0015910333,0.00039311775,0.00038851774,0.00014131382,0.00010680324,0.00020249898],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975207,0.00048598525,0.00081969553,0.00046733642,0.00024827023,0.00045801065],"domain_scores_gemma":[0.998508,0.00030256817,0.0004885595,0.00033261516,0.00014319974,0.00022506496],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00007295426,0.000570993,0.0023080783,0.0003902572,0.000048383066,0.00000768146,0.0002889365,0.0004181854,0.0017109441],"category_scores_gemma":[0.0000060761286,0.00041017326,0.0006813532,0.0004357855,0.00044609513,0.000064097876,0.00006471074,0.0006010011,0.000079503625],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013287728,0.00071358134,0.00060661376,0.0030783277,0.0013120659,0.00008275616,0.000095602816,0.0000010414528,0.00020301012,0.0000062612976,0.0006151139,0.99315274],"study_design_scores_gemma":[0.0018872084,0.00038220253,0.0011782612,0.0013778791,0.0033242593,0.000033668144,0.000041791038,0.0000073130077,0.00023698353,0.00002737877,0.99115705,0.00034600042],"about_ca_topic_score_codex":0.000011265677,"about_ca_topic_score_gemma":9.4312753e-7,"teacher_disagreement_score":0.99280673,"about_ca_system_score_codex":0.00014950527,"about_ca_system_score_gemma":0.000851611,"threshold_uncertainty_score":0.999835},"labels":[],"label_agreement":null},{"id":"W2025139420","doi":"10.1016/j.pharmthera.2009.04.001","title":"Pharmacological profiles of alpha 2 adrenergic receptor agonists identified using genetically altered mice and isobolographic analysis","year":2009,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Receptor Mechanisms and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":107,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Institute on Drug Abuse","keywords":"Alpha-2 adrenergic receptor; Alpha (finance); Pharmacology; Agonist; Adrenergic receptor; Receptor; β2 adrenergic receptor; Alpha-1B adrenergic receptor; Alpha-1A adrenergic receptor; Adrenergic; Biology; Chemistry; Endocrinology; Medicine; Beta-3 adrenergic receptor; Genetics","score_opus":0.06747052672864942,"score_gpt":0.3774997249217617,"score_spread":0.31002919819311225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025139420","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.036823645,0.9602215,0.0011392966,0.000029689454,0.0007318398,0.0008536809,0.00014336847,0.000028850289,0.000028092129],"genre_scores_gemma":[0.007693316,0.98730975,0.0029183174,0.000708436,0.0006268254,0.00007974203,0.0005092445,0.00007601486,0.000078352525],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960953,0.00087789516,0.0011058055,0.001052885,0.0002399514,0.0006281517],"domain_scores_gemma":[0.9983321,0.000097206714,0.00082539825,0.00033413016,0.00020608696,0.00020510012],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00050758093,0.00074532465,0.0020438202,0.00045891732,0.0001721488,0.00004547483,0.00063403434,0.00097639865,0.00043506303],"category_scores_gemma":[0.000006773996,0.000643383,0.0010163797,0.00074675045,0.0004026215,0.000007122517,0.0002406759,0.00048391847,0.000004698004],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012992312,0.0002827249,0.000019636032,0.00081300654,0.012454312,0.000009056283,0.000024770854,0.00006652898,0.8338554,0.000022295417,0.00018651389,0.15213582],"study_design_scores_gemma":[0.001383769,0.0009536429,0.000017694998,0.0003682257,0.07389789,0.000086125634,0.00002404617,0.00082824065,0.20775141,0.000066784676,0.7132139,0.0014082434],"about_ca_topic_score_codex":0.000006537226,"about_ca_topic_score_gemma":0.0000022374911,"teacher_disagreement_score":0.7130274,"about_ca_system_score_codex":0.00003566547,"about_ca_system_score_gemma":0.00024276553,"threshold_uncertainty_score":0.9996017},"labels":[],"label_agreement":null},{"id":"W2027033448","doi":"10.1016/j.pharmthera.2011.04.001","title":"Cellular and cytokine-based inflammatory processes as novel therapeutic targets for the prevention and treatment of atherosclerosis","year":2011,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Atherosclerosis and Cardiovascular Diseases","field":"Immunology and Microbiology","cited_by":72,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"McGill University","keywords":"Immune system; Inflammation; Medicine; Immunology; Cytokine; Disease; Lipoprotein; Pathology; Cholesterol; Internal medicine","score_opus":0.08797275758905344,"score_gpt":0.32627156771113447,"score_spread":0.23829881012208104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027033448","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011432485,0.9945598,0.00085997145,0.000034147793,0.00044361677,0.0026477834,0.00025158867,0.000047687117,0.000012108628],"genre_scores_gemma":[0.0064763282,0.9913566,0.000040940726,0.0002491426,0.000086634114,0.0013904193,0.00013276699,0.00009518947,0.00017197602],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981044,0.00036689156,0.00055767404,0.00052653294,0.000050932544,0.0003935745],"domain_scores_gemma":[0.9982146,0.00071273296,0.00053520064,0.0003575621,0.00014052038,0.000039380713],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002766253,0.00060261285,0.0013784271,0.000102805294,0.00030077522,0.000019556393,0.00028543122,0.00051947683,0.00010969771],"category_scores_gemma":[0.00000542085,0.00038045255,0.0006867918,0.00012612974,0.0006958745,0.000049003855,0.00005817513,0.00018322626,0.000010827118],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027532494,0.0011634855,0.00008002439,0.005241445,0.016190296,6.019642e-7,0.0006071604,0.0000017470269,0.032986738,0.00013400175,0.00006131637,0.94325787],"study_design_scores_gemma":[0.0026594494,0.0008567171,0.00006372302,0.00053291075,0.024674797,0.000014206801,0.00006230957,0.0000043050145,0.014126168,0.000040091927,0.95660096,0.00036434946],"about_ca_topic_score_codex":0.000010200957,"about_ca_topic_score_gemma":0.0000042160514,"teacher_disagreement_score":0.95653963,"about_ca_system_score_codex":0.000056665194,"about_ca_system_score_gemma":0.00041804454,"threshold_uncertainty_score":0.99986476},"labels":[],"label_agreement":null},{"id":"W2035090144","doi":"10.1016/j.pharmthera.2009.11.003","title":"Pharmacological strategies for improving the efficacy and therapeutic ratio of glucocorticoids in inflammatory lung diseases","year":2009,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Canadian Institutes of Health Research","keywords":"Transrepression; Transactivation; Glucocorticoid receptor; Glucocorticoid; Medicine; Asthma; COPD; Adverse effect; Pharmacology; Context (archaeology); Agonist; Bioinformatics; Transcription factor; Immunology; Receptor; Biology; Internal medicine; Gene","score_opus":0.05416291853502528,"score_gpt":0.3957997038277874,"score_spread":0.3416367852927621,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035090144","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0073261736,0.9875721,0.000086877226,0.00019802227,0.0003724354,0.0042992304,0.00005423267,0.00006614864,0.000024797462],"genre_scores_gemma":[0.028542962,0.9670605,0.000024837449,0.0029600647,0.0006418559,0.00063084916,0.00003616136,0.00006880433,0.00003396638],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997326,0.00049134577,0.0009731461,0.00048983574,0.0002155579,0.00050409505],"domain_scores_gemma":[0.9977345,0.0011952606,0.0005328628,0.0002526679,0.000116775715,0.000167967],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029292196,0.0005697624,0.0016416784,0.00022967056,0.00015303137,0.00004147802,0.00030572116,0.00036061797,0.000056444784],"category_scores_gemma":[0.000011964393,0.0003414949,0.00045062913,0.00025924365,0.0006147998,0.000072787145,0.000076910954,0.0006223496,0.000002210171],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006028694,0.0007027348,0.00024853882,0.00870972,0.0010923016,0.000054316326,0.00016554767,0.000010431659,0.0018766553,0.00011230354,0.00009562809,0.98632896],"study_design_scores_gemma":[0.006952451,0.0013086422,0.0019034032,0.0015035213,0.044435564,0.00007697591,0.00024780817,0.0010560673,0.00017593894,0.00015525226,0.9414966,0.0006877554],"about_ca_topic_score_codex":0.0000014176759,"about_ca_topic_score_gemma":8.3914654e-7,"teacher_disagreement_score":0.9856412,"about_ca_system_score_codex":0.00011223139,"about_ca_system_score_gemma":0.001369467,"threshold_uncertainty_score":0.9999037},"labels":[],"label_agreement":null},{"id":"W2035978580","doi":"10.1016/j.pharmthera.2009.07.002","title":"The role of pulmonary veins in atrial fibrillation: A complex yet simple story","year":2009,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"Heart and Stroke Foundation of Canada","keywords":"Atrial fibrillation; Medicine; Cardiology; Internal medicine; Radiofrequency ablation; Population; Heart failure; Atrial action potential; Catheter ablation; Ablation; Electrophysiology; Repolarization","score_opus":0.1591437558831627,"score_gpt":0.4399962619200565,"score_spread":0.28085250603689377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035978580","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000112940215,0.99497485,0.000003945446,0.0013301653,0.000621092,0.0016419458,0.00002132483,0.000047708265,0.0012460281],"genre_scores_gemma":[0.0014477544,0.99491215,0.00004270378,0.0004306332,0.0024749027,0.0000046386967,0.00017638283,0.00004451811,0.0004663423],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977687,0.0005277779,0.0008167894,0.00028507825,0.00026296198,0.00033869265],"domain_scores_gemma":[0.9978583,0.0011694898,0.00053798186,0.000299605,0.00007105056,0.00006355924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005267582,0.00034262726,0.0014621905,0.00024629178,0.00014204618,0.000012589922,0.0002398957,0.00027438797,0.0001920206],"category_scores_gemma":[0.000013753177,0.000242796,0.0007833062,0.00043300755,0.00015850118,0.00004364793,0.00008726283,0.00043907776,0.00003943175],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002603553,0.000013898635,0.0007741009,0.00064387737,0.0009447851,0.000012935443,0.000051189334,0.000027367589,0.00003976206,0.00016385342,0.00050167384,0.9965662],"study_design_scores_gemma":[0.00090277503,0.00014678513,0.0005106264,0.000225941,0.004330076,0.000019163353,0.000034180226,0.0005141361,0.000004315885,0.00028824975,0.9928349,0.00018884223],"about_ca_topic_score_codex":0.0000047499043,"about_ca_topic_score_gemma":0.000003680335,"teacher_disagreement_score":0.99637735,"about_ca_system_score_codex":0.00016194918,"about_ca_system_score_gemma":0.00027399004,"threshold_uncertainty_score":0.99009335},"labels":[],"label_agreement":null},{"id":"W2037671352","doi":"10.1016/j.pharmthera.2005.12.003","title":"Elastic fibres and vascular structure in hypertension","year":2006,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Connective tissue disorders research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":244,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; SickKids Foundation; University of Toronto","funders":"","keywords":"Extracellular matrix; Cell biology; Pathological; Vascular wall; Vascular remodelling in the embryo; Receptor; Phenotype; Extracellular; Biology; Chemistry; Medicine; Pathology; Internal medicine; Endocrinology; Biochemistry","score_opus":0.05044618950519723,"score_gpt":0.37626530913964545,"score_spread":0.3258191196344482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037671352","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005702391,0.99337727,0.000025759626,0.00005623197,0.00020905558,0.0005017302,0.00005341519,0.000011020111,0.00006311646],"genre_scores_gemma":[0.0015515636,0.9972121,0.00004687573,0.00035380185,0.00023100404,0.000060440405,0.00029358847,0.000073252006,0.00017735231],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99815387,0.00040680947,0.00030950044,0.00059048313,0.00013023087,0.00040908722],"domain_scores_gemma":[0.9994125,0.00009779895,0.000102933554,0.00025648714,0.00007066504,0.000059612343],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001328832,0.0003897554,0.00076091307,0.00018332619,0.000063786276,0.000017979995,0.00027010744,0.00054860546,0.000060032882],"category_scores_gemma":[0.000010386421,0.00034068737,0.00016836294,0.000191334,0.0001854755,0.0000025814047,0.00022586112,0.00047593773,0.00000841043],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004397113,0.00014035786,0.0001270437,0.002655864,0.0010512129,0.000041894848,0.00002410104,0.000020273763,0.024313483,0.000007161427,0.0012213227,0.9703533],"study_design_scores_gemma":[0.0006211531,0.00013431194,0.000088385015,0.00018951336,0.000854931,0.000047586433,0.0000067267224,0.000038547558,0.00033211103,0.000031589458,0.99732786,0.00032730208],"about_ca_topic_score_codex":0.000019491625,"about_ca_topic_score_gemma":0.000060532846,"teacher_disagreement_score":0.9961065,"about_ca_system_score_codex":0.000038894563,"about_ca_system_score_gemma":0.00018023992,"threshold_uncertainty_score":0.9999045},"labels":[],"label_agreement":null},{"id":"W2039425202","doi":"10.1016/j.pharmthera.2012.04.003","title":"Cardiovascular side-effects of antipsychotic drugs: The role of the autonomic nervous system","year":2012,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Cardiac electrophysiology and arrhythmias","field":"Medicine","cited_by":160,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Antipsychotic; Atypical antipsychotic; Orthostatic vital signs; Adverse effect; Pharmacology; Bioinformatics; Internal medicine; Schizophrenia (object-oriented programming); Psychiatry; Blood pressure; Biology","score_opus":0.021866180224796108,"score_gpt":0.30752868860096,"score_spread":0.2856625083761639,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039425202","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026736872,0.9916824,0.000005250327,0.00007463269,0.0025923636,0.0023540594,0.000016889204,0.00004427668,0.00055641145],"genre_scores_gemma":[0.1247805,0.8735867,0.000008653481,0.00042089052,0.00088525336,0.00016705209,0.000009015803,0.00007593054,0.00006597404],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99675465,0.0014402241,0.00071685656,0.0003437877,0.00024718817,0.00049730256],"domain_scores_gemma":[0.9973874,0.0007474421,0.0006456289,0.0010492082,0.000098706914,0.00007159157],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005413996,0.0004764771,0.002827908,0.0001070262,0.00013129778,0.0000035511935,0.00048666954,0.00047104992,0.000011528849],"category_scores_gemma":[0.0000044152434,0.00025076405,0.0029565024,0.00035195352,0.00053173344,0.000024637397,0.00013382793,0.0010080964,0.000035458663],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011664156,0.00020056008,0.000014586071,0.020135142,0.030263124,0.000030125722,0.00042142248,0.000040258856,0.0031757008,0.0002930343,0.00006546813,0.94524395],"study_design_scores_gemma":[0.00082367344,0.00014510026,0.00011867934,0.0022684096,0.09017315,0.00073436875,0.000053893327,0.000038480135,0.0034511231,0.000029447843,0.901922,0.00024171101],"about_ca_topic_score_codex":0.000010149359,"about_ca_topic_score_gemma":1.6041946e-7,"teacher_disagreement_score":0.9450022,"about_ca_system_score_codex":0.00016282171,"about_ca_system_score_gemma":0.00045422578,"threshold_uncertainty_score":0.99999446},"labels":[],"label_agreement":null},{"id":"W2040540600","doi":"10.1016/j.pharmthera.2007.03.014","title":"Potassium channel diversity in the pulmonary arteries and pulmonary veins: Implications for regulation of the pulmonary vasculature in health and during pulmonary hypertension","year":2007,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Ion channel regulation and function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":86,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada","keywords":"Hypoxic pulmonary vasoconstriction; Pulmonary hypertension; High-altitude pulmonary edema; Potassium channel; Hypoxia (environmental); Pulmonary artery; Inward-rectifier potassium ion channel; Internal medicine; Vascular resistance; Lung; Biology; Cardiology; Endocrinology; Medicine; Chemistry; Pulmonary edema; Ion channel; Hemodynamics; Receptor","score_opus":0.07941972703977618,"score_gpt":0.33755584423386986,"score_spread":0.2581361171940937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040540600","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01906674,0.9759662,0.00007613215,0.0022938678,0.0005986087,0.0018119237,0.000101013415,0.000013449756,0.00007204619],"genre_scores_gemma":[0.20251264,0.7953291,0.000021909385,0.0011382948,0.00032160053,0.00013478266,0.00039594146,0.000034668297,0.00011109205],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99800277,0.00044245497,0.0005643434,0.0005159952,0.00013545968,0.00033899632],"domain_scores_gemma":[0.998993,0.00011629767,0.0004016522,0.00033313184,0.000092993774,0.00006295623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006118321,0.00033982535,0.00056150433,0.00020232899,0.00042462442,0.000013204254,0.00027856583,0.0004888166,0.0000023329842],"category_scores_gemma":[0.000008970285,0.00024083814,0.00020308679,0.00033415083,0.00026370925,0.000019735398,0.00032140568,0.00037044348,2.5858603e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014040425,0.0019449053,0.005435588,0.013163864,0.00066164543,0.000030295258,0.0010355542,0.00024744766,0.041054413,0.00019373611,0.0003012232,0.9345273],"study_design_scores_gemma":[0.001322913,0.00038121126,0.13324927,0.0015574967,0.0010717344,0.0018163794,0.0007048,0.0028427534,0.00041851675,0.0010075815,0.8546744,0.00095295085],"about_ca_topic_score_codex":0.000016661335,"about_ca_topic_score_gemma":0.000011111563,"teacher_disagreement_score":0.9335743,"about_ca_system_score_codex":0.00006721899,"about_ca_system_score_gemma":0.0001216176,"threshold_uncertainty_score":0.9821094},"labels":[],"label_agreement":null},{"id":"W2042966602","doi":"10.1016/j.pharmthera.2014.02.007","title":"Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease","year":2014,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":167,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Manitoba; Children's Hospital Research Institute of Manitoba; St. Boniface Hospital; University of Calgary; University of Manitoba; University of Toronto; SickKids Foundation; Hospital for Sick Children","funders":"National Center for Advancing Translational Sciences; National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Disease; Medicine; Pulmonary disease; Pulmonary cancer; Heart disease; Cancer; Lung cancer; Internal medicine; Pharmacology; Intensive care medicine","score_opus":0.03917930264253614,"score_gpt":0.3601073125906336,"score_spread":0.32092800994809745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042966602","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000140264,0.99153596,0.0000712171,0.0018351763,0.0047830567,0.0014136906,0.00010595937,0.000025917598,0.00008878556],"genre_scores_gemma":[0.000465004,0.96903735,0.000039106995,0.015272738,0.012654525,0.000683556,0.00024043584,0.00013628097,0.001470997],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968992,0.000714212,0.00056691444,0.00091577246,0.00021862458,0.0006852665],"domain_scores_gemma":[0.9985961,0.000095891955,0.00027739804,0.0004788505,0.00005364146,0.0004981244],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00045905303,0.0006826468,0.0010719538,0.000115313545,0.00018721816,0.000047603884,0.0005716572,0.00035850878,0.000049794362],"category_scores_gemma":[0.000013272775,0.0004914504,0.00038312492,0.00022431815,0.00031498398,0.000008145049,0.00025692678,0.0006700684,0.000012618426],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009840103,0.0005314943,0.00052644755,0.007263117,0.0022796078,0.000006928681,0.00022641805,0.00020802545,0.004309249,0.00015875447,0.056531344,0.9269746],"study_design_scores_gemma":[0.0005694105,0.00003212858,0.000113702554,0.00021806444,0.0039728554,0.000026389338,0.0000145179865,0.00022416619,0.000015367083,0.00013767109,0.99413025,0.0005454752],"about_ca_topic_score_codex":0.00008902623,"about_ca_topic_score_gemma":0.000008597893,"teacher_disagreement_score":0.9375989,"about_ca_system_score_codex":0.000063598236,"about_ca_system_score_gemma":0.0015086142,"threshold_uncertainty_score":0.9997537},"labels":[],"label_agreement":null},{"id":"W2044317877","doi":"10.1016/j.pharmthera.2003.08.002","title":"Immunosuppression and transplant vascular disease: benefits and adverse effects","year":2003,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Signaling Pathways in Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; St. Paul's Hospital","funders":"","keywords":"Immunosuppression; Calcineurin; Immune system; Transplant rejection; Immunology; Pathogenesis; Transplantation; Medicine; Heart transplantation; Mechanism of action; Blockade; Receptor; Pharmacology; Biology; Internal medicine","score_opus":0.030878637645276066,"score_gpt":0.32408293340814354,"score_spread":0.2932042957628675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044317877","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006957025,0.9912598,0.000035465167,0.000019086801,0.00061962736,0.00088245777,0.00018327947,0.000025294721,0.000017947432],"genre_scores_gemma":[0.0014327251,0.99653983,0.00007260159,0.0010886029,0.00018974788,0.00019845455,0.00032690537,0.000096660144,0.000054470605],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979548,0.00052042986,0.00032353922,0.000689371,0.00013494809,0.0003769519],"domain_scores_gemma":[0.9990597,0.00010115952,0.00016156043,0.00036709436,0.000039311322,0.0002711837],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018572602,0.00054597907,0.00072298886,0.000064336906,0.00013937177,0.00001687927,0.0002445831,0.0004401064,0.000024729883],"category_scores_gemma":[0.0000058469336,0.00047334287,0.00029167027,0.00007739806,0.00022603644,0.00000401189,0.00012325608,0.00029820963,0.000006741968],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029892768,0.00043523926,0.0002990251,0.017808294,0.0052584196,0.00016475728,0.00008532818,0.000016425323,0.020203365,0.000036934794,0.00072506187,0.9546682],"study_design_scores_gemma":[0.0010629595,0.00012767456,0.000032036198,0.0014034915,0.009808601,0.000048447633,0.0000023299065,0.000007702569,0.0027535202,0.0000122932925,0.98420364,0.0005373325],"about_ca_topic_score_codex":7.587235e-7,"about_ca_topic_score_gemma":2.4708004e-7,"teacher_disagreement_score":0.98347855,"about_ca_system_score_codex":0.000021514421,"about_ca_system_score_gemma":0.00020062573,"threshold_uncertainty_score":0.99977183},"labels":[],"label_agreement":null},{"id":"W2046879146","doi":"10.1016/j.pharmthera.2012.03.005","title":"Novel therapeutic agents for lowering low density lipoprotein cholesterol","year":2012,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Kexin; PCSK9; Proprotein convertase; Tolerability; Pharmacology; Microsomal triglyceride transfer protein; Residual risk; Medicine; Apolipoprotein B; Apolipoprotein C2; Lipoprotein; Drug; Cholesterol; Endocrinology; LDL receptor; Internal medicine; Very low-density lipoprotein; Adverse effect","score_opus":0.14946259615083912,"score_gpt":0.40724969414004886,"score_spread":0.25778709798920973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046879146","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020831129,0.98168844,0.007129574,0.0002606109,0.0025459698,0.007813487,0.000080113045,0.0001846789,0.00008880364],"genre_scores_gemma":[0.00089745026,0.98410517,0.0006132088,0.008156701,0.0035960283,0.0016180258,0.0001601059,0.0003193362,0.00053394714],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99623847,0.00024268102,0.00095163495,0.00081140443,0.0005169011,0.0012389186],"domain_scores_gemma":[0.99769115,0.00016370924,0.00051992724,0.00095915864,0.00022445727,0.00044158616],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001191856,0.0009374399,0.0031029242,0.00026330748,0.00026482114,0.00003906149,0.00043611895,0.00093157176,0.00016611308],"category_scores_gemma":[0.000004820538,0.00076002436,0.0019790009,0.00032068166,0.00016515506,0.00010010726,0.00015104338,0.0012198639,0.00014764087],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011022628,0.0006372825,0.000006124176,0.021443235,0.0067939414,0.000014357616,0.00008882862,5.952875e-7,0.00040873518,0.000009278571,0.000078588404,0.9704088],"study_design_scores_gemma":[0.0028899673,0.00027316724,0.00007042023,0.0020008853,0.03225595,0.00057116506,0.000007867306,0.000029523428,0.0006879703,0.000009170423,0.9606027,0.0006011904],"about_ca_topic_score_codex":0.000048621518,"about_ca_topic_score_gemma":0.000008048981,"teacher_disagreement_score":0.9698076,"about_ca_system_score_codex":0.00048447042,"about_ca_system_score_gemma":0.00065002096,"threshold_uncertainty_score":0.9994851},"labels":[],"label_agreement":null},{"id":"W2048985510","doi":"10.1016/j.pharmthera.2013.04.004","title":"Functional genomics of pain in analgesic drug development and therapy","year":2013,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":65,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Drug repositioning; Analgesic; Drug development; Pharmacogenomics; Drug discovery; Computational biology; Functional genomics; Repurposing; Bioinformatics; Chronic pain; Medicine; Genomics; Neuroscience; Biology; Drug; Pharmacology; Gene; Genetics; Genome","score_opus":0.2564023176093579,"score_gpt":0.44987072339124473,"score_spread":0.19346840578188684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048985510","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013649806,0.9812792,0.00003695574,0.00020548835,0.0023048583,0.0020651335,0.00008821942,0.00006281069,0.00030751768],"genre_scores_gemma":[0.0005271025,0.9926817,0.0005532613,0.004205962,0.00051668804,0.000710151,0.00013453617,0.00015270179,0.000517893],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99321866,0.0029023068,0.0017718495,0.0008545601,0.00028307797,0.0009695442],"domain_scores_gemma":[0.99680537,0.00145229,0.00091091206,0.0003042941,0.00017233872,0.00035478233],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002868098,0.0010290887,0.002383872,0.0007835792,0.00021509995,0.00002724425,0.0007185615,0.0009683578,0.0017972587],"category_scores_gemma":[0.000008937086,0.0009173232,0.0003815154,0.00061416905,0.0005375969,0.00009873634,0.0002744095,0.0021074424,0.00014332653],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012486079,0.00065605785,0.00010042948,0.0017705025,0.0023852093,0.000025670952,0.0006818614,0.000039142713,0.0019267082,0.0000555357,0.0024704935,0.9897635],"study_design_scores_gemma":[0.002416667,0.00007138825,0.00004711346,0.00020587795,0.0020512696,0.00003204279,0.000045445933,0.00031653678,0.004493592,0.00012132361,0.98941654,0.00078223145],"about_ca_topic_score_codex":0.000013130102,"about_ca_topic_score_gemma":0.0000063264024,"teacher_disagreement_score":0.9889813,"about_ca_system_score_codex":0.00021377282,"about_ca_system_score_gemma":0.0010012998,"threshold_uncertainty_score":0.9993277},"labels":[],"label_agreement":null},{"id":"W2050052541","doi":"10.1016/j.pharmthera.2010.02.003","title":"Dehydroepiandrosterone: A new treatment for vascular remodeling diseases including pulmonary arterial hypertension","year":2010,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec; Université Laval","funders":"Canadian Institutes of Health Research; Centre National de la Recherche Scientifique","keywords":"Medicine; Pulmonary artery; Dehydroepiandrosterone; Pulmonary hypertension; Nitric oxide; Vascular resistance; Internal medicine; Vasodilation; Endothelial dysfunction; Vascular smooth muscle; Pharmacology; Cardiology; Endocrinology; Blood pressure; Androgen","score_opus":0.21614838109655593,"score_gpt":0.43458238886819367,"score_spread":0.21843400777163774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050052541","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001241919,0.9926615,0.00008143743,0.0006453998,0.0015746851,0.0033640652,0.00023257924,0.00015181628,0.000046637415],"genre_scores_gemma":[0.00025321174,0.99173635,0.00093462184,0.0018407839,0.0019564468,0.00071548077,0.0013258705,0.00021425168,0.0010229836],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99674696,0.00023453498,0.00074143626,0.0009629598,0.00037670528,0.00093738624],"domain_scores_gemma":[0.9977133,0.00044841965,0.00026418114,0.0006148916,0.00018077587,0.0007784223],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014482718,0.0009130725,0.0027329323,0.00036872824,0.00038192858,0.000040957664,0.00027278875,0.0006955477,0.00017990456],"category_scores_gemma":[0.000014315207,0.0006350485,0.0013628174,0.00022576567,0.00014080164,0.00009871506,0.0001460242,0.00061888964,0.000116595234],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008709713,0.0018255719,0.000016880163,0.0019632701,0.0039178524,0.0016085856,0.000016554126,0.0000011991715,0.0036464198,0.0000012655362,0.00047500173,0.98565644],"study_design_scores_gemma":[0.005099956,0.0009834921,0.0000088191355,0.0015281374,0.03145638,0.0017771408,0.0000058918054,0.0015138978,0.00007682921,0.000044973443,0.9570448,0.00045969003],"about_ca_topic_score_codex":0.000023207911,"about_ca_topic_score_gemma":0.0000019972892,"teacher_disagreement_score":0.9851967,"about_ca_system_score_codex":0.0004190738,"about_ca_system_score_gemma":0.0013929959,"threshold_uncertainty_score":0.99961007},"labels":[],"label_agreement":null},{"id":"W2054324255","doi":"10.1016/j.pharmthera.2009.03.019","title":"Possibility of a rebound phenomenon following antiplatelet therapy withdrawal: A look at the clinical and pharmacological evidence","year":2009,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Medicine; Discontinuation; Antiplatelet drug; Clopidogrel; Aspirin; Intensive care medicine; Coronary artery disease; Adverse effect; Cardiology; Internal medicine","score_opus":0.18953931495758358,"score_gpt":0.46842031270526946,"score_spread":0.2788809977476859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054324255","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.105356604,0.89018035,0.000018062632,0.0004232384,0.0006760786,0.0031103627,0.000030828458,0.00009833313,0.000106130814],"genre_scores_gemma":[0.012216703,0.98076177,0.00007295255,0.005807541,0.0006372493,0.00012984694,0.00003963377,0.00009415539,0.00024013134],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99340105,0.002558016,0.0016281264,0.0011214814,0.0005933327,0.0006980019],"domain_scores_gemma":[0.9961677,0.0018188915,0.0007590167,0.00079284696,0.00015457546,0.00030697693],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0028923547,0.0008775861,0.003966331,0.0001415285,0.00036130383,0.000040208437,0.0005712221,0.0007605853,0.00038215937],"category_scores_gemma":[0.000028703578,0.0005195349,0.0028505854,0.0004735977,0.0016783809,0.00012214945,0.0002364926,0.001404046,0.000030443012],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024866776,0.0008835365,0.0012742939,0.0016226583,0.017970761,0.00038361145,0.00015366128,6.2408117e-7,0.00036243134,0.0000050750427,0.0005021359,0.9743545],"study_design_scores_gemma":[0.0056288964,0.0016115813,0.0006779759,0.0024664248,0.036928494,0.00068035326,0.000033117718,0.000016475633,0.00021670116,0.000083091385,0.95106316,0.0005937058],"about_ca_topic_score_codex":0.0000054573293,"about_ca_topic_score_gemma":0.0000014593785,"teacher_disagreement_score":0.97376084,"about_ca_system_score_codex":0.00015703081,"about_ca_system_score_gemma":0.0007796835,"threshold_uncertainty_score":0.99972564},"labels":[],"label_agreement":null},{"id":"W2054487267","doi":"10.1016/j.pharmthera.2006.06.005","title":"The pharmacology of particulate matter air pollution-induced cardiovascular dysfunction","year":2006,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Air Quality and Health Impacts","field":"Environmental Science","cited_by":161,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; American Lung Association","keywords":"Medicine; Asthma; Stroke (engine); Particulates; Environmental health; Aerodynamic diameter; Disease; Air pollution; Cardiovascular health; Population; Heart disease; Air pollutants; Intensive care medicine; Pathology; Internal medicine; Biology","score_opus":0.09324609936987618,"score_gpt":0.38226987258947426,"score_spread":0.28902377321959805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054487267","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000424623,0.99073535,0.00012247119,0.0034464814,0.0029121733,0.0014355044,0.000034567034,0.000057781344,0.0008310364],"genre_scores_gemma":[0.0017867206,0.9827797,0.0000414134,0.014239697,0.00043125582,0.00021597558,0.000026777212,0.00006468154,0.0004137996],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99562705,0.0016061523,0.0010177033,0.0005017054,0.00040997626,0.000837428],"domain_scores_gemma":[0.99833727,0.00037049476,0.0006386209,0.0004615778,0.000033268218,0.00015875969],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0012989047,0.00048332888,0.0013332259,0.000069429065,0.0005087193,0.000013621334,0.0005597002,0.00049096026,0.0014260606],"category_scores_gemma":[0.000003122137,0.00033554432,0.000729492,0.00046528695,0.000589943,0.000103465914,0.00021170222,0.000770481,0.0013103656],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000066341,0.00028172796,0.000083988154,0.0018955726,0.0036781784,0.000015178485,0.00013623395,0.001391751,0.00023712304,0.0000134720185,0.082806066,0.9093944],"study_design_scores_gemma":[0.00048808422,0.00009262893,0.00047116645,0.00008806405,0.007222503,0.000033753306,0.0000063155753,0.00011048461,0.00021721289,0.000040871637,0.9909263,0.0003025904],"about_ca_topic_score_codex":0.00034397142,"about_ca_topic_score_gemma":0.000026110332,"teacher_disagreement_score":0.9090918,"about_ca_system_score_codex":0.000497246,"about_ca_system_score_gemma":0.000178095,"threshold_uncertainty_score":0.99990964},"labels":[],"label_agreement":null},{"id":"W2056362028","doi":"10.1016/j.pharmthera.2011.01.003","title":"Structure, function and pathophysiology of protease activated receptors","year":2011,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":363,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Pathophysiology; Receptor; Protease; Function (biology); Cell biology; Biology; Chemistry; Biochemistry; Endocrinology; Enzyme","score_opus":0.09560762350320695,"score_gpt":0.3675661067512082,"score_spread":0.27195848324800126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056362028","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013011171,0.9955507,0.000062621264,0.00004351132,0.0012689393,0.0015949644,0.000032702326,0.00006883828,0.0000765871],"genre_scores_gemma":[0.0023989256,0.995399,0.00027635606,0.0013828366,0.00019241087,0.000079692174,0.000117379364,0.00006518466,0.00008822997],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985106,0.0003377604,0.0004779546,0.0003577304,0.00009085081,0.00022510774],"domain_scores_gemma":[0.99901,0.00007529366,0.0004766433,0.00021655636,0.0001127531,0.00010871273],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00010235898,0.0003600653,0.0014515265,0.0002144575,0.000051775718,0.0000030714345,0.00009540216,0.0005691609,0.0009694097],"category_scores_gemma":[0.0000031313566,0.0002753101,0.00019965589,0.00022911515,0.00016623073,0.000034306526,0.00005696954,0.00053707615,0.000013298971],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025358953,0.00027445634,0.000010918164,0.005020652,0.0025949732,0.0000033517886,0.00006443584,5.92432e-8,0.053218458,0.00033389125,0.00011462873,0.9381106],"study_design_scores_gemma":[0.0015263038,0.0010855263,0.000054657772,0.00087163766,0.01939186,0.00005036036,0.000011014276,0.00000739714,0.010492897,0.002093626,0.9641039,0.00031081183],"about_ca_topic_score_codex":0.0000029447272,"about_ca_topic_score_gemma":2.634749e-7,"teacher_disagreement_score":0.96398926,"about_ca_system_score_codex":0.000036982336,"about_ca_system_score_gemma":0.00019576235,"threshold_uncertainty_score":0.9999699},"labels":[],"label_agreement":null},{"id":"W2060435183","doi":"10.1016/s0163-7258(01)00138-3","title":"Autonomic control of the venous system in health and disease: effects of drugs","year":2001,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Heart Rate Variability and Autonomic Control","field":"Medicine","cited_by":219,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Venous return curve; Medicine; Mean circulatory filling pressure; Orthostatic intolerance; Baroreflex; Anesthesia; Orthostatic vital signs; Vasovagal syncope; Pure autonomic failure; Blood volume; Vascular resistance; Sympathetic nervous system; Blood pressure; Cardiology; Baroreceptor; Circulatory system; Intravascular volume status; Presyncope; Central venous pressure; Internal medicine; Heart rate; Hemodynamics; Reflex","score_opus":0.027013753927118227,"score_gpt":0.3449197171781366,"score_spread":0.31790596325101833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060435183","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014908583,0.9932315,0.000027037413,0.0011202896,0.00059581926,0.0034363817,0.000051784762,0.000022399656,0.0000239411],"genre_scores_gemma":[0.06155748,0.9363841,0.000008229323,0.0017076114,0.00011171177,0.0001342825,0.000006707971,0.000034707457,0.000055201454],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972313,0.0010332664,0.0010147125,0.0002954701,0.00010565349,0.00031961265],"domain_scores_gemma":[0.9977597,0.0010365298,0.0006101539,0.00034290855,0.000038916314,0.000211806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006740959,0.00029035463,0.002465985,0.00014112612,0.00004493256,0.0000033448764,0.00017762966,0.00019992184,0.000012914186],"category_scores_gemma":[0.00001760623,0.00019781379,0.00032907978,0.00021795921,0.00024130681,0.000016530663,0.00004902128,0.00050157285,0.0000033276694],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015265182,0.0007521644,0.00027300479,0.11788486,0.0016887053,0.000023114684,0.000557794,0.000011801277,0.00023872315,0.0002020788,0.000024933646,0.87819016],"study_design_scores_gemma":[0.0036789142,0.00030807237,0.00021485092,0.010494365,0.005378923,0.000032447388,0.000027748883,0.0009359199,0.000020510708,0.000016061696,0.9787386,0.0001535697],"about_ca_topic_score_codex":0.000037517893,"about_ca_topic_score_gemma":0.0000011468545,"teacher_disagreement_score":0.9787137,"about_ca_system_score_codex":0.00041115689,"about_ca_system_score_gemma":0.0030132679,"threshold_uncertainty_score":0.80666125},"labels":[],"label_agreement":null},{"id":"W2061575441","doi":"10.1016/j.pharmthera.2005.10.009","title":"Peroxisome proliferator-activated receptor gamma as a drug target in the pathogenesis of insulin resistance","year":2005,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Peroxisome Proliferator-Activated Receptors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":118,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Insulin resistance; Peroxisome proliferator-activated receptor; Endocrinology; Internal medicine; Insulin; Insulin receptor; Biology; Nuclear receptor; Type 2 diabetes; Receptor; Diabetes mellitus; Medicine; Transcription factor; Biochemistry; Gene","score_opus":0.033472082563111884,"score_gpt":0.3436402264546939,"score_spread":0.310168143891582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061575441","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.025735058,0.9704267,0.0000074631234,0.00045183697,0.0006462168,0.0021516806,0.00030022085,0.000043596625,0.00023726285],"genre_scores_gemma":[0.0064101284,0.98749006,0.00043728578,0.0023853248,0.0010069896,0.0010159472,0.00050374476,0.00021200321,0.00053848897],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99403745,0.0022272987,0.0013523244,0.0010784322,0.0004386825,0.0008658253],"domain_scores_gemma":[0.9975976,0.00020596913,0.00094660476,0.00085913704,0.00024109326,0.00014961974],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009415125,0.0010219185,0.0017751554,0.00033903687,0.00015841858,0.000039303828,0.0015546302,0.0010915978,0.000263678],"category_scores_gemma":[0.0000402604,0.0007750852,0.0006092913,0.0009530058,0.00040601008,0.000018141654,0.00023355769,0.0011498869,0.00007511797],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010883051,0.0017344537,0.00011423223,0.0034770768,0.0030979707,0.000033896937,0.00093665416,0.000018217353,0.77381724,0.000028167462,0.0064222408,0.20923153],"study_design_scores_gemma":[0.0008568354,0.00017079343,0.000004841982,0.00042510754,0.0007249829,0.00003200754,0.00007587517,0.0000019634826,0.1296945,0.000012341833,0.8673569,0.0006438497],"about_ca_topic_score_codex":0.000006700741,"about_ca_topic_score_gemma":0.000014300686,"teacher_disagreement_score":0.8609347,"about_ca_system_score_codex":0.00019621672,"about_ca_system_score_gemma":0.0011274867,"threshold_uncertainty_score":0.99947},"labels":[],"label_agreement":null},{"id":"W2064685009","doi":"10.1016/j.pharmthera.2015.04.003","title":"Bivalirudin in stable angina and acute coronary syndromes","year":2015,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Acute Myocardial Infarction Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Bivalirudin; Medicine; Anticoagulant; Heparin; Acute coronary syndrome; Angina; Cardiology; Internal medicine; Unstable angina; Percutaneous coronary intervention; Coronary heart disease; Myocardial infarction","score_opus":0.19517346686504497,"score_gpt":0.4753410470091761,"score_spread":0.2801675801441311,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064685009","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020696105,0.99389946,0.000005463423,0.002436979,0.00062435627,0.001761861,0.00010894146,0.00008419525,0.00087180495],"genre_scores_gemma":[0.000031293333,0.9902157,0.00015679217,0.0066798306,0.00021441677,0.0002472472,0.00013730746,0.000107587686,0.0022098185],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99743044,0.0005149399,0.0005374336,0.00051455916,0.00035718447,0.00064545585],"domain_scores_gemma":[0.998819,0.00025634002,0.00016489334,0.00031413467,0.00016291626,0.00028273326],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00074441236,0.00046576944,0.0021104128,0.0006149411,0.00006363728,0.000021431772,0.00024003943,0.00052198657,0.00033828098],"category_scores_gemma":[0.000004913183,0.0003840874,0.00023007231,0.00063493877,0.00032864808,0.00008282516,0.00025288152,0.001292848,0.00019301767],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027201488,0.00032792633,0.00029392884,0.004680137,0.009648572,0.002140034,0.00016684658,6.048272e-7,0.00011412274,0.00002822662,0.04842689,0.9339007],"study_design_scores_gemma":[0.0013730323,0.00032753262,0.000037618356,0.0005621921,0.008366054,0.0021648337,0.000022909939,0.000037135153,0.00001073832,0.000030032385,0.9867803,0.00028765772],"about_ca_topic_score_codex":0.00002041688,"about_ca_topic_score_gemma":8.127783e-7,"teacher_disagreement_score":0.93835336,"about_ca_system_score_codex":0.00051001087,"about_ca_system_score_gemma":0.0009200331,"threshold_uncertainty_score":0.9998611},"labels":[],"label_agreement":null},{"id":"W2066671952","doi":"10.1016/j.pharmthera.2005.05.011","title":"Cytochrome P450 enzymes: Central players in cardiovascular health and disease","year":2006,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Eicosanoids and Hypertension Pharmacology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":181,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Disease; Cytochrome P450; Coronary artery disease; Heart failure; Medicine; Myocardial infarction; Internal medicine; Biology; Pharmacology; Bioinformatics","score_opus":0.05089147662185346,"score_gpt":0.36051361989264036,"score_spread":0.3096221432707869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066671952","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005625648,0.9969678,0.000060645663,0.000355545,0.0005541043,0.0012355923,0.0001889264,0.000029026429,0.00004582314],"genre_scores_gemma":[0.00072772626,0.98683935,0.00007188947,0.010327966,0.00072407996,0.000225525,0.00076737645,0.0001162802,0.00019980287],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963379,0.0008248842,0.000722249,0.0009812147,0.00018749127,0.00094624684],"domain_scores_gemma":[0.9985941,0.000058160673,0.00026137376,0.0004406729,0.000051040857,0.0005946278],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035555812,0.0006731418,0.0018390953,0.00022158305,0.00013750081,0.000025047406,0.00038382423,0.0005286156,0.00003836973],"category_scores_gemma":[0.0000067268984,0.0006096177,0.00069148873,0.00020058753,0.000281052,0.0000057419325,0.00023875068,0.0006159454,0.000011874118],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045131383,0.001132561,0.00025710437,0.011002231,0.009799452,0.0007014527,0.00013901209,0.00015230553,0.0043529347,0.000119594726,0.053296175,0.91859585],"study_design_scores_gemma":[0.001309557,0.00020883807,0.000055405315,0.00025145093,0.0025168227,0.000099410674,0.000010500374,0.000040571467,0.000063147534,0.000014636816,0.99488664,0.00054303976],"about_ca_topic_score_codex":0.00003562265,"about_ca_topic_score_gemma":0.000016497574,"teacher_disagreement_score":0.9415904,"about_ca_system_score_codex":0.00011709893,"about_ca_system_score_gemma":0.0013738174,"threshold_uncertainty_score":0.9996355},"labels":[],"label_agreement":null},{"id":"W2068781216","doi":"10.1016/j.pharmthera.2010.04.007","title":"Broad-spectrum amino acid-sensing class C G-protein coupled receptors: Molecular mechanisms, physiological significance and options for drug development","year":2010,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Receptor Mechanisms and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":74,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Medical Research Council; National Health and Medical Research Council","keywords":"Receptor; Broad spectrum; Drug development; G protein-coupled receptor; Amino acid; Biology; Computational biology; Cell biology; Biochemistry; Drug; Chemistry; Pharmacology; Combinatorial chemistry","score_opus":0.04237537587820275,"score_gpt":0.328150142341898,"score_spread":0.28577476646369526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068781216","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003542912,0.9468888,0.04524595,0.00017742248,0.0013315554,0.002669306,0.000058493257,0.00006925063,0.000016298123],"genre_scores_gemma":[0.0015345131,0.9633548,0.03146977,0.0012058598,0.00062672485,0.0006450269,0.00063120626,0.0001784172,0.00035366413],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99683315,0.00036984516,0.0007366714,0.0011069215,0.00020508986,0.00074829697],"domain_scores_gemma":[0.99870974,0.000070020615,0.00049433706,0.00037410588,0.00015530491,0.00019650852],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005822004,0.00079561345,0.0012315328,0.0001162046,0.00037741428,0.00006671344,0.00047633072,0.0011222026,0.000104365965],"category_scores_gemma":[0.000012650822,0.0007020744,0.0004192534,0.00014271845,0.00021518265,0.0000068766494,0.00023255074,0.00081154215,0.000013418418],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045785764,0.000098415156,2.7361073e-8,0.0006001482,0.0006636339,0.000004950367,0.000030564966,0.0000049092027,0.8536153,0.00052581733,0.00013742197,0.14427306],"study_design_scores_gemma":[0.00044206146,0.0001730917,8.707238e-8,0.00019184928,0.0007449844,0.00001799173,0.000017228645,0.00012813603,0.35171598,0.0003892063,0.645626,0.00055337575],"about_ca_topic_score_codex":0.0000032318715,"about_ca_topic_score_gemma":0.00000715989,"teacher_disagreement_score":0.6454886,"about_ca_system_score_codex":0.00008182333,"about_ca_system_score_gemma":0.00045985484,"threshold_uncertainty_score":0.999543},"labels":[],"label_agreement":null},{"id":"W2070458501","doi":"10.1016/s0163-7258(02)00300-5","title":"Role of palmitoylation/depalmitoylation reactions in G-protein-coupled receptor function","year":2002,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Receptor Mechanisms and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":263,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Palmitoylation; G protein-coupled receptor; Cell biology; G protein; Biology; G protein-coupled receptor kinase; Regulator of G protein signaling; Function (biology); Receptor; Signal transduction; Rhodopsin-like receptors; GTPase-activating protein; Biochemistry","score_opus":0.04084262781151204,"score_gpt":0.3226008424896731,"score_spread":0.28175821467816103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070458501","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025819317,0.99472237,0.0006017806,0.000020193687,0.0007900715,0.0009943298,0.000033311808,0.00002324581,0.00023279514],"genre_scores_gemma":[0.004333114,0.9933416,0.00035623045,0.000095509065,0.0006530772,0.00024491304,0.00044865595,0.00008230061,0.00044457515],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99784195,0.0003493771,0.0008328611,0.0004906553,0.00016807838,0.00031706452],"domain_scores_gemma":[0.9988594,0.00005006288,0.0006167727,0.0002878095,0.00012419462,0.000061757586],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030223845,0.00038794056,0.00076608476,0.00024382517,0.00008508781,0.000013419815,0.0002446253,0.0007519351,0.0008342592],"category_scores_gemma":[0.000007516489,0.00037548336,0.00035089217,0.0003197786,0.00006586001,0.000008436192,0.00006109251,0.00041144193,0.000044680095],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005713441,0.00015918697,0.0000080281025,0.0006608929,0.00052464724,6.763342e-7,0.000033583383,0.000062035964,0.6736839,0.000043114822,0.00007105047,0.32469574],"study_design_scores_gemma":[0.0004612348,0.00023057796,0.0000028262552,0.00040476842,0.0008723187,0.000007131717,0.000027757917,0.00038436052,0.024279421,0.00009965922,0.9728906,0.0003393364],"about_ca_topic_score_codex":0.000014900697,"about_ca_topic_score_gemma":0.0000074016966,"teacher_disagreement_score":0.97281957,"about_ca_system_score_codex":0.00007513255,"about_ca_system_score_gemma":0.0001435642,"threshold_uncertainty_score":0.9998697},"labels":[],"label_agreement":null},{"id":"W2071461607","doi":"10.1016/j.pharmthera.2005.10.004","title":"The effect of acute, chronic, and prenatal ethanol exposure on insulin sensitivity","year":2005,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Birth, Development, and Health","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Canadian Institutes of Health Research","keywords":"Insulin; Insulin resistance; Internal medicine; Endocrinology; Medicine; Ethanol; Diabetes mellitus; Biology; Biochemistry","score_opus":0.04634698262461511,"score_gpt":0.40154890848730945,"score_spread":0.35520192586269433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071461607","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015007912,0.99425113,0.0000046601963,0.00086092873,0.0007236985,0.0021167556,0.00007486346,0.000052519,0.0004146766],"genre_scores_gemma":[0.0018673505,0.99531204,0.000038412894,0.0017412482,0.0007244485,0.00011921374,0.000056754692,0.00006701186,0.00007351241],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973569,0.00095330394,0.00057264336,0.00040170856,0.0002398211,0.00047563913],"domain_scores_gemma":[0.9977776,0.0012920733,0.00041674916,0.00030285184,0.00006521244,0.0001455236],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00087518885,0.0004931018,0.0016942364,0.00012363508,0.00019027507,0.000009994058,0.00014374619,0.0005542107,0.000035770216],"category_scores_gemma":[0.0000063098328,0.0002871808,0.00025112132,0.00016934809,0.00033547494,0.000026795868,0.00008845236,0.0013344954,0.000032676733],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037031615,0.000086534914,0.000036988564,0.008333168,0.003333322,0.00006168241,0.00011758446,1.5020208e-7,0.00016735641,0.00007500111,0.0003352421,0.98708266],"study_design_scores_gemma":[0.0027924217,0.0026226642,0.00008822035,0.0021968926,0.010648515,0.00041570296,0.0000027441056,0.000026137424,0.0026793699,0.000014315728,0.9782473,0.0002657145],"about_ca_topic_score_codex":0.0000027933283,"about_ca_topic_score_gemma":0.000007040634,"teacher_disagreement_score":0.98681694,"about_ca_system_score_codex":0.0002578958,"about_ca_system_score_gemma":0.00082857977,"threshold_uncertainty_score":0.99995804},"labels":[],"label_agreement":null},{"id":"W2076110140","doi":"10.1016/j.pharmthera.2012.09.001","title":"Immediate early response genes and cell transformation","year":2012,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":142,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Children's Hospital Research Institute of Manitoba","funders":"","keywords":"Gene; Biology; Cancer; Disease; Phenotype; Function (biology); Cancer cell; Motley; Bioinformatics; Computational biology; Genetics; Medicine; Internal medicine","score_opus":0.0636225844210068,"score_gpt":0.36180223441686665,"score_spread":0.2981796499958599,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076110140","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005781098,0.9927263,0.00019396844,0.00011742712,0.00048119354,0.0004826461,0.000075988384,0.000013799652,0.00012757712],"genre_scores_gemma":[0.002926339,0.9950549,0.00006477883,0.0005556239,0.00049561285,0.00020644936,0.00015099694,0.000052741543,0.0004925681],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998669,0.00036918907,0.00031853403,0.00027471245,0.00007392243,0.00029463152],"domain_scores_gemma":[0.99941814,0.000040013154,0.00018217397,0.00021872635,0.000049125683,0.00009180821],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031881683,0.00028898142,0.00040240167,0.00007821546,0.00009966878,0.00002022931,0.00019875306,0.0004001178,0.000043228],"category_scores_gemma":[5.876907e-7,0.00024927076,0.00016030397,0.00008403351,0.00011141649,0.0000064462515,0.00004248598,0.00020304126,0.000039313207],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016947562,0.00007726675,0.0000062684658,0.000885437,0.00038112036,9.1103556e-7,0.00015718989,7.060748e-7,0.056120146,0.0000056773215,0.00020342918,0.94199234],"study_design_scores_gemma":[0.00035435872,0.000110973866,0.000016770346,0.000037172333,0.0020819928,0.000017862203,0.00001025867,0.0000032308267,0.0067856032,0.000003141235,0.9903202,0.0002584065],"about_ca_topic_score_codex":0.0000020133775,"about_ca_topic_score_gemma":7.368976e-7,"teacher_disagreement_score":0.9901168,"about_ca_system_score_codex":0.000026131072,"about_ca_system_score_gemma":0.00015838286,"threshold_uncertainty_score":0.99999595},"labels":[],"label_agreement":null},{"id":"W2077372959","doi":"10.1016/j.pharmthera.2009.11.001","title":"Glycaemic control in type 2 diabetes: Targets and new therapies","year":2009,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":192,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; National Institute for Health and Care Research","keywords":"Incretin; Medicine; Type 2 Diabetes Mellitus; Type 2 diabetes; Intensive care medicine; Diabetes mellitus; Disease; Bioinformatics; Pharmacology; Internal medicine; Endocrinology","score_opus":0.06878506968200675,"score_gpt":0.37326505116626324,"score_spread":0.3044799814842565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077372959","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020652413,0.99537003,0.000005081919,0.0013636017,0.0005629737,0.0018162684,0.0000067834912,0.00008305932,0.00058568595],"genre_scores_gemma":[0.00031303466,0.98365366,0.000120924175,0.014020457,0.00032699486,0.000083707244,0.0000694895,0.00006491642,0.0013468337],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982971,0.00017447745,0.00044629586,0.00042383687,0.00013214763,0.0005261334],"domain_scores_gemma":[0.9992102,0.00019674,0.00018518245,0.00022234043,0.000034816843,0.00015075554],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018171154,0.000518411,0.0018234967,0.0003131533,0.000038679715,0.00002105359,0.00015950167,0.00029519224,0.00022830145],"category_scores_gemma":[0.000002433095,0.0003925052,0.00020418873,0.0002811836,0.00009653647,0.00004946348,0.00004167117,0.00044840775,0.00008218451],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000070991315,0.00026215918,0.00028361136,0.0015555609,0.0034533152,0.000053254927,0.00010241807,2.2346538e-7,0.000037743204,0.000022369508,0.003778432,0.9903799],"study_design_scores_gemma":[0.0034576713,0.0006075741,0.00010411379,0.0010868247,0.013128453,0.0000063734346,0.0000062679524,0.000025487587,0.000008288909,0.00012261934,0.9811622,0.0002841562],"about_ca_topic_score_codex":0.0000033752494,"about_ca_topic_score_gemma":0.0000024339377,"teacher_disagreement_score":0.9900958,"about_ca_system_score_codex":0.00015913542,"about_ca_system_score_gemma":0.00021949179,"threshold_uncertainty_score":0.99985266},"labels":[],"label_agreement":null},{"id":"W2078660705","doi":"10.1016/j.pharmthera.2005.06.012","title":"Involving the pharmaceutical and biotech communities in medication development for substance abuse","year":2005,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nalcor Energy (Canada)","funders":"","keywords":"Legislation; General partnership; Substance abuse; Drug development; Business; Pharmaceutical industry; Medicine; Clinical trial; Marketing; Public relations; Risk analysis (engineering); Drug; Pharmacology; Psychiatry; Finance; Political science","score_opus":0.7951575327030591,"score_gpt":0.6443657248602361,"score_spread":0.15079180784282298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078660705","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000092585564,0.9814957,0.013699455,0.000768112,0.0009001555,0.0028586946,0.000068258894,0.00008149709,0.000035537352],"genre_scores_gemma":[0.000009982662,0.83712196,0.15906116,0.0022483738,0.00039421782,0.0010310505,0.000016084472,0.00008367959,0.000033507273],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99421996,0.002812427,0.0017680173,0.00039345573,0.00023981906,0.0005663295],"domain_scores_gemma":[0.9066846,0.09216198,0.0005987743,0.00034914058,0.00009651841,0.00010902423],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.006596103,0.0005072005,0.0017933827,0.00017093503,0.00025032446,0.00004025221,0.0007840065,0.0006278292,0.00019060884],"category_scores_gemma":[0.000503129,0.0003480162,0.00018561563,0.00027350255,0.0007736392,0.000048927286,0.00009612426,0.0015084895,0.000010434575],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049243234,0.00021068132,0.0000039046377,0.0037318985,0.0006400898,0.0000015804194,0.0019845597,1.5543881e-7,0.0000051983734,0.0026774972,0.00029872078,0.9903965],"study_design_scores_gemma":[0.0010512688,0.000034658144,0.0000014891673,0.0012767119,0.002971007,0.000012551579,0.00012721268,0.000348175,0.000048445527,0.02092114,0.9728521,0.00035525617],"about_ca_topic_score_codex":0.0000017804683,"about_ca_topic_score_gemma":0.000041399024,"teacher_disagreement_score":0.9900412,"about_ca_system_score_codex":0.00026502207,"about_ca_system_score_gemma":0.00025299645,"threshold_uncertainty_score":0.9998972},"labels":[],"label_agreement":null},{"id":"W2086677255","doi":"10.1016/j.pharmthera.2009.12.002","title":"Effect of cytochrome P450 polymorphism on arachidonic acid metabolism and their impact on cardiovascular diseases","year":2010,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Eicosanoids and Hypertension Pharmacology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":182,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Arachidonic acid; Epoxide hydrolase 2; CYP2C8; Cytochrome P450; Epoxyeicosatrienoic acid; Metabolism; CYP2C9; Enzyme; Biology; Pharmacology; Biochemistry; Internal medicine; Endocrinology; Chemistry; Medicine","score_opus":0.020863018408047187,"score_gpt":0.3449581415406133,"score_spread":0.3240951231325661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086677255","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04941433,0.94769114,0.000008440433,0.00005789921,0.0008741519,0.0012529648,0.0006067825,0.000030475334,0.00006382702],"genre_scores_gemma":[0.055323523,0.9410926,0.0000088829365,0.0017955095,0.0010287544,0.00023127894,0.00032170044,0.0001528886,0.000044869408],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961635,0.00146069,0.0005820083,0.0009545867,0.00021387148,0.0006253735],"domain_scores_gemma":[0.99805367,0.00034816665,0.00040928047,0.00083271967,0.000088370936,0.00026778833],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005330727,0.0011210453,0.0031363592,0.00027132608,0.00015280933,0.00002053082,0.00058365706,0.0010208784,0.00010308387],"category_scores_gemma":[0.000013929866,0.0006727181,0.0021792098,0.00016789918,0.00046975302,0.000005408543,0.00023900057,0.0010676426,0.000025270854],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082414947,0.0003778782,0.000006300109,0.00138148,0.012382486,0.000039107807,0.000017682856,0.000010218319,0.25749576,0.000013804129,0.0006245232,0.7268266],"study_design_scores_gemma":[0.0019468069,0.0029650512,0.000055334956,0.00021106953,0.01511561,0.00018730083,0.0000014963764,0.000012647073,0.07076316,0.000010350524,0.9081195,0.00061169104],"about_ca_topic_score_codex":0.0000042311804,"about_ca_topic_score_gemma":4.8533417e-7,"teacher_disagreement_score":0.90749496,"about_ca_system_score_codex":0.000035132645,"about_ca_system_score_gemma":0.00027794094,"threshold_uncertainty_score":0.9995724},"labels":[],"label_agreement":null},{"id":"W2089390830","doi":"10.1016/s0163-7258(03)00040-8","title":"The basic aspects of therapeutics in amyotrophic lateral sclerosis","year":2003,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Amyotrophic lateral sclerosis; Neuroscience; Motor neuron; Disease; Frontotemporal dementia; Neurodegeneration; Neuron; Biology; Excitotoxicity; Medicine; Programmed cell death; Dementia; Pathology; Apoptosis; Spinal cord; Genetics","score_opus":0.17867453421909316,"score_gpt":0.41817164014440245,"score_spread":0.2394971059253093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089390830","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00215796,0.99098945,0.000003947854,0.0023894827,0.00096880714,0.002445135,0.00003167943,0.00006071093,0.0009528125],"genre_scores_gemma":[0.0037212067,0.9889002,0.000062338775,0.005954362,0.0002365862,0.00032199704,0.000032009946,0.00021037672,0.0005609289],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9941288,0.0015081104,0.001543956,0.0007565554,0.00077197544,0.0012905687],"domain_scores_gemma":[0.9970518,0.000930903,0.0006349717,0.00089699327,0.0002662559,0.00021908725],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0010500835,0.000843276,0.0026444711,0.0004633937,0.00022357746,0.00005038597,0.0009090185,0.0007296047,0.0003662629],"category_scores_gemma":[0.000009858614,0.0005278216,0.00082214933,0.001294017,0.0009190505,0.00007626065,0.0002109222,0.0024353696,0.00013543082],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038091425,0.0009040113,0.00024360015,0.0042801546,0.004882467,0.00014076648,0.000202957,0.0000038429853,0.0034323747,0.0003702727,0.0007844131,0.9843742],"study_design_scores_gemma":[0.0019753692,0.00047395786,0.00057080353,0.0024744703,0.004457958,0.0001032502,0.000009829125,0.000063650084,0.00015090322,0.00020381127,0.9890767,0.00043931688],"about_ca_topic_score_codex":0.000022932407,"about_ca_topic_score_gemma":0.000013358545,"teacher_disagreement_score":0.9882923,"about_ca_system_score_codex":0.0006530222,"about_ca_system_score_gemma":0.001155456,"threshold_uncertainty_score":0.99986607},"labels":[],"label_agreement":null},{"id":"W2092023656","doi":"10.1016/j.pharmthera.2008.05.003","title":"Trans-arachidonic acids: new mediators of nitro-oxidative stress","year":2008,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Eicosanoids and Hypertension Pharmacology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Arachidonic acid; Chemistry; Peroxynitrite; Oxidative stress; Biochemistry; Polyunsaturated fatty acid; Isomerization; Unsaturated fatty acid; Lipid peroxidation; Fatty acid; Enzyme","score_opus":0.05141302311571751,"score_gpt":0.3628395860778493,"score_spread":0.3114265629621318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092023656","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001562132,0.99511355,0.00014236319,0.00017737215,0.001486765,0.0009114332,0.000380026,0.000034728833,0.00019163071],"genre_scores_gemma":[0.00079142983,0.99370337,0.00023952086,0.0026146143,0.001210812,0.00009974962,0.0006635669,0.00015126535,0.0005256702],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966467,0.0006557966,0.0009782071,0.00081402395,0.00024225509,0.00066301844],"domain_scores_gemma":[0.9982056,0.00015664235,0.000698394,0.00048248732,0.00017938731,0.000277504],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014334731,0.00080552296,0.001962745,0.0002373492,0.00013091604,0.000009032006,0.00090248935,0.0010792797,0.00039736734],"category_scores_gemma":[0.0000070345445,0.00068675715,0.00087198574,0.00028918116,0.0004907906,0.0000071781383,0.00020318192,0.00080343604,0.00003059303],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045820742,0.0012266265,0.000106067615,0.0030788514,0.01241867,0.00012445972,0.00036602907,0.000014004161,0.12937479,0.000031567743,0.043857533,0.8089432],"study_design_scores_gemma":[0.0015174679,0.0005582448,0.0000033590848,0.00020922124,0.004552159,0.00015440732,0.000018205992,0.0000055893847,0.026556388,0.000016502387,0.9658235,0.0005849617],"about_ca_topic_score_codex":0.0000111313875,"about_ca_topic_score_gemma":0.000009008506,"teacher_disagreement_score":0.92196596,"about_ca_system_score_codex":0.000045364835,"about_ca_system_score_gemma":0.0012920202,"threshold_uncertainty_score":0.9995584},"labels":[],"label_agreement":null},{"id":"W2092288835","doi":"10.1016/j.pharmthera.2013.06.006","title":"Vitamin D deficiency and severe asthma","year":2013,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Christie (Canada); McGill University","funders":"","keywords":"Asthma; Medicine; Vitamin D and neurology; vitamin D deficiency; Disease; Vitamin; Immunology; Internal medicine","score_opus":0.10368902920555677,"score_gpt":0.42944323697920744,"score_spread":0.32575420777365066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092288835","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019839486,0.99479145,0.000008996563,0.00074371917,0.00050607213,0.0019847893,0.000032220792,0.000096005686,0.0016383355],"genre_scores_gemma":[0.00008625498,0.9932596,0.00030193417,0.0018173107,0.00039014444,0.00044504422,0.00003285189,0.00009657329,0.0035702712],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975111,0.00034123042,0.00050844206,0.00058257254,0.00033376156,0.0007228903],"domain_scores_gemma":[0.99853265,0.0005218117,0.0002057984,0.00032476833,0.00017960333,0.00023538865],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032777488,0.0005779819,0.0018820886,0.00030046736,0.00019166037,0.00002921277,0.00027858705,0.00043267853,0.0005839526],"category_scores_gemma":[0.000015688753,0.00040302848,0.00029220825,0.00034523202,0.0005765575,0.000060402086,0.00035568498,0.0011552627,0.00047428487],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008663978,0.00019499013,0.000029177534,0.011981109,0.0015523501,0.0000999915,0.00012147157,4.4237755e-8,0.00008695391,0.00001556626,0.00784875,0.97806096],"study_design_scores_gemma":[0.00082707923,0.00036794905,0.00006970126,0.0012193779,0.0052782292,0.0007812843,0.00004741749,0.000013294078,0.000015247301,0.000019051726,0.991022,0.00033937272],"about_ca_topic_score_codex":0.0000045641077,"about_ca_topic_score_gemma":8.3678117e-7,"teacher_disagreement_score":0.98317325,"about_ca_system_score_codex":0.00018511376,"about_ca_system_score_gemma":0.0003861156,"threshold_uncertainty_score":0.99984217},"labels":[],"label_agreement":null},{"id":"W2095119333","doi":"10.1016/s0163-7258(02)00200-0","title":"Neurobiology of relapse to alcohol in rats","year":2002,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Neurotransmitter Receptor Influence on Behavior","field":"Neuroscience","cited_by":228,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health","funders":"Ontario Mental Health Foundation","keywords":"Neurochemical; Alcohol; Abstinence; Extinction (optical mineralogy); Drug; Alcohol dependence; Relapse prevention; Medicine; Self-administration; Psychology; Alcohol intake; Pharmacology; Alcohol use disorder; Neuroscience; Psychiatry; Biology","score_opus":0.22537885456115977,"score_gpt":0.43546030491671334,"score_spread":0.21008145035555356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095119333","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010677012,0.9807841,0.00000458589,0.0005039769,0.0035154808,0.0038491022,0.00016531907,0.00015287453,0.0003475074],"genre_scores_gemma":[0.0008076252,0.98724735,0.00005258496,0.010881561,0.00010276238,0.0004831688,0.0000041147937,0.00013836594,0.0002824688],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99497145,0.0016504755,0.0012421444,0.001096663,0.0002362791,0.0008030083],"domain_scores_gemma":[0.99795735,0.00078780967,0.0004832015,0.0005611313,0.000042455307,0.0001680781],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022278815,0.0006867955,0.001956923,0.0007696089,0.00005715679,0.000016199177,0.0014814916,0.0004940246,0.0008584734],"category_scores_gemma":[0.000017081285,0.0006259326,0.00041853572,0.0012564393,0.0003761727,0.000093593306,0.00019863165,0.0013500187,0.0008618287],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055986133,0.0007244691,0.000037799313,0.001691893,0.00007100901,0.00021620652,0.00028016733,0.00001226726,0.28223252,0.000032568805,0.0007615514,0.7138836],"study_design_scores_gemma":[0.00046772225,0.0002460733,0.00000522502,0.00047109576,0.00094136863,0.00009209483,0.0000013731077,0.0000033229092,0.0580599,0.000009046298,0.93925256,0.00045019793],"about_ca_topic_score_codex":0.0000036689135,"about_ca_topic_score_gemma":0.0000015753917,"teacher_disagreement_score":0.93849105,"about_ca_system_score_codex":0.00012228347,"about_ca_system_score_gemma":0.0001349685,"threshold_uncertainty_score":0.99991614},"labels":[],"label_agreement":null},{"id":"W2124894530","doi":"10.1016/j.pharmthera.2011.01.001","title":"Animal models of traumatic brain injury: A critical evaluation","year":2011,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Traumatic Brain Injury and Neurovascular Disturbances","field":"Medicine","cited_by":166,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Traumatic brain injury; Neuroscience; Medicine; Animal model; Physical medicine and rehabilitation; Psychology; Internal medicine","score_opus":0.3238355602847123,"score_gpt":0.480788684164854,"score_spread":0.1569531238801417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124894530","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00038279186,0.9946877,0.00016392618,0.00046015414,0.0006735849,0.0021250567,0.000066242166,0.00007400559,0.0013665771],"genre_scores_gemma":[0.004498625,0.9917848,0.00045385305,0.0023994332,0.00024070377,0.00040577826,0.000060136637,0.00009539942,0.00006125648],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99640024,0.0011268747,0.0010870383,0.0005173274,0.00045589596,0.00041265122],"domain_scores_gemma":[0.9978139,0.0009048258,0.0004116902,0.00046894915,0.00025520785,0.00014545326],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011835016,0.00051341555,0.0022356207,0.00026911806,0.00007358308,0.000009962809,0.00033202613,0.00047581378,0.0010049165],"category_scores_gemma":[0.00004702829,0.00041125232,0.0008265311,0.0003454737,0.00048287283,0.00011132743,0.000056318662,0.0007517984,0.000048793005],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027971156,0.00090665655,0.0000013647036,0.02095826,0.0031513395,0.0000125865645,0.00065912446,5.82974e-7,0.00016017004,0.0015125759,0.0013265264,0.9710311],"study_design_scores_gemma":[0.0016932954,0.0016565284,0.000016457934,0.0049181376,0.06362696,0.0002844774,0.000054441884,0.0015384866,0.0003104708,0.0021433802,0.92319745,0.000559899],"about_ca_topic_score_codex":0.0000031197233,"about_ca_topic_score_gemma":5.9745906e-7,"teacher_disagreement_score":0.9704712,"about_ca_system_score_codex":0.000100572244,"about_ca_system_score_gemma":0.0006492796,"threshold_uncertainty_score":0.9999083},"labels":[],"label_agreement":null},{"id":"W2135894529","doi":"10.1016/j.pharmthera.2005.10.008","title":"Vascular endothelial dysfunction in diabetic cardiomyopathy: Pathogenesis and potential treatment targets","year":2005,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Diabetes Association","keywords":"Diabetic cardiomyopathy; Internal medicine; Medicine; Diabetes mellitus; Pathogenesis; Cardiomyopathy; Population; Endocrinology; Myocyte; Endothelial dysfunction; Heart failure","score_opus":0.037951970075361156,"score_gpt":0.3263625641932271,"score_spread":0.28841059411786596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135894529","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00198288,0.9935654,0.00024992682,0.000054447708,0.002194967,0.0017341869,0.00008492266,0.00008799914,0.000045308556],"genre_scores_gemma":[0.001169706,0.9957555,0.000091790534,0.00046302006,0.0016012567,0.00032163283,0.00017710225,0.00011849465,0.00030148003],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99729824,0.00065374345,0.0005946044,0.0006797322,0.0002913441,0.00048235542],"domain_scores_gemma":[0.99908113,0.00012462465,0.00017320855,0.000365344,0.00006325418,0.00019240967],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033125345,0.000651246,0.0023265034,0.00048724684,0.000100990925,0.000020964379,0.00008666077,0.00055350736,0.00021726263],"category_scores_gemma":[0.000004317852,0.0004928002,0.0015796084,0.00028219575,0.00016224844,0.00004543764,0.00004976465,0.00044163677,0.00007266008],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009503129,0.00030674378,0.00075487694,0.0011862033,0.0051622945,0.00016095764,0.00007848385,0.0000305372,0.0002281213,0.0000011689974,0.000039822367,0.99195576],"study_design_scores_gemma":[0.0039340793,0.0002716878,0.0008000921,0.00027125774,0.035529923,0.00036948043,0.0000188521,0.00007801295,0.00005519733,0.0000015266236,0.9582969,0.00037301562],"about_ca_topic_score_codex":0.000021350217,"about_ca_topic_score_gemma":0.0000072636453,"teacher_disagreement_score":0.99158275,"about_ca_system_score_codex":0.0006152536,"about_ca_system_score_gemma":0.00040193248,"threshold_uncertainty_score":0.99975234},"labels":[],"label_agreement":null},{"id":"W2143989921","doi":"10.1016/s0163-7258(00)00064-4","title":"The structure and mechanism of bacterial type I signal peptidases","year":2000,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Bacterial Genetics and Biotechnology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":151,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of General Medical Sciences","keywords":"Signal peptidase; Proteases; Signal peptide; Bacillus subtilis; Serine; Catalytic triad; Escherichia coli; Biochemistry; Biology; Peptide sequence; Enzyme; Bacteria; Genetics; Gene","score_opus":0.027347976377115616,"score_gpt":0.3177953857794569,"score_spread":0.29044740940234126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143989921","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0067654843,0.99141604,0.000004889334,0.00006657213,0.0010212514,0.00046137464,0.00021969304,0.000011875361,0.00003280167],"genre_scores_gemma":[0.0026512274,0.995912,0.000082486615,0.0002018801,0.00071149674,0.000012735169,0.0002266626,0.00005312511,0.00014835042],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985682,0.00022752894,0.00041529624,0.00038743994,0.000079326746,0.0003222071],"domain_scores_gemma":[0.9992407,0.000052124687,0.00028336336,0.00030059545,0.000070297065,0.000052910636],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00011107783,0.00037553703,0.00065830926,0.00005313135,0.00013322764,0.000025517482,0.0004616424,0.00090451894,0.00022988401],"category_scores_gemma":[0.0000022906584,0.00025033814,0.00016262576,0.0001083742,0.00040579832,0.000001405318,0.00020628113,0.00031387305,0.000004353094],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016058315,0.000035991303,4.815658e-7,0.00037180565,0.0009792726,0.000002360895,0.00001176828,2.2519959e-7,0.2718884,0.00009305926,0.00038669692,0.72606933],"study_design_scores_gemma":[0.00026859972,0.00042433376,4.2029043e-7,0.000070264236,0.0013307616,0.00006264599,0.0000044293215,0.0000021314327,0.054647326,0.00013334164,0.9428211,0.00023468598],"about_ca_topic_score_codex":0.0000016479911,"about_ca_topic_score_gemma":0.000005610263,"teacher_disagreement_score":0.9424344,"about_ca_system_score_codex":0.000011343437,"about_ca_system_score_gemma":0.00022035696,"threshold_uncertainty_score":0.9999949},"labels":[],"label_agreement":null},{"id":"W2154437375","doi":"10.1016/j.pharmthera.2005.01.008","title":"Regulation of metabotropic glutamate receptor signaling, desensitization and endocytosis","year":2006,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Receptor Mechanisms and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":204,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Robarts Clinical Trials","funders":"","keywords":"Heterotrimeric G protein; Metabotropic glutamate receptor; Metabotropic glutamate receptor 1; G protein-coupled receptor; Cell biology; Metabotropic glutamate receptor 7; G protein-coupled receptor kinase; Biology; G protein; Metabotropic glutamate receptor 6; Signal transduction; Biochemistry; Receptor; Agonist","score_opus":0.03926971081452531,"score_gpt":0.33226427785816204,"score_spread":0.29299456704363674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154437375","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026017295,0.9940337,0.0020657144,0.00002130875,0.00067071844,0.00049829466,0.000060420472,0.000018135195,0.000030000207],"genre_scores_gemma":[0.0023264366,0.9945759,0.0014999758,0.00016803358,0.0005176529,0.000044242213,0.00056595897,0.00007211718,0.00022964682],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983102,0.00035792898,0.00054916285,0.0004095028,0.0001249476,0.000248273],"domain_scores_gemma":[0.9990802,0.000046891713,0.0005091075,0.00018611205,0.00012718135,0.000050549144],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020623517,0.00034874803,0.00080136675,0.000113443646,0.00008130359,0.000017486314,0.00015328161,0.00044065958,0.00012830824],"category_scores_gemma":[0.000002896402,0.00031494562,0.00024416376,0.00012340087,0.00010341022,0.000004656643,0.00007679651,0.00016354004,0.0000067326623],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034841632,0.00006162991,0.000005993903,0.0015833869,0.00088705745,0.000001035105,0.000016298514,0.000047582264,0.76303905,0.00005781251,0.00043097016,0.23383433],"study_design_scores_gemma":[0.0002745628,0.00014297418,0.0000012420952,0.00021231387,0.0022163086,0.000009708644,0.0000035258004,0.000049967395,0.19612949,0.00003958843,0.8006779,0.00024242923],"about_ca_topic_score_codex":0.0000052673654,"about_ca_topic_score_gemma":0.0000010307442,"teacher_disagreement_score":0.8002469,"about_ca_system_score_codex":0.000025351488,"about_ca_system_score_gemma":0.00010441758,"threshold_uncertainty_score":0.99993026},"labels":[],"label_agreement":null},{"id":"W2197016826","doi":"10.1016/j.pharmthera.2014.01.002","title":"Absorption, distribution and mechanism of action of SYSADOAS","year":2014,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Proteoglycans and glycosaminoglycans research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":113,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Chemistry; Mechanism of action; Receptor; Osteoclast; Pharmacology; Osteoarthritis; Hyaluronic acid; Chondroitin sulfate; Cell biology; Signal transduction; Biochemistry; Biology; Glycosaminoglycan; Medicine","score_opus":0.07080634141519065,"score_gpt":0.4062453407976818,"score_spread":0.33543899938249117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2197016826","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001649284,0.9923829,0.004662899,0.000036266327,0.00028226888,0.00065331225,0.00027774912,0.000007935149,0.000047421134],"genre_scores_gemma":[0.010629116,0.98823947,0.00006821488,0.00007030266,0.00019917304,0.00008113011,0.0005457155,0.000034163873,0.00013274043],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985013,0.00031378493,0.00047582074,0.00032876537,0.00014332167,0.0002369867],"domain_scores_gemma":[0.9990495,0.000045191755,0.00041838837,0.0002523069,0.00017175962,0.00006288258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035827627,0.00025719436,0.00077578943,0.000085833635,0.00004767856,0.000005828182,0.00024060975,0.00047705433,0.000029449982],"category_scores_gemma":[0.000007260964,0.00022393881,0.00020807845,0.00012634072,0.00023080983,0.0000029155058,0.00013122271,0.00024006315,0.0000031388477],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001313074,0.00016864589,0.000007508045,0.010228773,0.0013941162,0.0000015230947,0.000016915723,0.0000016993762,0.1525474,0.00057249883,0.0004948047,0.8344348],"study_design_scores_gemma":[0.0003836898,0.00039690972,0.0000033488554,0.0002897778,0.0012402216,0.000030100784,0.000005894572,0.000040057268,0.06524993,0.00009492405,0.93207884,0.00018628522],"about_ca_topic_score_codex":0.000011962543,"about_ca_topic_score_gemma":0.000003846444,"teacher_disagreement_score":0.93158406,"about_ca_system_score_codex":0.00002837388,"about_ca_system_score_gemma":0.00019145127,"threshold_uncertainty_score":0.913196},"labels":[],"label_agreement":null},{"id":"W2315584490","doi":"10.1016/j.pharmthera.2016.03.006","title":"Emerging pharmacologic targets and treatments for myocarditis","year":2016,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Viral Infections and Immunology Research","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Myocarditis; Medicine; Immune system; Immunosuppression; Immunology; Autoimmunity; Cardiomyopathy; Inflammation; Immune dysregulation; Dilated cardiomyopathy; Clinical trial; Heart failure; Internal medicine","score_opus":0.13518465142408614,"score_gpt":0.4900706542880334,"score_spread":0.3548860028639473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315584490","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007346106,0.9939328,0.00013233988,0.00096186524,0.0013652223,0.0028119655,0.00017220125,0.00010645869,0.00044371744],"genre_scores_gemma":[0.00003693052,0.99313515,0.00015649408,0.0017426028,0.00063059427,0.0015150806,0.00010509455,0.000095741685,0.002582281],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979152,0.0002856123,0.00047286684,0.0005427758,0.00011257816,0.0006709615],"domain_scores_gemma":[0.99886036,0.00043286715,0.00020969854,0.00021035118,0.00014173893,0.00014498601],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027024208,0.00049581594,0.0016351416,0.00035047176,0.0003023912,0.000016716785,0.00015641392,0.0004890153,0.0005913671],"category_scores_gemma":[0.000006733442,0.00032427598,0.0005263334,0.00019663258,0.0003541248,0.00006920971,0.00011541768,0.00054988434,0.00013413612],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010197596,0.00022823067,0.000023133824,0.0018736386,0.01016742,0.000040087278,0.000022476393,2.6719901e-8,0.00091423193,0.000014087101,0.003405101,0.9832096],"study_design_scores_gemma":[0.0028794063,0.00094084133,0.000012210961,0.0007016264,0.017086383,0.00027990193,0.000006376429,0.000013593094,0.00022551464,0.000054948465,0.9775253,0.00027392912],"about_ca_topic_score_codex":0.0000021093454,"about_ca_topic_score_gemma":1.631595e-7,"teacher_disagreement_score":0.98293567,"about_ca_system_score_codex":0.00024271362,"about_ca_system_score_gemma":0.00028492967,"threshold_uncertainty_score":0.9999209},"labels":[],"label_agreement":null},{"id":"W2328198526","doi":"10.1016/j.pharmthera.2016.03.003","title":"Emerging therapeutic targets in metastatic progression: A focus on breast cancer","year":2016,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":71,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Stem Cell Network; Howard Hughes Medical Institute; Brewster Foundation; Breast Cancer Research Foundation; U.S. Department of Defense","keywords":"Breast cancer; Metastasis; Metastatic breast cancer; Medicine; Cancer; Stromal cell; Oncology; Cancer research; Internal medicine","score_opus":0.0551328506508307,"score_gpt":0.4462391177077469,"score_spread":0.3911062670569162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328198526","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011379811,0.9957455,0.000051752275,0.0010998085,0.00093058206,0.0014849678,0.0002941973,0.00003509064,0.000244348],"genre_scores_gemma":[0.0010185171,0.9945636,0.000045718498,0.0011270284,0.0008897287,0.0014064187,0.00009455163,0.00020349844,0.0006509529],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957689,0.0011151651,0.0007406226,0.0009957122,0.00039257397,0.0009870196],"domain_scores_gemma":[0.9986136,0.00014554642,0.0003805924,0.0005520203,0.00012802599,0.00018023883],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005199985,0.00076966884,0.0012666269,0.000402237,0.00014123737,0.00002634158,0.00073497713,0.0005102758,0.0005999501],"category_scores_gemma":[0.000005554044,0.0005482195,0.0004694907,0.00039809718,0.0003038724,0.000007092792,0.00022815847,0.00083838694,0.00018678953],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019907116,0.00035289113,0.000006238653,0.001045877,0.001370833,0.00008791637,0.000053394633,0.0000028425725,0.008657915,0.000011913815,0.0017493588,0.98646176],"study_design_scores_gemma":[0.0010682162,0.00024841347,0.0000025359423,0.0020299468,0.00086924713,0.00011469865,0.000008061962,0.000011617126,0.0066498537,0.000033143144,0.988358,0.000606231],"about_ca_topic_score_codex":0.000008925252,"about_ca_topic_score_gemma":0.000022749096,"teacher_disagreement_score":0.9866087,"about_ca_system_score_codex":0.00032219777,"about_ca_system_score_gemma":0.0009014897,"threshold_uncertainty_score":0.9996969},"labels":[],"label_agreement":null},{"id":"W2412293388","doi":"10.1016/j.pharmthera.2016.06.005","title":"Phytochemicals in regulating fatty acid β-oxidation: Potential underlying mechanisms and their involvement in obesity and weight loss","year":2016,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Adipose Tissue and Metabolism","field":"Medicine","cited_by":168,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Beta oxidation; Weight loss; Lipolysis; Fatty acid; Endocrinology; Chemistry; Thermogenesis; Internal medicine; Lipid metabolism; Biochemistry; Adipose tissue; Biology; Obesity; Medicine","score_opus":0.08128609608245319,"score_gpt":0.3763389213670551,"score_spread":0.2950528252846019,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2412293388","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0150912395,0.9814828,0.0011376201,0.00052310346,0.0003627017,0.0013220182,0.000013911744,0.000032997377,0.000033617234],"genre_scores_gemma":[0.018827058,0.97860867,0.00076589594,0.0012385063,0.00028773263,0.000115993,0.000039847793,0.00005336344,0.00006293386],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979731,0.00028825647,0.0006425071,0.0005305742,0.00013681865,0.00042874526],"domain_scores_gemma":[0.99918556,0.00015545331,0.00028390976,0.00020291423,0.000045569515,0.00012661518],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00047547324,0.00044954426,0.0014830367,0.00025154965,0.00006990152,0.000013578964,0.00012854782,0.0004356715,0.0000965919],"category_scores_gemma":[0.000004519891,0.00031618465,0.00011551992,0.00020166667,0.00016716747,0.000085874584,0.00015751157,0.0005628683,0.0000067778396],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006657476,0.00021034745,0.00013511299,0.003164778,0.0006713819,0.00007708803,0.0005373725,1.3939213e-7,0.07979081,0.00019779828,0.00001621938,0.9151324],"study_design_scores_gemma":[0.010767429,0.00032742665,0.00074653205,0.013623173,0.007893267,0.0006906502,0.00023153817,0.00017515238,0.054539964,0.0073161386,0.9022126,0.0014761159],"about_ca_topic_score_codex":0.0000058814758,"about_ca_topic_score_gemma":0.0000055911055,"teacher_disagreement_score":0.9136563,"about_ca_system_score_codex":0.0001404782,"about_ca_system_score_gemma":0.00015172458,"threshold_uncertainty_score":0.999929},"labels":[],"label_agreement":null},{"id":"W2471053565","doi":"10.1016/j.pharmthera.2016.06.009","title":"Biologics and the lung: TSLP and other epithelial cell-derived cytokines in asthma","year":2016,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"IL-33, ST2, and ILC Pathways","field":"Immunology and Microbiology","cited_by":110,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Thymic stromal lymphopoietin; Immunology; Medicine; Asthma; Respiratory epithelium; Airway; Eosinophil; Inflammation; Lung; Wheeze; Internal medicine","score_opus":0.04567849226322612,"score_gpt":0.3298056613180669,"score_spread":0.28412716905484076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2471053565","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025587506,0.9915017,0.000026964137,0.00029929398,0.0017864924,0.001245141,0.0018754342,0.00007021712,0.0006360409],"genre_scores_gemma":[0.001957288,0.99350846,0.000019754902,0.0030700564,0.00027715086,0.00019961802,0.00005666862,0.000073833115,0.0008371811],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99600625,0.0018864141,0.00069769635,0.0006559133,0.00003846589,0.0007152864],"domain_scores_gemma":[0.99779725,0.0013473226,0.0004460915,0.00031071765,0.00006052028,0.000038106864],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00072995754,0.000706936,0.0017683718,0.000203501,0.00027906988,0.000023493452,0.0005096048,0.0011353322,0.00025112368],"category_scores_gemma":[0.000015084591,0.0003729771,0.00023314155,0.00018442427,0.001912201,0.000050162944,0.0002868799,0.0009784176,0.00019964881],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014835803,0.00049625867,0.00021081351,0.004130557,0.004689819,0.000057162168,0.0032254688,3.1990842e-7,0.06244229,0.0014461757,0.003029746,0.91878784],"study_design_scores_gemma":[0.0046874364,0.00013498314,0.000013794415,0.00041386162,0.0012880542,0.0001778955,0.000048631413,0.0000021244973,0.0015250383,0.00017902922,0.99107105,0.0004581229],"about_ca_topic_score_codex":0.000025291263,"about_ca_topic_score_gemma":0.000011488209,"teacher_disagreement_score":0.9880413,"about_ca_system_score_codex":0.000058640504,"about_ca_system_score_gemma":0.000208484,"threshold_uncertainty_score":0.9998722},"labels":[],"label_agreement":null},{"id":"W2533599595","doi":"10.1016/j.pharmthera.2016.10.011","title":"Treatment of brain metastases in the modern genomic era","year":2016,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Independent Electricity System Operator","keywords":"Medicine; Brain metastasis; Malignancy; Metastasis; Central nervous system; Breast cancer; Cancer; Bioinformatics; Pathology; Biology; Internal medicine","score_opus":0.13393524256777276,"score_gpt":0.43643469398679846,"score_spread":0.3024994514190257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2533599595","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00031533334,0.9936542,0.000033611952,0.0027239886,0.00027041655,0.0023602555,0.00040147468,0.000021973725,0.00021876891],"genre_scores_gemma":[0.00046478867,0.99531233,0.00022650616,0.0026230863,0.00026727945,0.0005149667,0.00015151291,0.00007201352,0.0003675047],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972146,0.0010094023,0.0007279908,0.00042123802,0.00020052087,0.0004262457],"domain_scores_gemma":[0.9977093,0.0012817038,0.00037243843,0.00052029797,0.000040054805,0.00007622581],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035285403,0.0005628185,0.0021410203,0.00024659745,0.000049542752,0.000008337225,0.00026531986,0.0002066926,0.0003417118],"category_scores_gemma":[0.0000028705213,0.0002614116,0.0007981536,0.00021756886,0.00019852005,0.000023588247,0.00003582639,0.00025139708,0.00007338351],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010902658,0.0015299341,0.000014470411,0.001229924,0.005257188,0.00028568588,0.0003543749,6.998136e-7,0.00011306382,0.000065068685,0.00038842735,0.99065214],"study_design_scores_gemma":[0.0033527804,0.0011450369,0.000014654575,0.0005680749,0.017727435,0.0003684411,0.000015636335,0.000011571337,0.00006721647,0.00013798317,0.9764002,0.00019097023],"about_ca_topic_score_codex":0.000018369568,"about_ca_topic_score_gemma":0.000005271765,"teacher_disagreement_score":0.9904612,"about_ca_system_score_codex":0.00035462776,"about_ca_system_score_gemma":0.00047844817,"threshold_uncertainty_score":0.9999838},"labels":[],"label_agreement":null},{"id":"W2588053926","doi":"10.1016/j.pharmthera.2017.02.029","title":"Myotoxicity of statins: Mechanism of action","year":2017,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":160,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"","keywords":"Pharmacology; Statin; Chemistry; Internal medicine; Myocyte; Endocrinology; Atorvastatin; Medicine","score_opus":0.3143587471228095,"score_gpt":0.4997394761489723,"score_spread":0.18538072902616282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588053926","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021365377,0.9963268,0.00032332478,0.000066088105,0.00084125996,0.0017196875,0.00007787464,0.000026536702,0.00040479557],"genre_scores_gemma":[0.0007775462,0.9977823,0.00027095128,0.0003944568,0.00040253383,0.00009960627,0.000040263072,0.000056921803,0.00017544918],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99804723,0.0003523612,0.0007169478,0.0002785926,0.00034464512,0.0002601991],"domain_scores_gemma":[0.9978552,0.00008252469,0.0011015991,0.00066568726,0.00020081447,0.00009421692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007503545,0.000299497,0.0025458883,0.0001715551,0.00007333732,0.0000037424468,0.0002493035,0.00042616713,0.00015490987],"category_scores_gemma":[0.000007732273,0.000232727,0.0009693609,0.00010620225,0.0001637519,0.000036387213,0.000065952765,0.0005639882,0.00001203728],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054660868,0.00022075982,0.0000013910151,0.026730232,0.0044185813,0.000013107429,0.0000548544,1.16258306e-7,0.0007066523,0.00011811586,0.00006351093,0.967618],"study_design_scores_gemma":[0.0011911796,0.00037327321,0.0000051840093,0.0020342176,0.016795937,0.00008395206,0.0000136209,0.000009367448,0.0056378082,0.00008879741,0.97361296,0.00015371596],"about_ca_topic_score_codex":0.000043851527,"about_ca_topic_score_gemma":0.000002501331,"teacher_disagreement_score":0.9735494,"about_ca_system_score_codex":0.00011372885,"about_ca_system_score_gemma":0.00085380767,"threshold_uncertainty_score":0.94903314},"labels":[],"label_agreement":null},{"id":"W2606691050","doi":"10.1016/j.pharmthera.2017.04.001","title":"Targeting Interleukin-17 signalling in cigarette smoke-induced lung disease: Mechanistic concepts and therapeutic opportunities","year":2017,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St Joseph's Health Care; McMaster University Medical Centre; St. Joseph’s Healthcare Hamilton","funders":"","keywords":"COPD; Medicine; Inflammation; Disease; Cigarette smoke; Immunology; Cytokine; Lung; Intervention (counseling); Intensive care medicine; Pulmonary disease; Smoke; Bioinformatics; Pathology; Environmental health; Biology; Internal medicine; Chemistry","score_opus":0.226846235770954,"score_gpt":0.45844757451062834,"score_spread":0.23160133873967434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606691050","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019911213,0.99264896,0.000047614074,0.00073600543,0.00088101666,0.0030858445,0.00017536608,0.000121095734,0.00031298454],"genre_scores_gemma":[0.030968606,0.96420264,0.000020764983,0.0020945284,0.0007459239,0.00058500736,0.00029728762,0.0002462786,0.00083895493],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949322,0.0009201368,0.0011360577,0.0011684659,0.00061862485,0.001224553],"domain_scores_gemma":[0.9968804,0.0007771688,0.0007300759,0.0006803849,0.00024582192,0.00068615103],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00086037826,0.0010522425,0.0026737098,0.00065916684,0.00041290766,0.00012613133,0.00077470206,0.0005556464,0.00085140223],"category_scores_gemma":[0.000035493347,0.0009526969,0.0005128896,0.000219427,0.0007233574,0.00014672028,0.00045052575,0.0021691741,0.000015465404],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043747755,0.00039721993,0.0003409801,0.025236286,0.0042356034,0.0035678782,0.00036561943,0.0000039045794,0.00040058055,0.00018265023,0.00023398611,0.9645978],"study_design_scores_gemma":[0.003735844,0.00023066039,0.00040089132,0.013136792,0.024240097,0.00023450902,0.00038721185,0.0073237494,0.000054001073,0.00042946517,0.94819635,0.001630399],"about_ca_topic_score_codex":0.000020392206,"about_ca_topic_score_gemma":0.0000030255371,"teacher_disagreement_score":0.9629674,"about_ca_system_score_codex":0.0010826715,"about_ca_system_score_gemma":0.00235942,"threshold_uncertainty_score":0.9992924},"labels":[],"label_agreement":null},{"id":"W2615223867","doi":"10.1016/j.pharmthera.2017.05.006","title":"Adverse outcome pathways: Application to enhance mechanistic understanding of neurotoxicity","year":2017,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"European Food Safety Authority","keywords":"Adverse Outcome Pathway; Mechanism (biology); Disease; Neurotoxicity; Neuroscience; Adverse effect; Bioinformatics; Biology; Computational biology; Medicine; Toxicity; Pharmacology; Pathology","score_opus":0.29256434067778636,"score_gpt":0.4757640480739471,"score_spread":0.18319970739616076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2615223867","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002083611,0.9737153,0.018709186,0.00015013127,0.0010382354,0.0051109493,0.00032431196,0.0001186352,0.00062487705],"genre_scores_gemma":[0.024556588,0.9724904,0.00038893378,0.0012937952,0.00017406016,0.00069748453,0.00008436975,0.00009739467,0.00021698825],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978926,0.00016310107,0.0006758173,0.00060477434,0.00026863298,0.00039503467],"domain_scores_gemma":[0.9980821,0.00014038704,0.00077358546,0.00065434386,0.00008215214,0.00026740818],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002364683,0.00049867714,0.0017929437,0.00024441822,0.00018429011,0.000010404263,0.0003742609,0.00029326277,0.00009936618],"category_scores_gemma":[0.000011127773,0.00042176066,0.00048803192,0.00016930385,0.00008993666,0.000041913656,0.0001230761,0.00037186133,0.0001574378],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038950346,0.0016577424,0.00008100911,0.015870726,0.0051753973,0.00032070428,0.00014448083,0.0000037634197,0.0046838624,0.0016260168,0.00013498883,0.9699118],"study_design_scores_gemma":[0.00075056887,0.00036983343,0.000016230873,0.0011210549,0.015647039,0.00003882435,0.000014132716,0.00008630071,0.0010898105,0.00042641518,0.9801135,0.00032627178],"about_ca_topic_score_codex":0.0000056604263,"about_ca_topic_score_gemma":0.0000019978027,"teacher_disagreement_score":0.9799785,"about_ca_system_score_codex":0.00052328693,"about_ca_system_score_gemma":0.00033026832,"threshold_uncertainty_score":0.99982345},"labels":[],"label_agreement":null},{"id":"W2617563780","doi":"10.1016/j.pharmthera.2017.05.005","title":"Cytochrome P450-derived eicosanoids and heart function","year":2017,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Eicosanoids and Hypertension Pharmacology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":120,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta; Canadian Institutes of Health Research; Alberta Innovates - Health Solutions","keywords":"Cytochrome P450; Arachidonic acid; Epoxygenase; Polyunsaturated fatty acid; CYP2C8; Monooxygenase; Biochemistry; Biology; Thromboxanes; Isozyme; Docosahexaenoic acid; Hydroxyeicosatetraenoic acid; Metabolism; Linoleic acid; Fatty acid; Enzyme; CYP2C9","score_opus":0.12911393359609602,"score_gpt":0.41846653650059423,"score_spread":0.2893526029044982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2617563780","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013033343,0.9954662,0.000059366706,0.0003448049,0.0014482344,0.00093271944,0.00008897455,0.000051728617,0.00030467316],"genre_scores_gemma":[0.0011417242,0.98729104,0.00011424502,0.008511116,0.0014424266,0.00024633086,0.00034870033,0.00014273064,0.000761668],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99719703,0.00048236822,0.0005779463,0.0009659987,0.000148397,0.00062828755],"domain_scores_gemma":[0.99847597,0.00007195867,0.00045889348,0.00063462544,0.00013639168,0.00022216128],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033066585,0.00072984764,0.0015616526,0.00016703986,0.00047480408,0.000073061645,0.0005497172,0.0010761068,0.00021589822],"category_scores_gemma":[0.000007601479,0.0006353959,0.0004654796,0.00007890802,0.00052777753,0.000010056136,0.00045704763,0.0006915891,0.00009753879],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016327386,0.00023730677,0.00001246327,0.0016157565,0.0030965547,0.000037809074,0.00001863322,6.4660827e-7,0.44168377,0.000022503267,0.01741298,0.5356983],"study_design_scores_gemma":[0.0009739035,0.00057171466,0.00007686345,0.00017367427,0.005587281,0.000323819,0.000004971372,0.000007837045,0.0018450225,0.000027336937,0.98978466,0.0006229454],"about_ca_topic_score_codex":0.0000038278445,"about_ca_topic_score_gemma":0.0000037855175,"teacher_disagreement_score":0.97237164,"about_ca_system_score_codex":0.000035158275,"about_ca_system_score_gemma":0.00037547637,"threshold_uncertainty_score":0.9996097},"labels":[],"label_agreement":null},{"id":"W2618666290","doi":"10.1016/j.pharmthera.2017.05.010","title":"Targeting GPNMB with glembatumumab vedotin: Current developments and future opportunities for the treatment of cancer","year":2017,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research; Celldex Therapeutics; McGill University; U.S. Department of Defense","keywords":"Clinical trial; Medicine; Context (archaeology); Metastasis; Cancer; Antibody-drug conjugate; Cancer research; Oncology; Bioinformatics; Internal medicine; Pharmacology; Immunology; Biology; Monoclonal antibody; Antibody","score_opus":0.41045955183852684,"score_gpt":0.519545667675315,"score_spread":0.10908611583678812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2618666290","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024452308,0.9940736,0.000004902905,0.0024475316,0.0008994473,0.0019848829,0.00024382657,0.00001232396,0.000088941044],"genre_scores_gemma":[0.000017375192,0.9952547,0.0001526825,0.00032895064,0.0015020135,0.0008398862,0.00013310071,0.000050209714,0.0017210938],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986061,0.000096416436,0.00039530065,0.00029065527,0.00022176791,0.00038978658],"domain_scores_gemma":[0.99870616,0.0003822988,0.00040798786,0.0001895731,0.00019945684,0.00011453729],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001626283,0.0004105764,0.0012617423,0.000091363574,0.0003645912,0.000020789705,0.00022872102,0.00014403732,0.00008627875],"category_scores_gemma":[0.0000012667942,0.00019612053,0.00021601215,0.000052329353,0.0004019775,0.000026707492,0.00005282766,0.00029986262,0.0000016771837],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041636417,0.00022282187,0.00014015788,0.0066454564,0.004644358,0.00002084577,0.00029078653,1.9663337e-7,0.000007813106,0.000022070793,0.00075158075,0.98683757],"study_design_scores_gemma":[0.0012704333,0.0006494199,0.000050591738,0.0011359209,0.008103171,0.000037834227,0.00008359788,0.000028945258,0.000038717946,0.000003596087,0.9884082,0.00018958648],"about_ca_topic_score_codex":0.000025081754,"about_ca_topic_score_gemma":0.000010961985,"teacher_disagreement_score":0.9876566,"about_ca_system_score_codex":0.00011940922,"about_ca_system_score_gemma":0.0010278447,"threshold_uncertainty_score":0.7997563},"labels":[],"label_agreement":null},{"id":"W2734722856","doi":"10.1016/j.pharmthera.2017.07.002","title":"Pharmacology of human trace amine-associated receptors: Therapeutic opportunities and challenges","year":2017,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Receptor Mechanisms and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":229,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"Russian Science Foundation","keywords":"Pharmacology; TRACE (psycholinguistics); Receptor; Chemistry; Medicine; Biochemistry","score_opus":0.3138377505589531,"score_gpt":0.42173314615166163,"score_spread":0.10789539559270855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2734722856","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011763306,0.9954131,0.000012425441,0.00029515137,0.00183166,0.0007893924,0.00008468867,0.000035557357,0.000361659],"genre_scores_gemma":[0.0017147876,0.9953152,0.000037701982,0.00047404907,0.0007766487,0.00017614105,0.00023019513,0.00015015276,0.00112513],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967724,0.00087167753,0.0008346529,0.00074365915,0.0001891276,0.00058845105],"domain_scores_gemma":[0.9978311,0.00013071833,0.0012459002,0.00044953404,0.00018834184,0.00015441573],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007224755,0.0007431696,0.0018551822,0.00019717395,0.00032681544,0.000034677014,0.0008113211,0.0010811538,0.00033158247],"category_scores_gemma":[0.0000065199483,0.00067382294,0.0004812585,0.000059279104,0.0005691304,0.000010976596,0.00026434386,0.0005171658,0.0000051778043],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052743933,0.00033295617,0.0000028401782,0.003185947,0.0054213726,0.000020057212,0.00020422606,6.070771e-7,0.07313448,0.000121822275,0.0008014112,0.9167215],"study_design_scores_gemma":[0.0008410069,0.00077905494,0.0000014687251,0.00047277703,0.0047165225,0.000040819585,0.000110478395,0.0000054058205,0.014584685,0.00005238351,0.9778032,0.00059222087],"about_ca_topic_score_codex":0.0000065126387,"about_ca_topic_score_gemma":0.0000070777105,"teacher_disagreement_score":0.9770018,"about_ca_system_score_codex":0.000047592675,"about_ca_system_score_gemma":0.0002852464,"threshold_uncertainty_score":0.9995713},"labels":[],"label_agreement":null},{"id":"W2745970345","doi":"10.1016/j.pharmthera.2017.08.002","title":"Binge-eating disorder: Clinical and therapeutic advances","year":2017,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Eating Disorders and Behaviors","field":"Psychology","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Binge-eating disorder; Endophenotype; Binge eating; Neuroimaging; Eating disorders; Population; Psychology; Clinical psychology; Cognition; Psychiatry; Neuroscience; Medicine; Bulimia nervosa","score_opus":0.2683092444013852,"score_gpt":0.5519874163262709,"score_spread":0.2836781719248857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2745970345","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00042793862,0.9904875,0.000026013005,0.00016288733,0.0052110436,0.0011280514,0.000039491857,0.00017099932,0.0023460456],"genre_scores_gemma":[0.0002529654,0.99493104,0.000115813564,0.0016040792,0.00080352003,0.00036947688,0.000035786903,0.00017971298,0.0017075929],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99536526,0.001309949,0.0012579536,0.0010713554,0.00018899587,0.00080649037],"domain_scores_gemma":[0.9966291,0.0010945313,0.0012582813,0.0007837717,0.00006753533,0.00016678566],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000884309,0.000822209,0.0023989314,0.00020499922,0.0006517309,0.00010119413,0.00096458115,0.0009655697,0.0008090175],"category_scores_gemma":[0.000009592902,0.0006622152,0.00065657066,0.00015433134,0.001144534,0.00008511063,0.0002266109,0.0016541893,0.00026694685],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025768932,0.00050387444,0.0062281545,0.0010538263,0.0015446657,0.000034337198,0.00027541892,1.1109407e-7,6.9855406e-7,0.000115817835,0.00028652372,0.9899308],"study_design_scores_gemma":[0.0009739251,0.00036302567,0.00024431475,0.0007416407,0.008486682,0.000061346196,0.00010733007,0.000007219479,1.2354799e-7,0.00016317744,0.98818713,0.00066408096],"about_ca_topic_score_codex":0.00002200111,"about_ca_topic_score_gemma":0.00001697316,"teacher_disagreement_score":0.9892667,"about_ca_system_score_codex":0.00003197212,"about_ca_system_score_gemma":0.0001703188,"threshold_uncertainty_score":0.9995829},"labels":[],"label_agreement":null},{"id":"W2746697572","doi":"10.1016/j.pharmthera.2017.08.009","title":"EMT: Mechanisms and therapeutic implications","year":2017,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":500,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Epithelial–mesenchymal transition; Metastasis; Cancer; Cancer stem cell; Cancer cell; Cancer research; Biology; Population; Mesenchymal stem cell; Medicine; Bioinformatics; Pathology; Genetics","score_opus":0.26383609961799576,"score_gpt":0.48431839133268617,"score_spread":0.22048229171469041,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2746697572","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000035170253,0.9943628,0.00028569845,0.0016233377,0.00087979494,0.0014351871,0.00010365219,0.000081285834,0.0012247472],"genre_scores_gemma":[0.000052921572,0.99089354,0.00051052636,0.005901321,0.00042494133,0.00036719357,0.000063426814,0.00011221512,0.0016739207],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99828506,0.00014161317,0.00046533858,0.00053927314,0.00013702245,0.0004317248],"domain_scores_gemma":[0.9984354,0.00015285106,0.00044148485,0.0006708488,0.00009072373,0.00020871824],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025169397,0.0004911718,0.0017693014,0.00018882133,0.00029481514,0.00004558707,0.00031670518,0.00038555465,0.00040296643],"category_scores_gemma":[0.0000020581651,0.00038188382,0.0004484079,0.000119002296,0.00020561436,0.00003115377,0.00012125282,0.0006563101,0.00009456929],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019794536,0.00011452664,0.0000024140413,0.002867561,0.0024204578,0.000015181986,0.000040630155,3.0508915e-8,0.00031377986,0.0004069152,0.00045133554,0.99334735],"study_design_scores_gemma":[0.0007104133,0.00014046498,0.000014981538,0.0005734816,0.029043615,0.00040979608,0.0000061256806,0.0000033692343,0.0000615483,0.00050552486,0.968232,0.00029869933],"about_ca_topic_score_codex":0.00000683538,"about_ca_topic_score_gemma":0.0000029303494,"teacher_disagreement_score":0.99304867,"about_ca_system_score_codex":0.00012729336,"about_ca_system_score_gemma":0.00052318134,"threshold_uncertainty_score":0.9998633},"labels":[],"label_agreement":null},{"id":"W2762816559","doi":"10.1016/j.pharmthera.2017.10.008","title":"CYP-mediated drug metabolism in the brain impacts drug response","year":2017,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":76,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"Ontario Ministry of Research and Innovation; Canadian Institutes of Health Research; Ontario Ministry of Research, Innovation and Science; Canada Research Chairs; Canada Foundation for Innovation; Campbell Family Mental Health Research Institute; Centre for Addiction and Mental Health","keywords":"Biology; Neuroscience; Drug development; Cytochrome P450; Pharmacology; Human brain; In vivo; Drug metabolism; Drug; Metabolism; Endocrinology","score_opus":0.2815211223130383,"score_gpt":0.5297347115403458,"score_spread":0.24821358922730752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2762816559","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025582116,0.9680988,0.000003391321,0.011858153,0.010034149,0.0042143795,0.001071868,0.00022723607,0.0019338185],"genre_scores_gemma":[0.00198155,0.94272286,0.00004223861,0.048479587,0.002416604,0.001239317,0.00031574303,0.0003358167,0.0024662944],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.97245073,0.020063624,0.0024192994,0.001613352,0.00080341846,0.002649579],"domain_scores_gemma":[0.98362964,0.011528291,0.0020993925,0.0017251925,0.00025872848,0.00075875333],"candidate_categories":["metaepi_narrow","sts","open_science","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.013697852,0.0021663627,0.0042939773,0.0012332367,0.0013030391,0.00026052294,0.0057915864,0.0017582837,0.0017343092],"category_scores_gemma":[0.00025457604,0.0015934407,0.0015500613,0.0011442237,0.0014272385,0.00032590542,0.00074619456,0.0080073355,0.0015221006],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025788832,0.0022378813,0.00004156766,0.0030204607,0.0064617037,0.0015500861,0.007329143,0.000033408975,0.0030220957,0.00023933085,0.11870676,0.85477865],"study_design_scores_gemma":[0.004538058,0.0000550211,0.0000845608,0.00039852053,0.01249763,0.00025381558,0.00012716583,0.00017580655,0.00050710276,0.00020933995,0.97964036,0.0015126432],"about_ca_topic_score_codex":0.000057550853,"about_ca_topic_score_gemma":0.000056963632,"teacher_disagreement_score":0.8609336,"about_ca_system_score_codex":0.00034772887,"about_ca_system_score_gemma":0.0020771676,"threshold_uncertainty_score":0.99999714},"labels":[],"label_agreement":null},{"id":"W2768032770","doi":"10.1016/j.pharmthera.2017.10.017","title":"Glioblastoma and chemoresistance to alkylating agents: Involvement of apoptosis, autophagy, and unfolded protein response","year":2017,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":320,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; University of British Columbia; CancerCare Manitoba; Vancouver General Hospital; Research Institute in Oncology and Hematology; University of Manitoba","funders":"Natural Sciences and Engineering Research Council of Canada; Cancer Research Society; Mitacs; Health Foundation; Canada Foundation for Innovation; Research Manitoba","keywords":"Autophagy; Apoptosis; Unfolded protein response; Glioblastoma; Cancer research; Biology; Cell biology; Chemistry; Genetics","score_opus":0.12713031849987205,"score_gpt":0.42980498265221645,"score_spread":0.3026746641523444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2768032770","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13489021,0.8611106,0.000001856456,0.00081209245,0.00015617424,0.0029068063,0.000054320975,0.00003330956,0.000034604425],"genre_scores_gemma":[0.019300897,0.9778636,0.0005633279,0.0011014601,0.00009833714,0.0008202305,0.000015871838,0.000072399045,0.00016383964],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99795526,0.00024404506,0.00065091735,0.0005473613,0.00022929357,0.00037310596],"domain_scores_gemma":[0.9983298,0.0002646887,0.00061156263,0.00044192155,0.00011262504,0.0002393564],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004876917,0.0005017514,0.001767256,0.00028369183,0.00016663955,0.000031925127,0.00019053002,0.00025849155,0.000052605865],"category_scores_gemma":[0.000025879948,0.0004006564,0.00019581817,0.00015693218,0.0002240406,0.00004362068,0.00020764119,0.000274771,0.000009029867],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015344514,0.0008044404,0.000106966145,0.011235885,0.0039987992,0.00014172989,0.00042914366,2.427861e-7,0.02059849,0.000023232004,0.00059361185,0.960533],"study_design_scores_gemma":[0.003125209,0.0012204723,0.00028336208,0.006775361,0.008653061,0.000058332043,0.000029620107,0.0000140905195,0.032458458,0.000020614307,0.94700366,0.00035776812],"about_ca_topic_score_codex":0.000010306307,"about_ca_topic_score_gemma":0.0000046118153,"teacher_disagreement_score":0.9601752,"about_ca_system_score_codex":0.00017455997,"about_ca_system_score_gemma":0.00023699921,"threshold_uncertainty_score":0.99984455},"labels":[],"label_agreement":null},{"id":"W2781460303","doi":"10.1016/j.pharmthera.2017.12.009","title":"Persistent induction of goblet cell differentiation in the airways: Therapeutic approaches","year":2017,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Neonatal Respiratory Health Research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Mucus; Goblet cell; Biology; Cellular differentiation; Cell; Immunology; Cell biology; Medicine; Pathology; Epithelium; Ecology; Biochemistry","score_opus":0.5237418225475805,"score_gpt":0.4891817140607917,"score_spread":0.03456010848678881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2781460303","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00065247784,0.99404943,0.000012498122,0.00096909713,0.00052621245,0.0030722592,0.000023623177,0.000021338812,0.00067306316],"genre_scores_gemma":[0.008686004,0.9888345,0.000021915632,0.0012507384,0.00034607307,0.00046493468,0.0000777961,0.000071624396,0.0002464268],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962007,0.0013154418,0.00085130974,0.0004799508,0.0005999138,0.00055269053],"domain_scores_gemma":[0.99772155,0.00051820546,0.0007777796,0.000755821,0.000118697906,0.00010796689],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013522247,0.00043939985,0.0015268399,0.00045523533,0.00018647457,0.00002693466,0.0007732624,0.0005620025,0.00012004189],"category_scores_gemma":[0.000011742129,0.00028061285,0.00060290395,0.0003164963,0.00036973917,0.00007479885,0.00010273722,0.0017977703,0.000047560527],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014274425,0.0006967058,0.000035666086,0.021443471,0.0006276897,0.000017926974,0.00061455584,0.0000011573276,0.00018778678,0.00002462472,0.00006699013,0.9761407],"study_design_scores_gemma":[0.0011980319,0.0005808168,0.000088908266,0.0009994793,0.0047682277,0.00005550042,0.00020997916,0.000083539446,0.00015938301,0.00002494024,0.9916304,0.00020081738],"about_ca_topic_score_codex":0.00001868272,"about_ca_topic_score_gemma":0.0000051837337,"teacher_disagreement_score":0.9915634,"about_ca_system_score_codex":0.00036072847,"about_ca_system_score_gemma":0.000961308,"threshold_uncertainty_score":0.9999646},"labels":[],"label_agreement":null},{"id":"W2787532065","doi":"10.1016/j.pharmthera.2018.01.002","title":"Cardiac repair by epicardial EMT: Current targets and a potential role for the primary cilium","year":2018,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Congenital heart defects research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research; Public Health Agency of Canada; Natural Sciences and Engineering Research Council of Canada; Heart and Stroke Foundation of Canada","keywords":"Myocardial infarction; Medicine; Neovascularization; Regeneration (biology); Epithelial–mesenchymal transition; Cilium; Heart development; Angiogenesis; Bioinformatics; Cardiology; Internal medicine; Biology; Cell biology; Cancer; Metastasis; Embryonic stem cell","score_opus":0.03665316162167776,"score_gpt":0.38113030492270494,"score_spread":0.3444771433010272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2787532065","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001984059,0.99404913,0.00015597773,0.00011869775,0.0021445036,0.0024871295,0.0007266665,0.00003411237,0.000085398926],"genre_scores_gemma":[0.00014926556,0.9944103,0.00006330897,0.0005366651,0.0027412728,0.00087239465,0.00058818626,0.000098488155,0.0005401555],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99742746,0.0005587397,0.00040285633,0.0007529532,0.00021357342,0.0006443903],"domain_scores_gemma":[0.998807,0.00023485527,0.00014919986,0.0004781103,0.00018497692,0.00014587416],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005980459,0.00047070775,0.00088375655,0.00006117804,0.00029428417,0.000039853843,0.00044494367,0.00046675993,0.0000303206],"category_scores_gemma":[0.000012851419,0.0003457956,0.0009538655,0.00010584717,0.00047156832,0.0000041897933,0.0005126919,0.0004991515,0.000024786772],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017620678,0.000110345114,0.0000068259583,0.0021360253,0.0035405306,0.0000024235474,0.000024455398,1.8876742e-7,0.0087080235,0.0000014792926,0.054169208,0.93112427],"study_design_scores_gemma":[0.00042900338,0.00035594733,0.0000048576176,0.00006412619,0.0040457416,0.000024545781,0.0000049125674,0.000037302903,0.0006909937,0.0000119156175,0.99398726,0.00034336455],"about_ca_topic_score_codex":0.000002777898,"about_ca_topic_score_gemma":0.0000013427958,"teacher_disagreement_score":0.9398181,"about_ca_system_score_codex":0.00006135396,"about_ca_system_score_gemma":0.00045630673,"threshold_uncertainty_score":0.9998994},"labels":[],"label_agreement":null},{"id":"W2793698856","doi":"10.1016/j.pharmthera.2018.02.008","title":"The relaxin receptor as a therapeutic target – perspectives from evolution and drug targeting","year":2018,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Pregnancy-related medical research","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Winnipeg","funders":"National Health and Medical Research Council; State Government of Victoria; Natural Sciences and Engineering Research Council of Canada; Australian Research Council; Norges Forskningsråd; Medical Research Council","keywords":"Relaxin; G protein-coupled receptor; Agonist; Biology; Receptor; Signal transduction; Computational biology; Bioinformatics; Cell biology; Pharmacology; Genetics","score_opus":0.052816808009784486,"score_gpt":0.4102530642263474,"score_spread":0.3574362562165629,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793698856","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009981464,0.9915279,0.00008456834,0.003535523,0.0015193609,0.0022690375,0.000050789615,0.00018432709,0.0007286727],"genre_scores_gemma":[0.00022293032,0.9929461,0.00042075646,0.0013544462,0.0017030986,0.00037078653,0.000106987616,0.00017923102,0.0026956804],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9945883,0.0017153125,0.00087209156,0.0010150258,0.0007442406,0.0010650299],"domain_scores_gemma":[0.9949799,0.0031347491,0.00047877795,0.0005822366,0.00037416656,0.00045015453],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016348548,0.0007214056,0.0016047301,0.00022950157,0.0006756419,0.000065841596,0.0006520365,0.0008382608,0.0011365995],"category_scores_gemma":[0.00024336996,0.00045506758,0.00046925925,0.0005534527,0.0017050989,0.00009442824,0.000328518,0.0031122952,0.0007735687],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006298529,0.00049340696,0.000027724303,0.0022460101,0.010196568,0.000085389765,0.0032154915,1.1090252e-7,0.0008188189,0.00050125126,0.027460707,0.95432466],"study_design_scores_gemma":[0.001227956,0.00032796984,0.000005390234,0.0061700847,0.006101263,0.000050800918,0.00060675875,0.0000921326,0.000083581865,0.0013183763,0.98362136,0.00039432794],"about_ca_topic_score_codex":0.00004889825,"about_ca_topic_score_gemma":0.0000025923428,"teacher_disagreement_score":0.95616066,"about_ca_system_score_codex":0.0008544061,"about_ca_system_score_gemma":0.0016937106,"threshold_uncertainty_score":0.99979013},"labels":[],"label_agreement":null},{"id":"W2888161369","doi":"10.1016/j.pharmthera.2018.08.005","title":"Air pollution and resistance to inhaled glucocorticoids: Evidence, mechanisms and gaps to fill","year":2018,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Air Quality and Health Impacts","field":"Environmental Science","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; Mitacs; AllerGen; Canada Research Chairs; Michael Smith Health Research BC","keywords":"Asthma; Glucocorticoid; Air pollution; Glucocorticoid receptor; Medicine; Environmental health; Pollution; Tobacco smoke; Immunology; Biology; Ecology","score_opus":0.1268597481005913,"score_gpt":0.4199678735962697,"score_spread":0.2931081254956784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888161369","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00058985694,0.98446214,0.0010599904,0.010742666,0.0005247927,0.0021922782,0.000054367065,0.000071370785,0.0003025217],"genre_scores_gemma":[0.00022218731,0.9171469,0.0051465495,0.07639632,0.00017059647,0.0001778472,0.000004244995,0.00004132281,0.0006940376],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99727,0.0005342279,0.00058051385,0.0007009095,0.0002674363,0.00064691284],"domain_scores_gemma":[0.9985632,0.00029497407,0.00025487907,0.0002842689,0.000020938629,0.00058179063],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009244007,0.00041448598,0.00086699275,0.000119768796,0.00031646166,0.00002851211,0.00033028534,0.0003298643,0.0005272934],"category_scores_gemma":[0.00003337017,0.00036101058,0.00007565383,0.00044932906,0.00030139618,0.0001597581,0.0004046145,0.00035461763,0.00058771006],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033856567,0.00019289152,0.000025585363,0.0069055455,0.00038273798,0.00005074647,0.0025927587,0.000010089347,0.00073295267,0.00041345836,0.063683,0.92467165],"study_design_scores_gemma":[0.00019717295,0.0003437529,0.00014177542,0.0013900856,0.00084754423,0.000037164686,0.00002029595,0.000011354871,0.0000852166,0.0006598754,0.9958867,0.00037909506],"about_ca_topic_score_codex":0.00003210046,"about_ca_topic_score_gemma":0.0001340224,"teacher_disagreement_score":0.93220365,"about_ca_system_score_codex":0.00038551175,"about_ca_system_score_gemma":0.00010416261,"threshold_uncertainty_score":0.9998842},"labels":[],"label_agreement":null},{"id":"W2894906598","doi":"10.1016/j.pharmthera.2018.10.001","title":"Endothelins in inflammatory neurological diseases","year":2018,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Neuroinflammation and Neurodegeneration Mechanisms","field":"Neuroscience","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"National Institute of Neurological Disorders and Stroke; National Institute of Allergy and Infectious Diseases; Canadian Institutes of Health Research","keywords":"Endothelins; Neurodegeneration; Medicine; Central nervous system; Mediator; Neuroinflammation; Immunology; Inflammation; Alzheimer's disease; Endothelin receptor; Disease; Neuroscience; Biology; Internal medicine; Receptor","score_opus":0.15141056782601725,"score_gpt":0.3972235473379428,"score_spread":0.24581297951192554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2894906598","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013793015,0.9918602,0.000042060143,0.0003827832,0.0036539733,0.0017468305,0.00013675226,0.00046771273,0.00033037266],"genre_scores_gemma":[0.000133281,0.9816007,0.00002482436,0.016720353,0.00072722236,0.00029047104,0.000015752064,0.00010995847,0.00037741484],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950356,0.002082936,0.0009408756,0.0010314747,0.00031403228,0.0005951124],"domain_scores_gemma":[0.99792886,0.00097342697,0.0004613416,0.00042544762,0.000037506503,0.00017341146],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020199532,0.00061471824,0.0010438666,0.0004645077,0.00017940956,0.00008200593,0.0008650945,0.00036215325,0.00077043433],"category_scores_gemma":[0.000051226816,0.0005163257,0.00036862883,0.0004836618,0.0003165797,0.00013543484,0.00021280162,0.0008990245,0.0012149869],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031561812,0.0017524569,0.000045990993,0.00549054,0.00023248336,0.0027402057,0.00028487184,0.000050176506,0.08214104,0.0067474367,0.0049554636,0.8952437],"study_design_scores_gemma":[0.00048818317,0.00015027862,0.0000021828178,0.00012020883,0.0005889376,0.00011497772,8.105958e-7,0.00033566396,0.008387134,0.0001857389,0.9892183,0.00040760095],"about_ca_topic_score_codex":1.8002574e-7,"about_ca_topic_score_gemma":0.0000010995874,"teacher_disagreement_score":0.9842628,"about_ca_system_score_codex":0.00005577697,"about_ca_system_score_gemma":0.00028090226,"threshold_uncertainty_score":0.99972886},"labels":[],"label_agreement":null},{"id":"W2921123848","doi":"10.1016/j.pharmthera.2019.03.003","title":"Emerging drug development technologies targeting ubiquitination for cancer therapeutics","year":2019,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":64,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph; University of Toronto","funders":"Canadian Institutes of Health Research; Cancer Research Society; Genome Canada","keywords":"Drug discovery; Proteasome; Cancer; Drug development; Ubiquitin; Medicine; Drug; Cancer therapy; Cancer research; Bioinformatics; Biology; Pharmacology; Cell biology; Internal medicine; Biochemistry","score_opus":0.08099226102202954,"score_gpt":0.3933408033563059,"score_spread":0.31234854233427634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921123848","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002262899,0.9940228,0.0009360016,0.0003923836,0.0015628396,0.0024288422,0.00013575956,0.00015747559,0.00013760285],"genre_scores_gemma":[0.00020794677,0.99148476,0.002075879,0.0015238535,0.00063876464,0.002076126,0.00073110545,0.00017881945,0.0010827724],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973047,0.00022916734,0.000742764,0.0008027558,0.00018195425,0.0007386972],"domain_scores_gemma":[0.99859923,0.00012956101,0.0006387758,0.00034798915,0.0002350357,0.000049398095],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005768608,0.0006929914,0.0010197831,0.00018875262,0.00028951824,0.00004219072,0.00076243933,0.00076010707,0.000049301547],"category_scores_gemma":[0.000009015044,0.0006195384,0.0004191709,0.00020162479,0.00013369716,0.000007422704,0.00030264075,0.0005027198,0.000035068642],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003700606,0.00008023949,0.0000069691832,0.0045445273,0.001725608,0.0000011949056,0.00017281629,0.000007622043,0.013154438,0.00002509022,0.0013387044,0.9789058],"study_design_scores_gemma":[0.00045924948,0.00008558579,2.2058622e-7,0.00049673667,0.0019803788,0.00000679085,0.00009929702,0.00004707518,0.087046646,0.000030369065,0.9090925,0.000655175],"about_ca_topic_score_codex":0.0000016650496,"about_ca_topic_score_gemma":0.0000047965473,"teacher_disagreement_score":0.9782506,"about_ca_system_score_codex":0.00014428857,"about_ca_system_score_gemma":0.0007972864,"threshold_uncertainty_score":0.9996256},"labels":[],"label_agreement":null},{"id":"W2944139900","doi":"10.1016/j.pharmthera.2019.05.004","title":"Primary aromatic amines and cancer: Novel mechanistic insights using 4-aminobiphenyl as a model carcinogen","year":2019,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Carcinogens and Genotoxicity Assessment","field":"Biochemistry, Genetics and Molecular Biology","cited_by":77,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Canada Research Chairs","funders":"Canadian Liver Foundation; Canadian Institutes of Health Research; Cancer Research Society","keywords":"Aromatic amine; Carcinogen; Chemistry; Carcinogenesis; Amine gas treating; Adduct; Electrophile; DNA; DNA adduct; Cancer; Enzyme; Biochemistry; Stereochemistry; Organic chemistry; Biology; Genetics; Gene","score_opus":0.11864873424115775,"score_gpt":0.39830663053531706,"score_spread":0.2796578962941593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944139900","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022633929,0.97348195,0.0014989764,0.000028716395,0.00064023334,0.0013885968,0.00021800822,0.000022030219,0.00008757971],"genre_scores_gemma":[0.0031097839,0.9921036,0.0009131989,0.0023339805,0.00043678776,0.00020714792,0.0002779318,0.00013820085,0.00047938398],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976803,0.00015662826,0.0005736975,0.00086069846,0.00021294251,0.00051573175],"domain_scores_gemma":[0.9988381,0.000055942837,0.00041708775,0.0004558847,0.00008663381,0.0001463079],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012434635,0.0007177067,0.0013880455,0.00015757998,0.00016382129,0.000038975115,0.0004052801,0.0006227397,0.000020793732],"category_scores_gemma":[0.0000022104023,0.0006384303,0.00035418637,0.0001519043,0.00015562413,0.0000063637694,0.0004019972,0.00035232105,0.000010031533],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006299336,0.00028876925,0.000010819902,0.008220332,0.0033746306,0.000016934007,0.00014517958,0.0004349958,0.85123116,0.000041402884,0.000098853394,0.13607393],"study_design_scores_gemma":[0.0014027274,0.00038014314,0.0000053215185,0.00088376505,0.016828034,0.0003100434,0.00003129868,0.0115356855,0.011357441,0.00012885881,0.9557503,0.0013863723],"about_ca_topic_score_codex":0.00004067309,"about_ca_topic_score_gemma":0.000014560458,"teacher_disagreement_score":0.95565146,"about_ca_system_score_codex":0.00018773487,"about_ca_system_score_gemma":0.0009243548,"threshold_uncertainty_score":0.99960667},"labels":[],"label_agreement":null},{"id":"W2944411542","doi":"10.1016/j.pharmthera.2019.05.006","title":"Biased signaling of G protein coupled receptors (GPCRs): Molecular determinants of GPCR/transducer selectivity and therapeutic potential","year":2019,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Receptor Mechanisms and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":151,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Canadian Institutes of Health Research; Bushehr University of Medical Sciences","keywords":"G protein-coupled receptor; Functional selectivity; Signal transduction; Receptor; Biology; Cell biology; G protein; Computational biology; Chemistry; Biochemistry","score_opus":0.04506476697623272,"score_gpt":0.3434759537930001,"score_spread":0.29841118681676737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944411542","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15385482,0.84275323,0.0012350548,0.00000813512,0.0005306847,0.001542561,0.00005313329,0.000013931633,0.000008451271],"genre_scores_gemma":[0.15572506,0.8431786,0.00041201367,0.0001601979,0.00014875479,0.00010696701,0.00006899221,0.00013505084,0.00006436904],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969213,0.0006727915,0.00093070045,0.00072500424,0.00026754235,0.00048265222],"domain_scores_gemma":[0.9983388,0.00007462233,0.00089928595,0.0003750217,0.00021509096,0.00009718996],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005857797,0.00063494523,0.0017789291,0.0001846752,0.0000738662,0.000015293224,0.00044174746,0.00081060233,0.00017204443],"category_scores_gemma":[0.0000061359733,0.0005656221,0.000591382,0.00023784806,0.00023678926,0.0000059077875,0.000119602315,0.00041808945,0.0000033919475],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014220657,0.00015771545,0.000010044182,0.0035749518,0.0014277038,0.00000506598,0.000045937093,0.000035868354,0.82702076,0.0000047526737,0.000004094736,0.16757087],"study_design_scores_gemma":[0.0011281326,0.00089855364,0.000001020823,0.00095867127,0.004815252,0.000035081986,0.000021437545,0.0004398678,0.881141,0.00003522138,0.109884664,0.00064109406],"about_ca_topic_score_codex":0.000012557915,"about_ca_topic_score_gemma":0.0000015985056,"teacher_disagreement_score":0.16692978,"about_ca_system_score_codex":0.000031231673,"about_ca_system_score_gemma":0.00042832218,"threshold_uncertainty_score":0.9996795},"labels":[],"label_agreement":null},{"id":"W2953476200","doi":"10.1016/j.pharmthera.2019.06.008","title":"Endozepines and their receptors: Structure, functions and pathophysiological significance","year":2019,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Cardiovascular, Neuropeptides, and Oxidative Stress Research","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Normandie Université; Institut National de la Santé et de la Recherche Médicale; Agence Nationale de la Recherche; Canadian Institutes of Health Research; European Commission","keywords":"Receptor; Translocator protein; Allosteric regulation; Cell biology; Biology; Neuropeptide; Biochemistry; Neuroactive steroid; Astrocyte; GABAA receptor; Central nervous system; Neuroscience","score_opus":0.131795032796298,"score_gpt":0.39725909914937524,"score_spread":0.26546406635307723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953476200","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013665074,0.9956243,0.000022789816,0.00009973203,0.0007640306,0.001581905,0.00025294372,0.000060606424,0.00022716551],"genre_scores_gemma":[0.00088394305,0.9962345,0.00004204327,0.0008119455,0.00080386095,0.00011850395,0.00016046088,0.0000735723,0.000871216],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975316,0.0007349097,0.00037685162,0.0007462231,0.00017940409,0.00043100832],"domain_scores_gemma":[0.9985124,0.0006565079,0.00015635882,0.0003542019,0.000141311,0.00017922751],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017328828,0.0005357626,0.0019550729,0.00018195888,0.0001391352,0.00003263042,0.0001603581,0.0003542089,0.0002829553],"category_scores_gemma":[0.000017351136,0.00033512048,0.0004428316,0.0002509969,0.0005875776,0.000048042395,0.0001973813,0.0011086771,0.000033589327],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009855386,0.00007067943,0.000025070303,0.005115166,0.0026239161,0.000033925484,0.000058154317,5.251621e-7,0.005116979,0.0000067663614,0.0007321766,0.9861181],"study_design_scores_gemma":[0.0008132474,0.00037789968,0.000101890146,0.00058467133,0.0039634723,0.00026666294,0.000040841544,0.000013299074,0.00026296283,0.000026298616,0.9932611,0.00028766904],"about_ca_topic_score_codex":0.0000037719983,"about_ca_topic_score_gemma":7.73222e-7,"teacher_disagreement_score":0.9925289,"about_ca_system_score_codex":0.00005700286,"about_ca_system_score_gemma":0.00020296015,"threshold_uncertainty_score":0.99991006},"labels":[],"label_agreement":null},{"id":"W2980394299","doi":"10.1016/j.pharmthera.2019.107415","title":"Modulation of retinoid signaling: therapeutic opportunities in organ fibrosis and repair","year":2019,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Laurentian University","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; Natural Sciences and Engineering Research Council of Canada; National Institutes of Health","keywords":"Retinoic acid; Retinoid; Fibrosis; Biology; Cell biology; Cancer research; Tretinoin; Retinoid X receptor; Myofibroblast; Medicine; Internal medicine; Nuclear receptor; Transcription factor; Biochemistry","score_opus":0.1055039827864401,"score_gpt":0.35868926067922585,"score_spread":0.2531852778927858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980394299","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010904762,0.98781806,0.00006012866,0.000037212107,0.00030323432,0.00060712633,0.000030737494,0.000023948354,0.00021477735],"genre_scores_gemma":[0.015604897,0.982695,0.00016667014,0.00045174232,0.00018953672,0.000063771025,0.0002347121,0.00008485793,0.000508823],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99789417,0.00042401525,0.0006891345,0.0005348737,0.00014260373,0.00031520988],"domain_scores_gemma":[0.9989207,0.00010368388,0.00046662206,0.00034643192,0.00010749807,0.000055058936],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003713629,0.00043147578,0.0009921802,0.00017057681,0.000047233767,0.000013668548,0.00030716628,0.00066157436,0.000050838997],"category_scores_gemma":[0.0000059450754,0.00038888364,0.0002769114,0.00017219613,0.00025308743,0.000006532152,0.00014415501,0.00033823136,0.000004147322],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023981798,0.00032409353,0.0006992697,0.030968882,0.0027540787,0.000021505615,0.00035468716,0.00006038638,0.24385814,0.000119030694,0.0003762461,0.72022384],"study_design_scores_gemma":[0.0005663174,0.0003520969,0.000015060265,0.0007230174,0.0021292572,0.000037396996,0.00007435275,0.00010137831,0.020894974,0.00006104089,0.9745612,0.00048389274],"about_ca_topic_score_codex":0.0000036426582,"about_ca_topic_score_gemma":9.823452e-7,"teacher_disagreement_score":0.974185,"about_ca_system_score_codex":0.000042489217,"about_ca_system_score_gemma":0.00044102923,"threshold_uncertainty_score":0.9998563},"labels":[],"label_agreement":null},{"id":"W2980699954","doi":"10.1016/j.pharmthera.2019.107416","title":"The role of DNA-demethylating agents in cancer therapy","year":2019,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Princess Margaret Cancer Foundation","keywords":"DNA methylation; Methylation; Cancer; Cancer research; Demethylating agent; DNA; Biology; Bioinformatics; Medicine; Genetics; Gene; Gene expression","score_opus":0.12906671855277452,"score_gpt":0.44240017953152533,"score_spread":0.3133334609787508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980699954","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005016294,0.9929573,0.000010180422,0.000039727398,0.00073732395,0.0008090723,0.000032787102,0.000005579516,0.00039174352],"genre_scores_gemma":[0.0022083935,0.9966538,0.000034116256,0.00023436807,0.00030530235,0.00017056454,0.0000644636,0.00006927478,0.0002597113],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979795,0.0005112266,0.00062392734,0.00037954643,0.0001466495,0.0003591424],"domain_scores_gemma":[0.9988099,0.00017331004,0.000533399,0.00035453297,0.00009025783,0.000038648428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051046995,0.00033375405,0.0006845016,0.00008327591,0.00008159566,0.00001478884,0.0005039117,0.0004370734,0.0000364676],"category_scores_gemma":[0.000005949287,0.00023731228,0.0002969461,0.0001938752,0.000117208445,0.0000023164405,0.00012691226,0.00032405986,0.000008331833],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003054432,0.00006969304,0.00033581542,0.00029350747,0.00066705246,4.5988153e-7,0.000045382167,0.000033818807,0.037957914,0.000008942765,0.0000341902,0.96052265],"study_design_scores_gemma":[0.000379499,0.00012568226,0.000032738146,0.00016182246,0.00045798236,6.5382295e-7,0.0000141431265,0.000054788317,0.033511467,0.00007886906,0.9649609,0.00022145321],"about_ca_topic_score_codex":0.000021106627,"about_ca_topic_score_gemma":0.00002109455,"teacher_disagreement_score":0.9649267,"about_ca_system_score_codex":0.000043794116,"about_ca_system_score_gemma":0.00031636574,"threshold_uncertainty_score":0.9677314},"labels":[],"label_agreement":null},{"id":"W2981122688","doi":"10.1016/j.pharmthera.2019.107417","title":"Lorcaserin: A review of its preclinical and clinical pharmacology and therapeutic potential","year":2019,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Pharmacology and Obesity Treatment","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"","keywords":"Medicine; Clinical trial; Preclinical research; Weight management; Pharmacology; Obesity; Weight loss; Internal medicine","score_opus":0.1982653151549345,"score_gpt":0.5178402653829525,"score_spread":0.31957495022801796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981122688","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008234924,0.9895555,0.0000073151577,0.0016187892,0.003163764,0.0045038466,0.00010239049,0.00007637964,0.00014851885],"genre_scores_gemma":[0.00020014678,0.9674469,0.0001034757,0.030510746,0.00088538293,0.00020499603,0.00008346393,0.00010891443,0.0004559544],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9940476,0.0018738023,0.0020509767,0.0010851756,0.0002774238,0.00066501833],"domain_scores_gemma":[0.99631196,0.0015827457,0.0010544476,0.0003966468,0.00023741506,0.0004167622],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001318738,0.0008855242,0.0052255956,0.00024316781,0.00010894598,0.0000088445995,0.00033937185,0.001164299,0.0012375794],"category_scores_gemma":[0.000015479993,0.0006884594,0.0009863172,0.00027541138,0.00093915424,0.000060302216,0.0003699514,0.0019195424,0.00014419064],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071272906,0.0020450961,0.00020310763,0.16692595,0.017424181,0.00034349476,0.000033725,1.5162638e-7,0.00017171945,0.000015171572,0.0035388656,0.8085858],"study_design_scores_gemma":[0.0045370655,0.0016842684,0.000107989865,0.011650014,0.11714207,0.0013087423,0.000003973361,0.00008287258,0.00008269895,0.000008580897,0.8629547,0.0004370731],"about_ca_topic_score_codex":0.0000013577633,"about_ca_topic_score_gemma":3.4646365e-7,"teacher_disagreement_score":0.85941577,"about_ca_system_score_codex":0.00010772733,"about_ca_system_score_gemma":0.00088457996,"threshold_uncertainty_score":0.99967545},"labels":[],"label_agreement":null},{"id":"W2984934522","doi":"10.1016/j.pharmthera.2019.107431","title":"Adolescent neurodevelopment and substance use: Receptor expression and behavioral consequences","year":2019,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Context (archaeology); Cannabis; Neuroscience; Addiction; Psychology; Nicotine; Developmental cognitive neuroscience; Cognition; Developmental psychology; Neurotransmission; Medicine; Psychiatry; Receptor; Biology; Cognitive neuroscience; Internal medicine","score_opus":0.203660820893517,"score_gpt":0.44430934327187427,"score_spread":0.24064852237835727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984934522","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00888988,0.98703754,0.0000028886902,0.0015320727,0.00071089476,0.001712411,0.000054233304,0.000039349477,0.000020751218],"genre_scores_gemma":[0.00017104561,0.99322355,0.00013038373,0.0019084368,0.00013760578,0.00017227097,0.00005086896,0.00006520806,0.004140647],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99793047,0.00028042542,0.0004386769,0.00060361857,0.00029488545,0.00045190638],"domain_scores_gemma":[0.99916345,0.000052468655,0.00019481331,0.00022384923,0.00012534278,0.000240106],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022428326,0.0004199921,0.0012008019,0.00016699097,0.00011197486,0.000054085485,0.00014261396,0.00032261977,0.0002748379],"category_scores_gemma":[0.0000027168817,0.0003115211,0.00012969211,0.0001589376,0.00054060936,0.00006842445,0.00012206725,0.000876034,0.000022920578],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020152348,0.00031727002,0.0005603801,0.010631283,0.00031749997,0.000099721576,0.00023694178,4.9546692e-8,0.011793028,0.0000068895683,0.022910872,0.95292455],"study_design_scores_gemma":[0.0008271757,0.0002520102,0.00020330616,0.0024552543,0.002084255,0.0002152248,0.000023249993,0.000002037239,0.0007910576,0.0000015455587,0.99285716,0.00028774395],"about_ca_topic_score_codex":0.000007444037,"about_ca_topic_score_gemma":0.0000023452494,"teacher_disagreement_score":0.96994627,"about_ca_system_score_codex":0.0001488772,"about_ca_system_score_gemma":0.00061227137,"threshold_uncertainty_score":0.99993366},"labels":[],"label_agreement":null},{"id":"W3000390392","doi":"10.1016/j.pharmthera.2020.107474","title":"Hyperthermia induced by transient receptor potential vanilloid-1 (TRPV1) antagonists in human clinical trials: Insights from mathematical modeling and meta-analysis","year":2020,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Ion Channels and Receptors","field":"Neuroscience","cited_by":153,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NEOMED Institute","funders":"National Research, Development and Innovation Office; National Institutes of Health; Nemzeti Kutatási Fejlesztési és Innovációs Hivatal; Emberi Eroforrások Minisztériuma; National Institute of Neurological Disorders and Stroke; National Institute of General Medical Sciences; Magyar Tudományos Akadémia","keywords":"TRPV1; Transient receptor potential channel; Hyperthermia; Pharmacology; Medicine; Clinical trial; Receptor; Chemistry; Internal medicine","score_opus":0.5022325656836364,"score_gpt":0.5064738300341799,"score_spread":0.0042412643505435055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3000390392","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0053974004,0.98872226,0.00089376495,0.0010705227,0.0012202851,0.0020292872,0.00050486694,0.00011596219,0.00004562548],"genre_scores_gemma":[0.022576587,0.97318983,0.00011130719,0.0030088292,0.0005434324,0.00021063953,0.000120873825,0.00013500219,0.00010347858],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9857415,0.008154404,0.0033513936,0.0016582737,0.00052924093,0.00056521094],"domain_scores_gemma":[0.99592596,0.0023208943,0.0010064949,0.00032378992,0.000054342152,0.0003684985],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016611454,0.000969812,0.008733005,0.00040492407,0.0002715768,0.00011570668,0.0008106747,0.0011137519,0.0022259578],"category_scores_gemma":[0.00008136714,0.0006532778,0.0036171114,0.0007909246,0.0002992882,0.00011711749,0.00018315166,0.0019044918,0.000114519746],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070869754,0.0046163783,3.2466593e-7,0.002761932,0.35088214,0.00034874302,0.0031614713,0.00048275542,0.3078808,0.00020473044,0.0009548154,0.32799724],"study_design_scores_gemma":[0.0013919635,0.00020092842,2.1781315e-8,0.00004932816,0.5370188,0.000009640661,0.000037850285,0.015645033,0.0033477994,0.00025185806,0.4411774,0.0008694348],"about_ca_topic_score_codex":0.000017605633,"about_ca_topic_score_gemma":0.0000034467128,"teacher_disagreement_score":0.44022256,"about_ca_system_score_codex":0.00010277353,"about_ca_system_score_gemma":0.00019348071,"threshold_uncertainty_score":0.9995918},"labels":[],"label_agreement":null},{"id":"W3028846804","doi":"10.1016/j.pharmthera.2020.107593","title":"Induction of programmed necrosis: A novel anti-cancer strategy for natural compounds","year":2020,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":81,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Necroptosis; Necrosis; Programmed cell death; Pyroptosis; Mitochondrial permeability transition pore; Apoptosis; Tumor necrosis factor alpha; Biology; Cancer research; Immunology; Biochemistry; Genetics","score_opus":0.10971256069958427,"score_gpt":0.40659153091187544,"score_spread":0.29687897021229115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028846804","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00033047036,0.995478,0.0011120711,0.00011581255,0.0012729729,0.001499481,0.00015862599,0.00002027108,0.000012311597],"genre_scores_gemma":[0.003080441,0.99360883,0.0005661739,0.00033998163,0.0008109192,0.0004250726,0.0008773492,0.000070862334,0.0002203773],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986441,0.00007811534,0.00045980737,0.00043897008,0.000099210294,0.00027975792],"domain_scores_gemma":[0.9991372,0.000022444841,0.00046800156,0.00015739152,0.00015662731,0.00005832588],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00011773658,0.0003515592,0.0008217803,0.00006435641,0.00007481624,0.00001791707,0.00024607158,0.00050841825,0.000012348492],"category_scores_gemma":[0.000001680594,0.00029434205,0.00043012036,0.00015287801,0.00011498334,0.000003879031,0.00007021616,0.00024958843,0.0000011899183],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000061988736,0.00014270704,6.4404446e-7,0.0019005559,0.0012856978,3.2612633e-7,0.000015588304,0.000014347814,0.36114377,0.000027597473,0.00026641882,0.63514036],"study_design_scores_gemma":[0.00086541765,0.0003338411,0.000001815024,0.00017059669,0.0027629894,0.000013785383,0.000009638524,0.00023318328,0.0310301,0.000016080352,0.96427864,0.00028391354],"about_ca_topic_score_codex":0.0000043562104,"about_ca_topic_score_gemma":0.0000027689468,"teacher_disagreement_score":0.9640122,"about_ca_system_score_codex":0.000035092235,"about_ca_system_score_gemma":0.00030257608,"threshold_uncertainty_score":0.9999509},"labels":[],"label_agreement":null},{"id":"W3032256921","doi":"10.1016/j.pharmthera.2020.107589","title":"Important lessons learned from studies on the pharmacology of glucocorticoids in human airway smooth muscle cells: Too much of a good thing may be a problem","year":2020,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact","funders":"National Institute of Environmental Health Sciences; National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Bronchoconstriction; Asthma; Medicine; Inflammation; Pathogenesis; Airway; Disease; Adverse effect; Immunology; Bioinformatics; Pharmacology; Biology; Pathology; Anesthesia","score_opus":0.2068737814131119,"score_gpt":0.45032863443134247,"score_spread":0.24345485301823055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3032256921","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.026083564,0.96458864,0.0000021439625,0.0054178075,0.000706012,0.0026478667,0.00027841338,0.000064369575,0.00021119989],"genre_scores_gemma":[0.032119855,0.95986295,0.00005658938,0.006853751,0.0004174441,0.00043531132,0.000049932674,0.000120140896,0.00008402809],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99516356,0.0012665892,0.0018940765,0.0007276688,0.00040327664,0.00054485735],"domain_scores_gemma":[0.9963743,0.0013067748,0.001555399,0.0004161199,0.00017433021,0.00017305343],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00063632877,0.00070785324,0.0031707124,0.0002874028,0.00014871506,0.00000833602,0.0005800825,0.00042082084,0.0003808564],"category_scores_gemma":[0.0000211369,0.0004518424,0.00073072896,0.0005638007,0.000777748,0.00004034433,0.00026161797,0.0014377973,0.000010128213],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089511956,0.0047681676,0.00022579092,0.018729586,0.013849842,0.0010004683,0.008317811,0.0000301912,0.17858471,0.0004550992,0.0036833233,0.7694599],"study_design_scores_gemma":[0.0026460246,0.0012283208,0.000032545453,0.0024104388,0.015360731,0.00000511315,0.0012711115,0.000046913374,0.012644554,0.00012460875,0.9638186,0.00041100156],"about_ca_topic_score_codex":0.000030718824,"about_ca_topic_score_gemma":0.000011722552,"teacher_disagreement_score":0.96013534,"about_ca_system_score_codex":0.00020403706,"about_ca_system_score_gemma":0.0010368723,"threshold_uncertainty_score":0.99979335},"labels":[],"label_agreement":null},{"id":"W3036441491","doi":"10.1016/j.pharmthera.2020.107610","title":"The Multiple Roles of the IAP Super-family in cancer","year":2020,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":65,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Queen's University; Queen's University Belfast; European Commission; Prostate Cancer UK; Movember Foundation","keywords":"Inhibitor of apoptosis; XIAP; Ubiquitin ligase; Ubiquitin; Caspase; Apoptosis; Cell biology; Biology; Cancer; Signal transduction; Cancer research; Programmed cell death; Genetics; Gene","score_opus":0.055115468406358316,"score_gpt":0.3641897385539061,"score_spread":0.30907427014754774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036441491","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00081946,0.99697447,0.000022466644,0.0004379995,0.0009765854,0.0006674569,0.00004563019,0.000005476242,0.000050481067],"genre_scores_gemma":[0.002462716,0.9958422,0.000017211056,0.00089166086,0.00034900536,0.00014037828,0.000032506185,0.000041883235,0.00022242809],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99865633,0.0003197114,0.00039163127,0.00028533448,0.00011037273,0.00023658891],"domain_scores_gemma":[0.9993284,0.00007949144,0.0002390632,0.00027114592,0.00004950602,0.000032430253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017201721,0.00025497153,0.00047523293,0.00002636696,0.000111018264,0.000009864655,0.0005366512,0.00032863766,0.000013292813],"category_scores_gemma":[0.0000043218847,0.00013837122,0.00032210568,0.0001638754,0.0001599786,0.0000013935204,0.0002000356,0.00029786443,0.000003114665],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003996503,0.000059634134,0.0000500085,0.00046138203,0.0005677362,0.0000015494037,0.000055339082,0.00003690049,0.06528362,0.000026469581,0.0006173474,0.93280005],"study_design_scores_gemma":[0.00030852202,0.00004966797,0.00003111728,0.00015711156,0.0007667033,0.0000041043504,0.000024806677,0.0001257873,0.0060887113,0.000018970832,0.9922772,0.00014731463],"about_ca_topic_score_codex":0.000019537481,"about_ca_topic_score_gemma":0.00014091561,"teacher_disagreement_score":0.9916598,"about_ca_system_score_codex":0.000034931323,"about_ca_system_score_gemma":0.00029723265,"threshold_uncertainty_score":0.5642615},"labels":[],"label_agreement":null},{"id":"W3040080222","doi":"10.1016/j.pharmthera.2020.107621","title":"Phytocannabinoid drug-drug interactions and their clinical implications","year":2020,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Alberta Innovates; University of Alberta","keywords":"Context (archaeology); Drug; Cannabis; In silico; Computational biology; Pharmacology; Drug discovery; Drug metabolism; Medicine; Bioinformatics; Biology; Psychiatry; Biochemistry; Gene","score_opus":0.14520803666416685,"score_gpt":0.490354883899166,"score_spread":0.3451468472349991,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3040080222","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000050666866,0.921544,0.000028436747,0.07409881,0.0010524841,0.0020885393,0.00019784908,0.00013999452,0.00079921936],"genre_scores_gemma":[0.0001305832,0.97656476,0.000051839077,0.010290809,0.0018059751,0.00088070927,0.0001468683,0.00013818052,0.009990262],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99668074,0.00063773105,0.0010668238,0.00084885326,0.00017872604,0.0005871139],"domain_scores_gemma":[0.99801224,0.00024215716,0.00037303468,0.0005215167,0.00025917962,0.0005918701],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0004802539,0.0006133088,0.0022227813,0.00026252388,0.00024660537,0.000051984898,0.00040066705,0.00023391473,0.00050723105],"category_scores_gemma":[0.000017562723,0.000450161,0.00091290224,0.00056004914,0.00049837376,0.00006817036,0.00030854376,0.0025155228,0.00017207724],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056118715,0.00032379574,0.000040929743,0.0021549787,0.001709629,0.00002234668,0.00015622431,4.8402114e-8,0.000059873473,0.00005163982,0.17755318,0.8178712],"study_design_scores_gemma":[0.00081026874,0.00012957994,0.00007678398,0.0004912893,0.005147268,0.0004213913,0.00006365961,0.0000388126,0.000034615605,0.00006560407,0.9923739,0.00034685415],"about_ca_topic_score_codex":0.000011520198,"about_ca_topic_score_gemma":0.000012588208,"teacher_disagreement_score":0.8175244,"about_ca_system_score_codex":0.00021732108,"about_ca_system_score_gemma":0.0014030444,"threshold_uncertainty_score":0.999795},"labels":[],"label_agreement":null},{"id":"W3040342671","doi":"10.1016/j.pharmthera.2020.107622","title":"Metal-dependent Ser/Thr protein phosphatase PPM family: Evolution, structures, diseases and inhibitors","year":2020,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Trace Elements in Health","field":"Nursing","cited_by":122,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Global Institution for Collaborative Research and Education, Hokkaido University; Natural Sciences and Engineering Research Council of Canada; Japan Society for the Promotion of Science; Hokkaido University","keywords":"Phosphatase; Biology; Phosphorylation; Kinase; Gene isoform; Biochemistry; Protein phosphatase 2; Enzyme; Cell biology; Gene","score_opus":0.057501578434014745,"score_gpt":0.3831514129225235,"score_spread":0.32564983448850876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3040342671","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003406455,0.98617214,0.000034585322,0.0011664468,0.005651429,0.004663631,0.0016073169,0.0003462109,0.000017590626],"genre_scores_gemma":[0.0020141192,0.99077845,0.0003698004,0.0040702014,0.0015425952,0.00059193425,0.00031958075,0.00025080895,0.000062506035],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947061,0.0013107219,0.0012567606,0.001184315,0.00057451054,0.0009675823],"domain_scores_gemma":[0.99767876,0.00032379857,0.0008916078,0.00049454573,0.00011570541,0.0004955772],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031851616,0.0010589297,0.0020989997,0.0002570749,0.00044252083,0.000081585495,0.00067535345,0.00057423755,0.00020120638],"category_scores_gemma":[0.000018644749,0.00094121014,0.00036397311,0.0004921658,0.000379953,0.0002017476,0.00029829066,0.0015958368,0.000083632134],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032328404,0.00036624414,0.00013428714,0.013161353,0.0025040403,0.00012211988,0.0002271251,0.000004672218,0.00032773678,0.0003255026,0.0033292223,0.97917444],"study_design_scores_gemma":[0.0012431676,0.00030472953,0.000072709496,0.00078512996,0.011103952,0.00004736092,0.000052786574,0.000026864212,0.00034380864,0.00062581786,0.9846295,0.00076414243],"about_ca_topic_score_codex":0.00005450477,"about_ca_topic_score_gemma":0.000009022162,"teacher_disagreement_score":0.9813003,"about_ca_system_score_codex":0.0009186352,"about_ca_system_score_gemma":0.00059292454,"threshold_uncertainty_score":0.9993038},"labels":[],"label_agreement":null},{"id":"W3046762849","doi":"10.1016/j.pharmthera.2020.107648","title":"TSLP as druggable target – a silver-lining for atopic diseases?","year":2020,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Svenska Sällskapet för Medicinsk Forskning; Michael Smith Health Research BC","keywords":"Thymic stromal lymphopoietin; Immunology; Atopic dermatitis; Medicine; Immune system; Allergy; Cytokine; Autocrine signalling; Asthma; Paracrine signalling; Internal medicine","score_opus":0.0776112845617467,"score_gpt":0.4264957714524802,"score_spread":0.3488844868907335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3046762849","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00002304644,0.9924617,0.000077178185,0.0020644227,0.0015717517,0.0024415397,0.0003136953,0.0002589025,0.000787775],"genre_scores_gemma":[0.00014062598,0.9740374,0.00036573946,0.021242399,0.0010765851,0.00095711584,0.0006961942,0.00014695255,0.0013369822],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974018,0.00029780096,0.0007267407,0.0007052049,0.0001988044,0.0006696626],"domain_scores_gemma":[0.9978192,0.00087171,0.00038622678,0.0003501901,0.00011956058,0.00045314152],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00011640753,0.0006539653,0.0026337656,0.00017357121,0.00022759553,0.000022520439,0.00040276503,0.000573219,0.0010998412],"category_scores_gemma":[0.00003633947,0.00055578066,0.0011205858,0.00029066927,0.0002491078,0.000064260406,0.00012166416,0.00074134517,0.0005166383],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006909636,0.00114064,0.0005018063,0.03482244,0.012772427,0.0015491586,0.00027606793,0.0000017157276,0.000016010039,0.00021903496,0.123225816,0.8247839],"study_design_scores_gemma":[0.0019338329,0.00018423518,0.000007703747,0.0009821616,0.03225999,0.00033007612,0.000022493321,0.00010580922,0.000032838958,0.00044406147,0.9632669,0.0004298694],"about_ca_topic_score_codex":0.0000012620014,"about_ca_topic_score_gemma":1.786563e-7,"teacher_disagreement_score":0.8400411,"about_ca_system_score_codex":0.00014308645,"about_ca_system_score_gemma":0.0014186157,"threshold_uncertainty_score":0.9998133},"labels":[],"label_agreement":null},{"id":"W3090601183","doi":"10.1016/j.pharmthera.2020.107701","title":"Mineralocorticoid receptor antagonists in patients with chronic kidney disease","year":2020,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Hormonal Regulation and Hypertension","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Impact; McMaster University","funders":"Université de Genève","keywords":"Medicine; Kidney disease; Mineralocorticoid receptor; Hyperkalemia; Intensive care medicine; Eplerenone; Population; Internal medicine; Heart failure; Randomized controlled trial; Disease; Dialysis; Clinical trial; Aldosterone","score_opus":0.044181003898104004,"score_gpt":0.34804717721190526,"score_spread":0.3038661733138013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3090601183","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007543998,0.9932946,0.0000045338875,0.0032797612,0.0004520942,0.0019860915,0.00009497684,0.00006970349,0.00006386938],"genre_scores_gemma":[0.0007650493,0.98687,0.00008367893,0.01031576,0.00047302272,0.00012048,0.0009718307,0.000104639475,0.0002955235],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99808365,0.00018524715,0.0005425084,0.00048358363,0.00031966015,0.00038532933],"domain_scores_gemma":[0.9987221,0.00006380017,0.00024268593,0.0002313922,0.000125399,0.0006146598],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0000702618,0.00046154688,0.0014657937,0.00019470735,0.00005566452,0.00001273786,0.00015210538,0.00022617223,0.00058519153],"category_scores_gemma":[0.000009694307,0.00032287606,0.0002330345,0.00038799207,0.00013873357,0.00004579379,0.000053982378,0.00063719746,0.00022171451],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013281363,0.0008360127,0.0022003155,0.004724671,0.0012353772,0.00031691673,0.000043484575,0.000001026117,0.00012226004,0.000010978444,0.005369692,0.98381114],"study_design_scores_gemma":[0.0038239239,0.00047913825,0.0018638228,0.0017446204,0.005798897,0.00001273982,8.4359357e-7,0.000103868304,0.000006242079,0.0000015766213,0.98585606,0.00030826658],"about_ca_topic_score_codex":0.000002697818,"about_ca_topic_score_gemma":0.0000013619651,"teacher_disagreement_score":0.98350286,"about_ca_system_score_codex":0.00051689864,"about_ca_system_score_gemma":0.0019029614,"threshold_uncertainty_score":0.99992234},"labels":[],"label_agreement":null},{"id":"W3091517598","doi":"10.1016/j.pharmthera.2020.107703","title":"Can N-3 polyunsaturated fatty acids be considered a potential adjuvant therapy for COVID-19-associated cardiovascular complications?","year":2020,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Eicosanoids and Hypertension Pharmacology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research; Alberta Innovates","keywords":"Polyunsaturated fatty acid; Eicosapentaenoic acid; Docosahexaenoic acid; Medicine; Oxidative stress; Adjuvant; Coronavirus disease 2019 (COVID-19); Coagulopathy; Coronavirus; Adjuvant therapy; Immune system; Immunology; Disease; Pharmacology; Internal medicine; Fatty acid; Infectious disease (medical specialty); Biology; Biochemistry; Chemotherapy","score_opus":0.12527740639909804,"score_gpt":0.39178185658929787,"score_spread":0.26650445019019986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3091517598","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024276688,0.9835004,0.0011484494,0.0074873916,0.0013187162,0.0037177477,0.0024171341,0.00014139511,0.00002597477],"genre_scores_gemma":[0.002348559,0.9231804,0.00025555643,0.06664767,0.0007119764,0.0011910365,0.005366917,0.0002121443,0.00008571473],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951409,0.0013017,0.0009909862,0.0013986301,0.00027795765,0.00088979077],"domain_scores_gemma":[0.99741626,0.0002243374,0.00064553536,0.000690001,0.00045066385,0.0005731834],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004909871,0.0010000485,0.0025857766,0.00017541969,0.0005427336,0.000059341146,0.00086179527,0.0012870046,0.00012661806],"category_scores_gemma":[0.00005294593,0.0008916689,0.0019773294,0.00037208034,0.00048722222,0.000006032049,0.0002503081,0.000751436,0.000014965348],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014974161,0.0016907017,0.00002562369,0.0029011765,0.079254836,0.00034239574,0.00028049125,0.00015408461,0.17488384,0.000084225416,0.09338937,0.64549583],"study_design_scores_gemma":[0.0047072764,0.00057507365,0.0000068608565,0.00006040604,0.009984061,0.00020723368,0.000024955429,0.00016067928,0.0019939672,0.00004985138,0.98134494,0.0008846694],"about_ca_topic_score_codex":0.000024797719,"about_ca_topic_score_gemma":0.000013514614,"teacher_disagreement_score":0.8879556,"about_ca_system_score_codex":0.00020158582,"about_ca_system_score_gemma":0.0023748109,"threshold_uncertainty_score":0.9993534},"labels":[],"label_agreement":null},{"id":"W3097452637","doi":"10.1016/j.pharmthera.2020.107712","title":"Pharmacological targets and emerging treatments for respiratory syncytial virus bronchiolitis","year":2020,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Respiratory viral infections research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Palivizumab; Bronchiolitis; Medicine; Intensive care medicine; Antiviral drug; Drug; Virus; Respiratory tract infections; Drug development; Immunology; Respiratory system; Pharmacology; Internal medicine","score_opus":0.21098325714261143,"score_gpt":0.5049178486705563,"score_spread":0.2939345915279449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097452637","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026543415,0.9925421,0.00012202741,0.00039359715,0.0009875523,0.004800738,0.0002585631,0.00020905989,0.0004209485],"genre_scores_gemma":[0.000087378176,0.98776287,0.00023286225,0.0076537337,0.0018176974,0.0018825368,0.00009181089,0.00017756368,0.00029357447],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961467,0.0007534733,0.00092034985,0.0009835674,0.0003170303,0.0008788822],"domain_scores_gemma":[0.99808604,0.000630534,0.00033380528,0.00025577185,0.0001739296,0.00051992014],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037121764,0.0007916254,0.0024417678,0.00040986008,0.0003674786,0.000045855817,0.0002922903,0.0006710014,0.00056814327],"category_scores_gemma":[0.00002839976,0.0006370914,0.0006556449,0.0004333087,0.0004175283,0.0000999818,0.00021795239,0.0013110726,0.00014553667],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033093113,0.00044542796,0.000026711756,0.0034628385,0.00791805,0.00033519763,0.00005551062,4.6784734e-7,0.0048702704,0.00002652811,0.0029780855,0.97955],"study_design_scores_gemma":[0.0032325499,0.0016494851,0.000018817447,0.00034872696,0.022440286,0.00014626097,0.0000067118503,0.00008728026,0.0010273185,0.000022512617,0.97057503,0.00044502306],"about_ca_topic_score_codex":0.000005310715,"about_ca_topic_score_gemma":0.0000011523576,"teacher_disagreement_score":0.97910494,"about_ca_system_score_codex":0.0005985107,"about_ca_system_score_gemma":0.0008877697,"threshold_uncertainty_score":0.99960804},"labels":[],"label_agreement":null},{"id":"W3116084499","doi":"10.1016/j.pharmthera.2020.107798","title":"Idiopathic pulmonary fibrosis: Disease mechanisms and drug development","year":2020,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","field":"Medicine","cited_by":652,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"National Heart, Lung, and Blood Institute; National Institute for Health and Care Research; Doris Duke Charitable Foundation","keywords":"Nintedanib; Pirfenidone; Idiopathic pulmonary fibrosis; Medicine; Pathogenesis; Disease; Pulmonary fibrosis; Fibrosis; Population; Immunology; Bioinformatics; Pathology; Lung; Internal medicine; Biology","score_opus":0.04158523965668724,"score_gpt":0.3365329437397102,"score_spread":0.29494770408302295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3116084499","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000018296565,0.9953089,0.00013634979,0.0014124166,0.0009529995,0.0016438223,0.0001541809,0.0002084698,0.00016459185],"genre_scores_gemma":[0.0010375701,0.99064034,0.00051808654,0.005593786,0.0008723772,0.00046011014,0.0002588731,0.00017925765,0.00043958152],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968193,0.00036911346,0.00088567095,0.00092978036,0.00037939224,0.00061669905],"domain_scores_gemma":[0.99822795,0.00010341377,0.00034347037,0.0003252435,0.000097133045,0.00090276566],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002523842,0.0008658347,0.0021536406,0.0002126039,0.00025895966,0.000042883916,0.00032646177,0.00034344406,0.00019385952],"category_scores_gemma":[0.000005838732,0.0007269796,0.0006291737,0.00027717586,0.00021465044,0.000087262546,0.000324036,0.0009804254,0.00020668734],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018811158,0.0005462597,0.0000058911237,0.03840113,0.002382463,0.0024382658,0.00021066068,2.401977e-7,0.00027829452,0.00018220683,0.0007248538,0.95294863],"study_design_scores_gemma":[0.00046573658,0.0004095658,0.00000998134,0.008604888,0.019809524,0.00033238376,0.000028512295,0.00014637763,0.000031587842,0.00011392836,0.96940774,0.00063979044],"about_ca_topic_score_codex":0.0000023509033,"about_ca_topic_score_gemma":2.02218e-7,"teacher_disagreement_score":0.9686829,"about_ca_system_score_codex":0.0002827787,"about_ca_system_score_gemma":0.0015997429,"threshold_uncertainty_score":0.99951816},"labels":[],"label_agreement":null},{"id":"W3135852625","doi":"10.1016/j.pharmthera.2021.107826","title":"Cyclic nucleotide phosphodiesterase inhibitors as therapeutic interventions for cystic fibrosis","year":2021,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Phosphodiesterase function and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research","keywords":"Cystic fibrosis; Cyclic nucleotide; Phosphodiesterase; Cyclic nucleotide phosphodiesterase; Secretion; Effector; Nucleotide; Cystic fibrosis transmembrane conductance regulator; Bronchodilation; Cell biology; Biology; Kinase; Chemistry; Biochemistry; Enzyme; Immunology; Asthma; Genetics; Bronchodilator","score_opus":0.06958626375991891,"score_gpt":0.40169356126188915,"score_spread":0.3321072975019702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135852625","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002713866,0.9914264,0.0024002336,0.00021448509,0.0037036699,0.001606868,0.00020794015,0.00006943658,0.00009958894],"genre_scores_gemma":[0.0004064805,0.98893505,0.00041233745,0.0030044713,0.0010396503,0.00090343633,0.0021618805,0.00018565099,0.0029510362],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969027,0.00051130046,0.00095693284,0.00088553946,0.0001705456,0.0005729666],"domain_scores_gemma":[0.998273,0.00023256226,0.00056855974,0.00053216115,0.00022868616,0.00016500347],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032242914,0.00072926184,0.0013100648,0.0001816658,0.0003214943,0.000088830566,0.00040466298,0.00071946427,0.0002720992],"category_scores_gemma":[0.00002207407,0.00066251063,0.0018849344,0.00027537777,0.00022112866,0.00001140014,0.00020306538,0.0003855251,0.00007894183],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025889388,0.0007597065,0.0000115212815,0.008428746,0.0065530627,0.000018274086,0.00011203133,0.000049196315,0.01606936,0.00011379217,0.013600227,0.9540252],"study_design_scores_gemma":[0.00090958574,0.0004354042,0.000002638635,0.0019017396,0.0065752454,0.00008213843,0.000037891972,0.000025193302,0.0076213004,0.00005146863,0.98171556,0.0006418317],"about_ca_topic_score_codex":0.0000047836115,"about_ca_topic_score_gemma":0.000008839561,"teacher_disagreement_score":0.9681153,"about_ca_system_score_codex":0.00012138234,"about_ca_system_score_gemma":0.0004138061,"threshold_uncertainty_score":0.9995826},"labels":[],"label_agreement":null},{"id":"W3138379453","doi":"10.1016/j.pharmthera.2021.107840","title":"Purinergic signaling in nervous system health and disease: Focus on pannexin 1","year":2021,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Pannexin; Purinergic receptor; Purinergic signalling; Neuroscience; Biology; Adenosine; Nervous system; Context (archaeology); Signal transduction; Neuropil; Adenosine receptor; Central nervous system; Cell biology; Receptor; Intracellular; Biochemistry; Connexin; Gap junction","score_opus":0.0569545438682833,"score_gpt":0.3706683661038727,"score_spread":0.3137138222355894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3138379453","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000688494,0.9975785,0.00005630814,0.0004644222,0.0004411337,0.0006025895,0.000055002816,0.000030545434,0.000082975654],"genre_scores_gemma":[0.0039568646,0.99142486,0.000056438483,0.00279528,0.00084441324,0.00015754139,0.00043209203,0.00010100468,0.00023152758],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971421,0.0007658187,0.000645218,0.00076168333,0.00014852399,0.00053667097],"domain_scores_gemma":[0.9988623,0.0000891851,0.00032796976,0.00032395808,0.00004795818,0.00034861703],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030682076,0.00054030085,0.0012122036,0.00016436756,0.000113657086,0.000031449832,0.00028622505,0.00034965135,0.000027269289],"category_scores_gemma":[0.0000061625074,0.0004846289,0.00027719146,0.00022627514,0.00007907168,0.000002966555,0.00017598734,0.0004915296,0.000008957269],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004209968,0.00080247945,0.00010935919,0.020734768,0.0036529722,0.0012353925,0.00023470119,0.00060101267,0.0015171242,0.0007989832,0.02176575,0.94812644],"study_design_scores_gemma":[0.0005913451,0.0002711091,0.000001336074,0.0022373374,0.00084539974,0.00010056434,0.000057989375,0.00004188241,0.00019427808,0.000015260543,0.99516565,0.00047784988],"about_ca_topic_score_codex":0.000011782933,"about_ca_topic_score_gemma":0.0000013947413,"teacher_disagreement_score":0.9733999,"about_ca_system_score_codex":0.00010267054,"about_ca_system_score_gemma":0.00090819615,"threshold_uncertainty_score":0.9997605},"labels":[],"label_agreement":null},{"id":"W3146301611","doi":"10.1016/j.pharmthera.2021.107848","title":"Targeting autophagy in ischemic stroke: From molecular mechanisms to clinical therapeutics","year":2021,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":322,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Okanagan University College; University of British Columbia, Okanagan Campus; University of British Columbia","funders":"Canada Research Chairs; National Institutes of Health; Bundesministerium für Bildung, Wissenschaft und Forschung; University of Wyoming; National Natural Science Foundation of China; Austrian Science Fund; Agence Nationale de la Recherche; National Key Research and Development Program of China; National Institute of Neurological Disorders and Stroke; National Institute of General Medical Sciences; Österreichischen Akademie der Wissenschaften; American Diabetes Association","keywords":"Autophagy; Autophagosome; Programmed cell death; Context (archaeology); Cell biology; Stroke (engine); Mechanism (biology); Biology; Cause of death; Neuroscience; Organelle; Medicine; Bioinformatics; Apoptosis; Disease; Pathology; Genetics","score_opus":0.10068779652878013,"score_gpt":0.46007897810654014,"score_spread":0.35939118157776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3146301611","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018577375,0.99028116,0.0019804426,0.0005753062,0.0025541754,0.0020753513,0.00020690067,0.00018616904,0.00028276347],"genre_scores_gemma":[0.00043735743,0.9570567,0.0035526005,0.036400057,0.001034853,0.00034543214,0.000575742,0.00028926512,0.0003079674],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99393046,0.0012436492,0.0019710155,0.0013387713,0.00051142933,0.0010046668],"domain_scores_gemma":[0.9971744,0.00078907696,0.0005543601,0.00083504943,0.0001741744,0.0004729655],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00076718716,0.0010437464,0.0039481674,0.00037839683,0.00009216878,0.00004459759,0.00072714954,0.0013512543,0.0013708534],"category_scores_gemma":[0.000015054956,0.00094362046,0.0013359247,0.0007023352,0.00016272035,0.000060201575,0.00029362028,0.0023741622,0.00026511512],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024799304,0.0020443755,0.00003327162,0.0013814634,0.011943363,0.0027104146,0.0002433857,0.00001338442,0.01879139,0.000083259074,0.0015964657,0.9609112],"study_design_scores_gemma":[0.002456144,0.00030715772,0.000008406744,0.0018427324,0.013865927,0.000050062044,0.000052216667,0.00021684045,0.0063071,0.000097460805,0.9740307,0.000765305],"about_ca_topic_score_codex":0.0000126032,"about_ca_topic_score_gemma":0.0000012993414,"teacher_disagreement_score":0.97243416,"about_ca_system_score_codex":0.00034551654,"about_ca_system_score_gemma":0.0014233731,"threshold_uncertainty_score":0.9999452},"labels":[],"label_agreement":null},{"id":"W3159581952","doi":"10.1016/j.pharmthera.2021.107875","title":"Targeting the dysfunction of glutamate receptors for the development of novel antidepressants","year":2021,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Treatment of Major Depression","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Glutamate receptor; Animal models of depression; NMDA receptor; Antidepressant; Neuroscience; Receptor; Metabotropic glutamate receptor; Major depressive disorder; Pharmacology; Biology; Psychology; Medicine; Internal medicine; Hippocampus; Cognition","score_opus":0.16064109626399048,"score_gpt":0.42722762015917554,"score_spread":0.26658652389518506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3159581952","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00035923053,0.9930578,0.0019218087,0.0002941609,0.0018777245,0.0023802237,0.000042506857,0.000028994684,0.000037565947],"genre_scores_gemma":[0.00040797287,0.99500036,0.0032530548,0.0002793943,0.00024137711,0.0003777371,0.00013893362,0.00007528195,0.00022586192],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99789846,0.00021001656,0.0009774402,0.0003264708,0.0002957435,0.00029188645],"domain_scores_gemma":[0.9969131,0.0014930008,0.00096121273,0.00034364066,0.00024846237,0.00004062916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071784126,0.00036613073,0.001353266,0.00009460256,0.00019539238,0.0000067948336,0.0003197195,0.00026122064,0.00013371678],"category_scores_gemma":[0.000025850588,0.00018181976,0.00043386852,0.00025094353,0.00018439553,0.000028011404,0.00014130397,0.00038708517,0.0000035212745],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015371734,0.0006657609,0.000070405265,0.006258684,0.006955809,0.0000018194874,0.0005340104,0.000018068622,0.00646876,0.0000085015745,0.0012636447,0.9776008],"study_design_scores_gemma":[0.0017384053,0.000097004464,0.000029666102,0.002793865,0.015563415,0.00002191704,0.00012188469,0.00014075123,0.009130992,0.0000014614895,0.97021294,0.00014771022],"about_ca_topic_score_codex":0.0000020527116,"about_ca_topic_score_gemma":7.310041e-7,"teacher_disagreement_score":0.9774531,"about_ca_system_score_codex":0.000104407154,"about_ca_system_score_gemma":0.0005696264,"threshold_uncertainty_score":0.7414395},"labels":[],"label_agreement":null},{"id":"W3163931645","doi":"10.1016/j.pharmthera.2021.107893","title":"Resolving inflammation by TAM receptor activation","year":2021,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Coordenação de Aperfeiçoamento de Pessoal de Nível Superior; Arthritis Society; ReumaNederland; Dutch Arthritis Society","keywords":"MERTK; Efferocytosis; Inflammation; Receptor tyrosine kinase; GAS6; Receptor Protein-Tyrosine Kinases; Receptor; Lipid signaling; Cell biology; Immunology; Signal transduction; Biology; Cancer research; Macrophage; Biochemistry; In vitro","score_opus":0.06348266167707882,"score_gpt":0.3623809560026403,"score_spread":0.2988982943255615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3163931645","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019347787,0.99564576,0.00016601197,0.00036494265,0.0024651268,0.0007685489,0.00006874771,0.00013018626,0.00019719228],"genre_scores_gemma":[0.000088331944,0.99220514,0.000045661134,0.0004956485,0.0002931123,0.00021115446,0.0045533823,0.00008658863,0.0020209632],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99679077,0.0012739368,0.0008505622,0.0005352532,0.00006422227,0.00048524133],"domain_scores_gemma":[0.99850947,0.00042829904,0.0005437959,0.00033952223,0.00015344545,0.000025470592],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003635188,0.0005262983,0.0013912546,0.00020558771,0.0003005524,0.000039603015,0.00037472436,0.0011271118,0.001936031],"category_scores_gemma":[0.0000125226015,0.00048188737,0.0004113485,0.00036062778,0.00016039131,0.00020028569,0.00013241448,0.0009313587,0.0006259403],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017106358,0.00008902086,7.9875423e-7,0.00057482824,0.0016993836,4.5630478e-7,0.00009020926,6.2569495e-7,0.22109136,0.000031086223,0.02978297,0.74662215],"study_design_scores_gemma":[0.0005457389,0.00005600149,8.157219e-7,0.0010253813,0.0022234987,0.000018031116,0.000018146362,0.0000039742044,0.08506115,0.0000055919677,0.91065454,0.00038712722],"about_ca_topic_score_codex":0.0000065303434,"about_ca_topic_score_gemma":4.5796196e-7,"teacher_disagreement_score":0.8808716,"about_ca_system_score_codex":0.00031169993,"about_ca_system_score_gemma":0.0002938162,"threshold_uncertainty_score":0.99976325},"labels":[],"label_agreement":null},{"id":"W3173514551","doi":"10.1016/j.pharmthera.2021.107941","title":"The role of osteoprotegerin (OPG) in fibrosis: its potential as a biomarker and/or biological target for the treatment of fibrotic diseases","year":2021,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Bone Metabolism and Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact","funders":"","keywords":"Osteoprotegerin; Fibrosis; RANKL; Extracellular matrix; Medicine; Biomarker; Cancer research; Pathology; Receptor; Activator (genetics); Internal medicine; Biology; Cell biology","score_opus":0.0491953520006915,"score_gpt":0.3661879670218742,"score_spread":0.3169926150211827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3173514551","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0052528707,0.99196595,0.00001617534,0.00009076322,0.0002493794,0.001724954,0.00068732694,0.0000051937777,0.0000073896945],"genre_scores_gemma":[0.011457347,0.9868922,0.00005598728,0.00010840513,0.00018373757,0.0009635893,0.00021430256,0.000031265583,0.000093164876],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99828416,0.00043767545,0.0005034814,0.00038114586,0.00008758893,0.00030596118],"domain_scores_gemma":[0.99885684,0.00039612828,0.00029671675,0.00029563793,0.00008609619,0.00006857596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012709493,0.00034924733,0.0008816294,0.00004433408,0.000109353656,0.000016174217,0.00030077493,0.00027179727,0.0000496032],"category_scores_gemma":[0.000023848994,0.00016806941,0.00052644097,0.00013400681,0.00034315186,0.0000027682916,0.00011711987,0.00007214643,0.0000010241697],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014745696,0.0009788322,0.000069092835,0.0011315799,0.0026657046,0.000008082117,0.00004274903,0.000005398028,0.021540433,0.000049468155,0.00013151734,0.97190255],"study_design_scores_gemma":[0.0009906724,0.0010540463,0.00008767829,0.00015660793,0.0034201392,0.000016748514,0.00008242687,0.000052423537,0.010274303,0.00006399774,0.98360515,0.00019579208],"about_ca_topic_score_codex":0.0000088378465,"about_ca_topic_score_gemma":0.0000040037985,"teacher_disagreement_score":0.98347366,"about_ca_system_score_codex":0.000013544977,"about_ca_system_score_gemma":0.00036684767,"threshold_uncertainty_score":0.68536717},"labels":[],"label_agreement":null},{"id":"W3174476862","doi":"10.1016/j.pharmthera.2021.107923","title":"Exploiting the obesity-associated immune microenvironment for cancer therapeutics","year":2021,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Canadian Institutes of Health Research","keywords":"Tumor microenvironment; Medicine; Immune system; Cancer; Context (archaeology); Immunotherapy; Obesity; Inflammation; Immunology; Cancer immunotherapy; Bioinformatics; Oncology; Internal medicine; Biology","score_opus":0.08837133753291015,"score_gpt":0.3666481755044898,"score_spread":0.27827683797157965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3174476862","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000102960395,0.981663,0.00016954886,0.0008459896,0.015162858,0.0017417085,0.00009306907,0.00011379246,0.0001070898],"genre_scores_gemma":[0.00013737123,0.9803367,0.000015301399,0.006166627,0.00028421386,0.0013599152,0.0010626512,0.0001479775,0.010489229],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99604553,0.001410503,0.0010349496,0.0006266459,0.000066954155,0.00081542454],"domain_scores_gemma":[0.9972181,0.0011637197,0.0009651595,0.0004627148,0.0001667857,0.000023574461],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005771827,0.0007323177,0.0016938605,0.00013420623,0.0008440756,0.0000516207,0.0006684463,0.00093360525,0.0034517578],"category_scores_gemma":[0.000008749878,0.0005309336,0.00111936,0.00024889281,0.00032748302,0.0000787344,0.00019893025,0.0015753552,0.00035758704],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013376516,0.0011714707,0.00001162937,0.0013529911,0.025537431,0.000006635454,0.000863164,0.000007967724,0.049694877,0.00007065671,0.02116591,0.8999835],"study_design_scores_gemma":[0.0010653823,0.00012901457,0.0000043052614,0.0009324899,0.012699393,0.000061063925,0.00035757915,0.000009019456,0.0073883976,0.0000073067417,0.97684836,0.00049767713],"about_ca_topic_score_codex":0.000025342917,"about_ca_topic_score_gemma":0.0000065767613,"teacher_disagreement_score":0.95568246,"about_ca_system_score_codex":0.00054876396,"about_ca_system_score_gemma":0.00030605315,"threshold_uncertainty_score":0.9997142},"labels":[],"label_agreement":null},{"id":"W3175085359","doi":"10.1016/j.pharmthera.2021.107929","title":"Microvascular basis of cognitive impairment in type 1 diabetes","year":2021,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Advanced Glycation End Products research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Victoria","funders":"Canadian Institutes of Health Research; Michael Smith Health Research BC; Canada Foundation for Innovation; Natural Sciences and Engineering Research Council of Canada; Heart and Stroke Foundation of Canada","keywords":"Type 2 diabetes; Neuroscience; Diabetes mellitus; Pathological; Blood flow; Blood–brain barrier; Cognition; Blood vessel; Neovascularization; Medicine; Cognitive decline; Cerebral blood flow; Internal medicine; Endocrinology; Psychology; Angiogenesis; Dementia; Central nervous system","score_opus":0.059773680820891004,"score_gpt":0.41552533729567487,"score_spread":0.35575165647478385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3175085359","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018963258,0.99685717,0.000026310261,0.00006529062,0.00033524973,0.000697604,0.00006479219,0.000005849179,0.000051401523],"genre_scores_gemma":[0.0004517525,0.9976052,0.00017205162,0.000498505,0.00018606399,0.00012335503,0.00068155624,0.000058197922,0.00022331852],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99794096,0.00060923834,0.00044022326,0.0005114431,0.00013649493,0.0003616695],"domain_scores_gemma":[0.9990005,0.00013515385,0.00020816823,0.00030134752,0.00030127785,0.00005356875],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033180957,0.00029303317,0.0008534033,0.00015181374,0.000029372799,0.0000061271135,0.00029509148,0.00031515592,0.0001722309],"category_scores_gemma":[0.000032963813,0.00027497482,0.00026657246,0.00044185057,0.0001713746,0.0000027429928,0.0002093248,0.00034586256,0.000017101034],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058922007,0.0005559899,0.00009401905,0.0035243009,0.0035489101,0.000015607488,0.00007214631,0.000011681228,0.021006634,0.0000047025546,0.00060243957,0.97050464],"study_design_scores_gemma":[0.00046297102,0.000209021,0.0000068721897,0.00074066344,0.0010805412,0.0000079807105,0.00002231454,0.0000024574879,0.06612793,0.0000051568195,0.9310941,0.00023994833],"about_ca_topic_score_codex":0.0000014631493,"about_ca_topic_score_gemma":0.0000015867947,"teacher_disagreement_score":0.9702647,"about_ca_system_score_codex":0.00004964444,"about_ca_system_score_gemma":0.0005445115,"threshold_uncertainty_score":0.99997026},"labels":[],"label_agreement":null},{"id":"W3176976840","doi":"10.1016/j.pharmthera.2021.107939","title":"Novel treatments for autism spectrum disorder based on genomics and systems biology","year":2021,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Autism Spectrum Disorder Research","field":"Neuroscience","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Holland Bloorview Kids Rehabilitation Hospital; University of Toronto","funders":"","keywords":"Autism spectrum disorder; Autism; Genomics; Clinical trial; Neuroscience; Systems biology; Biomarker; Neurodevelopmental disorder; Medicine; Computational biology; Biology; Bioinformatics; Psychiatry; Genetics; Genome; Gene","score_opus":0.17243242449245913,"score_gpt":0.43775271142532995,"score_spread":0.2653202869328708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3176976840","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006211346,0.98657984,0.0029299033,0.0031640623,0.0018155058,0.004133327,0.0009781513,0.00012335359,0.00021373383],"genre_scores_gemma":[0.0005259146,0.9946413,0.00013550269,0.0021457053,0.00018069986,0.0014052782,0.0001491432,0.0002150536,0.0006013787],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956446,0.0008535962,0.0006855696,0.0014536416,0.00022802906,0.0011345056],"domain_scores_gemma":[0.9966478,0.0021858895,0.00041770635,0.0005518031,0.000012035512,0.00018479131],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002991529,0.00082579715,0.0019105255,0.00044333743,0.00039803894,0.00011017358,0.00072917825,0.0006192046,0.0001227545],"category_scores_gemma":[0.00001716146,0.000706311,0.00042266073,0.00047625776,0.00044074483,0.000052808835,0.00022656358,0.00078518194,0.000060808197],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033431294,0.004881965,0.00004445271,0.0098973885,0.0040406915,0.0001704471,0.00025986394,0.00024967623,0.010525655,0.07982241,0.00041687788,0.88935626],"study_design_scores_gemma":[0.0021657327,0.00058477465,0.0000020973227,0.00035548635,0.0027653452,0.000090899586,0.0000053381686,0.00651343,0.00032681134,0.00046017364,0.98613286,0.000597034],"about_ca_topic_score_codex":0.000019761543,"about_ca_topic_score_gemma":0.0000046197088,"teacher_disagreement_score":0.985716,"about_ca_system_score_codex":0.00047331478,"about_ca_system_score_gemma":0.00079306425,"threshold_uncertainty_score":0.9995388},"labels":[],"label_agreement":null},{"id":"W3192608892","doi":"10.1016/j.pharmthera.2021.107963","title":"Xyloketal B: A marine compound with medicinal potential","year":2021,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Metabolomics and Mass Spectrometry Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Oxidative stress; In vivo; Apoptosis; Programmed cell death; Biology; Disease; Pharmacology; Medicine; Biochemistry; Biotechnology","score_opus":0.03843326347705066,"score_gpt":0.3568455903046338,"score_spread":0.31841232682758314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3192608892","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00028319826,0.99634826,0.0003000867,0.00015588687,0.0013838279,0.00047132283,0.000059022863,0.00002075021,0.0009776565],"genre_scores_gemma":[0.0001486258,0.99414665,0.00063833705,0.0014257735,0.0013634568,0.00010764495,0.00072082103,0.00009506213,0.0013536112],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978465,0.00029114579,0.0004465899,0.0006926864,0.00021048251,0.00051263504],"domain_scores_gemma":[0.9990239,0.000038268878,0.00030728112,0.00037096982,0.00014426887,0.000115292445],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002043879,0.0005949473,0.0015017566,0.00012061751,0.0001546847,0.000030509158,0.00040556764,0.0003784053,0.00039067204],"category_scores_gemma":[0.0000030739275,0.00044486023,0.00041091593,0.0002340701,0.0003051057,0.0000023442085,0.0004672277,0.00050712365,0.000017830336],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023572556,0.00061739166,0.000047837017,0.0025943725,0.022419328,0.00058034644,0.000033904962,0.0000051886464,0.0077435835,0.00016641481,0.009082065,0.9564738],"study_design_scores_gemma":[0.0008287692,0.0004032449,0.00000278481,0.00015033576,0.007760231,0.00094475504,0.000018593648,0.0000047130743,0.00041112144,0.000009674401,0.9890032,0.0004625818],"about_ca_topic_score_codex":0.0000047664703,"about_ca_topic_score_gemma":0.000011656499,"teacher_disagreement_score":0.9799211,"about_ca_system_score_codex":0.00003964409,"about_ca_system_score_gemma":0.00041062935,"threshold_uncertainty_score":0.9998003},"labels":[],"label_agreement":null},{"id":"W3197822352","doi":"10.1016/j.pharmthera.2021.107976","title":"Cell-based therapies for vascular regeneration: Past, present and future","year":2021,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"3D Printing in Biomedical Research","field":"Engineering","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Heart and Stroke Foundation; University of Toronto; University Health Network; Toronto General Hospital","funders":"Breakthrough T1D Canada; Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; Ontario Ministry of Research, Innovation and Science","keywords":"Regenerative medicine; Regeneration (biology); Organ transplantation; Transplantation; Neuroscience; Organ system; Biology; Cell; Medicine; Bioinformatics; Pathology; Stem cell; Cell biology; Internal medicine; Disease","score_opus":0.06875405149630719,"score_gpt":0.37860788767432196,"score_spread":0.30985383617801476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3197822352","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000048355046,0.9915635,0.0039115986,0.0015493532,0.0015560841,0.0011135733,0.00004206193,0.00016572399,0.00009329801],"genre_scores_gemma":[0.0000052676633,0.9904846,0.002078763,0.00053434103,0.0057672877,0.00071072736,0.0001526609,0.0001356716,0.00013067962],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981146,0.00031488086,0.00041021442,0.00039969693,0.0002707823,0.00048985705],"domain_scores_gemma":[0.9986946,0.00065711566,0.000075510616,0.0003145487,0.00011961582,0.00013863706],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004386873,0.00042989326,0.0009484033,0.00015189909,0.00012657471,0.000069603935,0.00036177103,0.00051955145,0.00023946726],"category_scores_gemma":[0.000001456948,0.00036442955,0.000344871,0.00026109783,0.00014636133,0.000031126663,0.00007690086,0.0006708115,0.000011583588],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000037088723,0.00005946355,7.3038217e-7,0.010279867,0.0015984403,0.0000098631035,0.00006484854,0.00012304111,0.00016176575,0.000016720278,0.018888999,0.96879256],"study_design_scores_gemma":[0.00047407867,0.000043865188,4.5515446e-7,0.00027600542,0.0016477178,0.000005295433,0.00001029181,0.0036647208,0.0005425252,0.000014916703,0.9930009,0.00031923258],"about_ca_topic_score_codex":4.4784517e-7,"about_ca_topic_score_gemma":1.5413225e-7,"teacher_disagreement_score":0.9741119,"about_ca_system_score_codex":0.00010084528,"about_ca_system_score_gemma":0.00020589151,"threshold_uncertainty_score":0.9998808},"labels":[],"label_agreement":null},{"id":"W3198246574","doi":"10.1016/j.pharmthera.2021.107977","title":"G protein-coupled receptor-effector macromolecular membrane assemblies (GEMMAs)","year":2021,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Receptor Mechanisms and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Heart, Lung, and Blood Institute; Fundación Dr. Antoni Esteve; National Institute of General Medical Sciences; National Institute of Mental Health; Centre National de la Recherche Scientifique; Universitat de Barcelona; National Institute on Drug Abuse; Agencia Estatal de Investigación; Ministerio de Ciencia, Innovación y Universidades; Agence Nationale de la Recherche; Institut National de la Santé et de la Recherche Médicale","keywords":"G protein-coupled receptor; Effector; Heterotrimeric G protein; Cell biology; Biology; Receptor; Rhodopsin-like receptors; G protein; Cell signaling; Signal transduction; Chemistry; Biochemistry; Agonist","score_opus":0.047112551343446524,"score_gpt":0.34941911501873985,"score_spread":0.3023065636752933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3198246574","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001184529,0.9936483,0.0010889118,0.00007618133,0.0018551048,0.00181539,0.0001086166,0.00007008646,0.00015288524],"genre_scores_gemma":[0.00014056967,0.9921296,0.0010455983,0.001130286,0.0013985274,0.00076499954,0.0016950368,0.00026657985,0.0014287787],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958556,0.001018824,0.00081117573,0.0011697178,0.0003257743,0.00081890554],"domain_scores_gemma":[0.9982804,0.000083820276,0.0005184689,0.0006807494,0.00023167432,0.00020489539],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00056144455,0.0009844336,0.0019059367,0.00016100312,0.00021879171,0.00009927056,0.00080100534,0.0011969223,0.0017349594],"category_scores_gemma":[0.000016367841,0.00088713143,0.0011045395,0.0003517362,0.00014331238,0.000006728815,0.00036072897,0.00077015936,0.00018515607],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036715537,0.00017533118,3.3096777e-7,0.002434526,0.0032559927,0.00005815363,0.000019125846,0.000004895933,0.8575451,0.00004373723,0.0011334387,0.13529266],"study_design_scores_gemma":[0.00045710374,0.00022273907,2.4500538e-8,0.00070682075,0.0021787244,0.000061338586,0.000009483405,0.000020669688,0.2547461,0.000005466753,0.7409263,0.00066522515],"about_ca_topic_score_codex":0.0000056768104,"about_ca_topic_score_gemma":0.0000020490188,"teacher_disagreement_score":0.7397929,"about_ca_system_score_codex":0.00008677871,"about_ca_system_score_gemma":0.0006155821,"threshold_uncertainty_score":0.99935794},"labels":[],"label_agreement":null},{"id":"W3200728597","doi":"10.1016/j.pharmthera.2021.107988","title":"Gut dysbiosis, defective autophagy and altered immune responses in neurodegenerative diseases: Tales of a vicious cycle","year":2021,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":191,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"Department of Biotechnology, Ministry of Science and Technology, India","keywords":"Dysbiosis; Neuroinflammation; Gut flora; Neurodegeneration; Biology; Immune system; Gut–brain axis; Immunology; Autophagy; Immune dysregulation; Enteric nervous system; Inflammation; Disease; Neuroscience; Medicine; Pathology","score_opus":0.05273484474548461,"score_gpt":0.41311546558070317,"score_spread":0.36038062083521855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200728597","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.038868174,0.95828193,0.000009875014,0.00012141222,0.0005042246,0.0017748051,0.00033407303,0.00005824922,0.000047226276],"genre_scores_gemma":[0.02406273,0.972941,0.00006145588,0.0017804606,0.00024283337,0.00050464657,0.00017570236,0.00010890319,0.0001222591],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963409,0.0013865617,0.00090838375,0.0006940062,0.00022150493,0.00044864605],"domain_scores_gemma":[0.997912,0.00083210965,0.00049149455,0.0004285795,0.00015260366,0.00018325198],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020656869,0.00063301617,0.002757737,0.00041218754,0.000088928675,0.000016680948,0.00022712997,0.0003703083,0.00019512337],"category_scores_gemma":[0.00002412248,0.00053856877,0.00057487254,0.0004992597,0.00047655113,0.00006434067,0.00015660403,0.000667887,0.000009695062],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021114904,0.0037642878,0.00032994564,0.011663558,0.012716083,0.001864853,0.0016793257,0.0000086657465,0.013432346,0.0002214554,0.00017960543,0.9520284],"study_design_scores_gemma":[0.013454961,0.0024185667,0.006334076,0.011456173,0.0547636,0.0010024898,0.00036637264,0.0003654547,0.012560064,0.00041313155,0.8948792,0.0019858992],"about_ca_topic_score_codex":0.000012023992,"about_ca_topic_score_gemma":0.0000032717521,"teacher_disagreement_score":0.9500425,"about_ca_system_score_codex":0.00016080475,"about_ca_system_score_gemma":0.0009751303,"threshold_uncertainty_score":0.99970657},"labels":[],"label_agreement":null},{"id":"W3202955147","doi":"10.1016/j.pharmthera.2021.107995","title":"Emerging methods for and novel insights gained by absolute quantification of mitochondrial DNA copy number and its clinical applications","year":2021,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Mitochondrial Function and Pathology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Digital polymerase chain reaction; Computational biology; Mitochondrial DNA; Biology; Mitochondrial biogenesis; Bioinformatics; Polymerase chain reaction; Genetics; Mitochondrion; Gene","score_opus":0.12646892341761443,"score_gpt":0.4961319838192645,"score_spread":0.3696630604016501,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3202955147","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006711647,0.78738075,0.20954521,0.000092811075,0.0014328285,0.0012678838,0.00016526856,0.000010931802,0.0000372077],"genre_scores_gemma":[0.000013754231,0.9768523,0.01928969,0.00072647294,0.0008788261,0.00062795915,0.0010534386,0.000055560664,0.0005020029],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975189,0.0006527384,0.00083365024,0.0007121852,0.000057845013,0.00022465493],"domain_scores_gemma":[0.99841046,0.00044936442,0.00053535827,0.0002706349,0.00023121391,0.00010297034],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039293995,0.00032357173,0.0010210158,0.00005801167,0.00012083316,0.000015065362,0.00018495323,0.0007563798,0.000037428283],"category_scores_gemma":[0.000035327044,0.0003035086,0.0002778576,0.00013242017,0.0001867279,0.0000045164843,0.0001129719,0.0002636073,0.0000034319696],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014382994,0.00027848058,0.000004368865,0.0013744518,0.0014513856,4.2401172e-7,0.000035625977,4.7001802e-7,0.61580104,0.00077944965,0.0040185624,0.37611192],"study_design_scores_gemma":[0.0010599766,0.00013331439,4.5428754e-7,0.000071256385,0.0023142863,0.000034671717,0.000008355321,0.00007738818,0.016488137,0.00003723178,0.9795151,0.0002598645],"about_ca_topic_score_codex":7.9715716e-7,"about_ca_topic_score_gemma":0.0000012281695,"teacher_disagreement_score":0.9754965,"about_ca_system_score_codex":0.0000107781025,"about_ca_system_score_gemma":0.00019014903,"threshold_uncertainty_score":0.9999417},"labels":[],"label_agreement":null},{"id":"W3211626450","doi":"10.1016/j.pharmthera.2021.108033","title":"Spexin: Its role, regulation, and therapeutic potential in the hypothalamus","year":2021,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Hypothalamic control of reproductive hormones","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Energy homeostasis; Kisspeptin; Homeostasis; Biology; Hypothalamus; Glucose homeostasis; Neuropeptide; Hormone; Receptor; Endocrinology; Internal medicine; Insulin resistance; Insulin; Medicine; Genetics","score_opus":0.07132814476992425,"score_gpt":0.3730474276461073,"score_spread":0.3017192828761831,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211626450","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00088676217,0.99145657,0.000021984923,0.0040121493,0.0006773183,0.0024151118,0.00001515562,0.000058635993,0.00045631686],"genre_scores_gemma":[0.00444814,0.98893005,0.000082284016,0.004199391,0.0012639998,0.0002574524,0.000055577635,0.000115399685,0.0006477079],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99600804,0.0012641338,0.0008243039,0.0008992576,0.00042439043,0.0005798756],"domain_scores_gemma":[0.998115,0.0005295184,0.00038205434,0.0006566684,0.00022080749,0.00009594571],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008751981,0.00067664945,0.002139024,0.000361389,0.00012905228,0.000054522385,0.00039726603,0.00050808606,0.00029528004],"category_scores_gemma":[0.000016994534,0.00046354497,0.0004636957,0.0005800703,0.0002862042,0.00006601089,0.00012192692,0.0013032012,0.000066122324],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000748136,0.0003727187,0.000050335424,0.0015556286,0.0024022344,0.00032879677,0.00044099792,0.000003033579,0.0013437188,0.00018250616,0.00020917579,0.99303603],"study_design_scores_gemma":[0.0015688492,0.00014926883,0.0008236811,0.00063826406,0.013117379,0.002145244,0.00010828263,0.00011140702,0.000062044535,0.00016799294,0.98071843,0.0003891595],"about_ca_topic_score_codex":0.000004637915,"about_ca_topic_score_gemma":0.0000030401854,"teacher_disagreement_score":0.9926469,"about_ca_system_score_codex":0.00015855713,"about_ca_system_score_gemma":0.00051177084,"threshold_uncertainty_score":0.9997816},"labels":[],"label_agreement":null},{"id":"W3215196528","doi":"10.1016/j.pharmthera.2021.108046","title":"Sex differences in eicosanoid formation and metabolism: A possible mediator of sex discrepancies in cardiovascular diseases","year":2021,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Eicosanoids and Hypertension Pharmacology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Eicosanoid; Eicosanoid metabolism; Endocrinology; Internal medicine; Estrogen; Cyclooxygenase; Hormone; Cytochrome P450; Lipoxygenase; Arachidonic acid; Androgen; Hydroxyeicosatetraenoic acid; Biology; Metabolism; Enzyme; Medicine; Biochemistry","score_opus":0.0440021301849173,"score_gpt":0.33170501616819337,"score_spread":0.2877028859832761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215196528","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.033238903,0.965439,0.00002097884,0.000088165674,0.00037329606,0.00063276914,0.00016965061,0.000010257086,0.000026952379],"genre_scores_gemma":[0.021311555,0.9772274,0.0000637816,0.00052807626,0.00022138644,0.00023939698,0.00030715158,0.000046389177,0.00005484375],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970504,0.0009503179,0.00077975617,0.0006014753,0.00019174904,0.00042628942],"domain_scores_gemma":[0.9990898,0.00012442484,0.0002768211,0.0003219422,0.000081199396,0.00010585293],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003567947,0.00046796596,0.0023939284,0.00028381278,0.00005235534,0.000019147452,0.00031102865,0.00047846104,0.000038629747],"category_scores_gemma":[0.000012837943,0.00038749707,0.00049768126,0.00033527982,0.00025534083,0.00001440998,0.00028653978,0.0003651216,0.0000014374926],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015686735,0.0015536787,0.0039704884,0.010038033,0.008871415,0.00024293004,0.0009331871,0.000023450155,0.034466513,0.00009322072,0.00072684424,0.93892336],"study_design_scores_gemma":[0.0016215183,0.000119557335,0.00028118162,0.0003980221,0.0050552376,0.000086509885,0.00022843195,0.00008673069,0.008221022,0.000025659714,0.9833383,0.000537831],"about_ca_topic_score_codex":0.000024489354,"about_ca_topic_score_gemma":0.000034280558,"teacher_disagreement_score":0.9826115,"about_ca_system_score_codex":0.000030797968,"about_ca_system_score_gemma":0.00034333707,"threshold_uncertainty_score":0.99985766},"labels":[],"label_agreement":null},{"id":"W4220811347","doi":"10.1016/j.pharmthera.2022.108173","title":"The emerging potential of Aptamers as therapeutic agents in infection and inflammation","year":2022,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Advanced biosensing and bioanalysis techniques","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Aptamer; Nucleic acid; Oligonucleotide; Computational biology; Flexibility (engineering); Biology; Molecular biology; Genetics; DNA","score_opus":0.04710168952318693,"score_gpt":0.3975823484510262,"score_spread":0.35048065892783925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220811347","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0071508638,0.9916679,0.00007668973,0.000117297044,0.0003467281,0.000524577,0.000009314095,0.000020887304,0.00008573459],"genre_scores_gemma":[0.012728701,0.98656833,0.0000539339,0.00024476936,0.00013344754,0.000067604065,0.00009472599,0.00003331386,0.000075158176],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998393,0.00047996108,0.00046048727,0.00031236478,0.00013057755,0.00022362624],"domain_scores_gemma":[0.9992431,0.000059676924,0.00043014862,0.00020262552,0.000037924943,0.00002657236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040889008,0.00025682928,0.00045261643,0.00014457892,0.00018012764,0.000014367128,0.00018039373,0.00022768941,0.000010097832],"category_scores_gemma":[0.0000062295735,0.00019231424,0.00021399344,0.000239078,0.00019980944,0.000004108671,0.00015479035,0.00032896583,7.9034027e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004555303,0.000036962836,0.000026983278,0.00026514663,0.0007404865,0.0000031525076,0.000023790024,0.0000049325363,0.013876539,0.000011032251,0.000029057754,0.98493636],"study_design_scores_gemma":[0.00019937588,0.00015250627,0.000015325884,0.00006859351,0.0014164724,0.00003134041,0.000027672208,0.00005600177,0.0053803492,0.00009598185,0.99236286,0.00019352778],"about_ca_topic_score_codex":0.00001207766,"about_ca_topic_score_gemma":0.000016182841,"teacher_disagreement_score":0.99233377,"about_ca_system_score_codex":0.00004903393,"about_ca_system_score_gemma":0.000098705,"threshold_uncertainty_score":0.7842347},"labels":[],"label_agreement":null},{"id":"W4220832674","doi":"10.1016/j.pharmthera.2022.108171","title":"Enhancing autophagy in Alzheimer's disease through drug repositioning","year":2022,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Institute in Oncology and Hematology; Children's Hospital Research Institute of Manitoba; CancerCare Manitoba; Research Manitoba; St. Boniface Hospital; University of Manitoba","funders":"National Institute of General Medical Sciences","keywords":"Autophagy; Drug repositioning; Repurposing; Drug; Disease; Medicine; Drug development; Drug discovery; Downregulation and upregulation; Pharmacology; Bioinformatics; Neuroscience; Biology; Apoptosis; Pathology","score_opus":0.10775986567795742,"score_gpt":0.42727322396027134,"score_spread":0.3195133582823139,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220832674","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00031675983,0.9947398,0.000023622619,0.0003604299,0.00159969,0.0018450486,0.000059498314,0.00022805219,0.0008271491],"genre_scores_gemma":[0.0004237062,0.98538965,0.00015419515,0.01129673,0.00068080437,0.0010450467,0.00042987347,0.00019369689,0.0003862707],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99618155,0.00078296906,0.0010858472,0.00083171524,0.00040495608,0.00071297266],"domain_scores_gemma":[0.9980759,0.0005128575,0.00051409745,0.0005837865,0.000042799722,0.0002705636],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00040066964,0.00070324756,0.001946867,0.0003257145,0.0002945254,0.000027395408,0.00040801303,0.00024371917,0.0045131766],"category_scores_gemma":[0.0000062396093,0.0006585286,0.00083627267,0.0006619185,0.00017080808,0.00013258329,0.00018750984,0.001536206,0.00011511125],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007759847,0.0025718182,0.00005716382,0.008217838,0.013028019,0.008477104,0.0019452007,0.000024680903,0.00019334152,0.00028294444,0.0016245123,0.9628014],"study_design_scores_gemma":[0.0013593459,0.00009372294,0.00002198841,0.0015587978,0.02240567,0.00017225296,0.000047706595,0.000042428917,0.00039538112,0.00023347157,0.9731543,0.0005149169],"about_ca_topic_score_codex":0.000018682244,"about_ca_topic_score_gemma":0.000002039794,"teacher_disagreement_score":0.9715298,"about_ca_system_score_codex":0.00047667278,"about_ca_system_score_gemma":0.0013824687,"threshold_uncertainty_score":0.9995866},"labels":[],"label_agreement":null},{"id":"W4283513535","doi":"10.1016/j.pharmthera.2022.108236","title":"Clozapine’s multiple cellular mechanisms: What do we know after more than fifty years? A systematic review and critical assessment of translational mechanisms relevant for innovative strategies in treatment-resistant schizophrenia","year":2022,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Receptor Mechanisms and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":79,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Clozapine; Antipsychotic; Neuroscience; Schizophrenia (object-oriented programming); Pharmacology; Dopamine receptor D2; Medicine; Bioinformatics; Computational biology; Psychology; Biology; Dopamine; Psychiatry","score_opus":0.039409106150187084,"score_gpt":0.3724288141002001,"score_spread":0.333019707950013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283513535","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012341453,0.98415816,0.010806112,0.00017214047,0.00035608796,0.0038674083,0.0005024191,0.000012651629,0.0000016377052],"genre_scores_gemma":[0.0016735673,0.9877848,0.0061342153,0.00033204167,0.00006828177,0.003455136,0.000434946,0.00009389958,0.000023131752],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99673855,0.0007390783,0.0011493595,0.00071208354,0.0002573542,0.00040354882],"domain_scores_gemma":[0.99857974,0.00037482905,0.0004903243,0.0003212373,0.0001556368,0.00007822414],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00069917133,0.0006067762,0.002054242,0.00019043854,0.000094193245,0.000063352134,0.00030609392,0.00037711472,0.00024272958],"category_scores_gemma":[0.00001666236,0.0005042024,0.00043351497,0.00027182212,0.000117315205,0.000026329359,0.000104457125,0.00032211005,7.2114506e-7],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085561373,0.0012619368,9.4212743e-7,0.70078707,0.0070164907,0.00009266747,0.00075910415,0.000023416807,0.15329711,0.011008149,0.000027164657,0.124870345],"study_design_scores_gemma":[0.009225545,0.0069861277,0.0000026280418,0.20649016,0.045398723,0.00013739675,0.0031360805,0.0011779625,0.021107178,0.010862379,0.6920046,0.0034711887],"about_ca_topic_score_codex":0.0000034891289,"about_ca_topic_score_gemma":0.000008304884,"teacher_disagreement_score":0.69197744,"about_ca_system_score_codex":0.00011024961,"about_ca_system_score_gemma":0.0006294463,"threshold_uncertainty_score":0.99974096},"labels":[],"label_agreement":null},{"id":"W4293577675","doi":"10.1016/j.pharmthera.2022.108275","title":"Targeting mGluR2/3 for treatment of neurodegenerative and neuropsychiatric diseases","year":2022,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Neuroscience and Neuropharmacology Research","field":"Neuroscience","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Canadian Institutes of Health Research; Alberta Innovates - Health Solutions","keywords":"Metabotropic glutamate receptor 2; Metabotropic glutamate receptor; Neuroscience; Glutamate receptor; Metabotropic glutamate receptor 5; Metabotropic glutamate receptor 3; Metabotropic glutamate receptor 7; Biology; Pharmacology; Medicine; Receptor; Internal medicine","score_opus":0.24077991407317773,"score_gpt":0.4636560308859477,"score_spread":0.22287611681276998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293577675","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020498896,0.99097294,0.00000875491,0.00030144912,0.0026703908,0.003157782,0.0007272608,0.00008616465,0.000025344474],"genre_scores_gemma":[0.00038744597,0.99494517,0.000018469884,0.0025008407,0.0003737387,0.0013595099,0.000014509222,0.00012749448,0.00027281352],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949651,0.0019473397,0.00071048544,0.0012984923,0.00032470972,0.00075390335],"domain_scores_gemma":[0.9953671,0.0035516198,0.0005613482,0.00028288443,0.00004189207,0.0001951609],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016043897,0.0006316874,0.0015427682,0.000495314,0.0006828307,0.000038821985,0.00073483615,0.00012693756,0.00025112208],"category_scores_gemma":[0.00004955934,0.00051423634,0.00046845723,0.00089103234,0.00082305196,0.00010843231,0.00027434464,0.00037114535,0.0000084368785],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038251723,0.0022264612,0.000017276734,0.00372962,0.0003129493,0.00025676502,0.0002261549,0.00003775984,0.23996185,0.000121736244,0.0011885553,0.75153834],"study_design_scores_gemma":[0.0010285272,0.0020850685,9.4316135e-7,0.000020839398,0.0031207413,0.00008001614,0.00000735383,0.00032318378,0.012874729,0.000029986772,0.98008364,0.00034498167],"about_ca_topic_score_codex":0.0000010847118,"about_ca_topic_score_gemma":1.0827006e-7,"teacher_disagreement_score":0.97889507,"about_ca_system_score_codex":0.00009351628,"about_ca_system_score_gemma":0.00047149797,"threshold_uncertainty_score":0.99973094},"labels":[],"label_agreement":null},{"id":"W4311500730","doi":"10.1016/j.pharmthera.2022.108330","title":"Sodium-glucose co-transporter 2 inhibitors in patients with chronic kidney disease","year":2022,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"Fonds de Recherche du Québec - Santé","keywords":"Empagliflozin; Canagliflozin; Medicine; Dapagliflozin; Kidney disease; Diabetes mellitus; Population; Heart failure; Disease; Internal medicine; Pharmacology; Type 2 diabetes; Intensive care medicine; Endocrinology","score_opus":0.03482235961102632,"score_gpt":0.33522370355686626,"score_spread":0.30040134394583995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311500730","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011559945,0.99281704,0.0000012799536,0.0003085585,0.0008506061,0.004006147,0.00019666711,0.00010019697,0.00056351733],"genre_scores_gemma":[0.00059744436,0.98825604,0.000014416011,0.0055955118,0.00025202913,0.0010653409,0.0034004627,0.00014004181,0.00067868887],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99768734,0.00019129354,0.00054687966,0.0005895262,0.00038519088,0.0005997915],"domain_scores_gemma":[0.99890196,0.0000715451,0.00025866658,0.00037067814,0.000029177483,0.0003679887],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014201536,0.0006142071,0.0013713167,0.0004052322,0.00008576133,0.000013996899,0.00024039928,0.00014277747,0.0029116438],"category_scores_gemma":[0.000001144851,0.00045994626,0.0003478714,0.0003742566,0.00013930303,0.00006783942,0.00007115884,0.00066987774,0.0000989708],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069857365,0.0035788086,0.015512588,0.011521506,0.00559349,0.00045548574,0.00009315308,0.0000015887238,0.000001244044,0.000008300882,0.005276261,0.957259],"study_design_scores_gemma":[0.0067514116,0.00079486653,0.0010520183,0.0011764602,0.02211717,0.0000010420761,0.0000029914847,0.0000038194926,0.000006011227,0.0000032268163,0.9677,0.00039095854],"about_ca_topic_score_codex":0.0000033912359,"about_ca_topic_score_gemma":0.0000022508284,"teacher_disagreement_score":0.96242374,"about_ca_system_score_codex":0.00094013085,"about_ca_system_score_gemma":0.0008545779,"threshold_uncertainty_score":0.99978524},"labels":[],"label_agreement":null},{"id":"W4317931771","doi":"10.1016/j.pharmthera.2023.108351","title":"Targeting the Semaphorin3E-plexinD1 complex in allergic asthma","year":2023,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Axon Guidance and Neuronal Signaling","field":"Neuroscience","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Saint-Boniface; University of Manitoba","funders":"Canadian Institutes of Health Research","keywords":"Asthma; Semaphorin; Immunology; Angiogenesis; Inflammation; Medicine; Airway; Airway hyperresponsiveness; Pathophysiology of asthma; Lung; Tissue remodeling; Neuroscience; Biology; Cancer research; Receptor; Internal medicine","score_opus":0.3363744088841353,"score_gpt":0.44459833291162737,"score_spread":0.10822392402749209,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317931771","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024757793,0.99530774,0.000016865086,0.00078741525,0.0016479102,0.0013951358,0.000047628673,0.00023752163,0.00031221405],"genre_scores_gemma":[0.00055221864,0.98700076,0.000014160127,0.010885195,0.0006857612,0.00030468393,0.000018262479,0.00016118909,0.00037773926],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951989,0.0015958061,0.000997522,0.0008758206,0.0004010167,0.00093092077],"domain_scores_gemma":[0.9964366,0.002579335,0.0005315596,0.00033054568,0.000031383977,0.00009056338],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00075716514,0.00062387186,0.0012697323,0.0002623266,0.00041233865,0.000058582926,0.0014722854,0.000302026,0.0003968531],"category_scores_gemma":[0.00003032586,0.0004376845,0.00041161975,0.0012331483,0.00032661526,0.00008164544,0.00038655737,0.0016447678,0.00094096817],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019175225,0.0008127062,0.000017941798,0.010240193,0.0012298198,0.002225713,0.0015731284,0.0013954227,0.070950456,0.0015253627,0.017502036,0.8923355],"study_design_scores_gemma":[0.0003053744,0.000053157462,0.0000021271926,0.00050401414,0.00037755043,0.000054474138,0.00002658416,0.0008336339,0.0006478473,0.00013478636,0.99665225,0.00040823207],"about_ca_topic_score_codex":0.000008734922,"about_ca_topic_score_gemma":0.000004191618,"teacher_disagreement_score":0.9791502,"about_ca_system_score_codex":0.00014114559,"about_ca_system_score_gemma":0.00020734956,"threshold_uncertainty_score":0.9998369},"labels":[],"label_agreement":null},{"id":"W4361228527","doi":"10.1016/j.pharmthera.2023.108398","title":"The pathomimetic oAβ25–35 model of Alzheimer's disease: Potential for screening of new therapeutic agents","year":2023,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Alzheimer's disease research and treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Montpellier Université d'Excellence; Université de Montpellier; Fédération pour la Recherche sur le Cerveau; Institut National de la Santé et de la Recherche Médicale; Agence Nationale de la Recherche","keywords":"Neuroscience; Context (archaeology); Neuroinflammation; Dementia; Senile plaques; Disease; Tau protein; Amyloid (mycology); Cholinergic; Medicine; Alzheimer's disease; Amyloid beta; Bioinformatics; Psychology; Biology; Pathology","score_opus":0.2822206754738892,"score_gpt":0.47057293973763825,"score_spread":0.18835226426374907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361228527","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006259775,0.99250036,0.00120929,0.000377443,0.00041340818,0.0045848605,0.0007507401,0.000078626625,0.00002268989],"genre_scores_gemma":[0.0019183254,0.9954443,0.000441776,0.00038249837,0.00033561798,0.0005869362,0.00037628616,0.0002360132,0.00027826845],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99627376,0.0003759935,0.0011678666,0.00059344876,0.0007033649,0.00088556315],"domain_scores_gemma":[0.99692726,0.0006866303,0.00080973655,0.00068035757,0.00029300482,0.0006029799],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000499366,0.00067303464,0.0020561107,0.00030435124,0.00026733187,0.00002215049,0.00059839094,0.00031094428,0.00006613125],"category_scores_gemma":[0.000014169206,0.0004449625,0.0016132935,0.00045155827,0.00047862067,0.000055920496,0.00019824255,0.0005060248,0.00003174353],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015938655,0.0008188148,0.00004151979,0.0056970515,0.1455416,0.000072674746,0.000067173074,0.0001503751,0.000047197766,0.00008214734,0.0011859398,0.84470165],"study_design_scores_gemma":[0.012210097,0.0015385916,0.0001865766,0.0071052387,0.56216866,0.0000468451,0.000077396595,0.05858931,0.0004176191,0.0026288752,0.35378638,0.0012444096],"about_ca_topic_score_codex":0.000010885901,"about_ca_topic_score_gemma":7.6477806e-7,"teacher_disagreement_score":0.8434572,"about_ca_system_score_codex":0.000081283586,"about_ca_system_score_gemma":0.0023764907,"threshold_uncertainty_score":0.9998002},"labels":[],"label_agreement":null},{"id":"W4362469106","doi":"10.1016/j.pharmthera.2023.108402","title":"Selective JAK1 inhibitors for the treatment of inflammatory bowel disease","year":2023,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"","keywords":"Tofacitinib; Medicine; Janus kinase; Inflammatory bowel disease; Adverse effect; Disease; Immunology; Pharmacology; Cytokine; Internal medicine; Rheumatoid arthritis","score_opus":0.14242696018402856,"score_gpt":0.4385827025708251,"score_spread":0.29615574238679654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362469106","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000151306,0.99366933,0.00003548928,0.0005196728,0.0017855167,0.0033984005,0.0003070635,0.000090802656,0.000042444215],"genre_scores_gemma":[0.00015802565,0.995343,0.000018655262,0.00048339428,0.0013586788,0.0016568415,0.000119382625,0.00010690258,0.00075510977],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99855655,0.000115817755,0.0005911135,0.00030015683,0.00013484494,0.00030149083],"domain_scores_gemma":[0.9977745,0.0012787045,0.00038024088,0.0002681228,0.00018166797,0.000116807474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013809967,0.00037253584,0.0009832374,0.00019437543,0.00014735316,0.0000083043515,0.00013855053,0.00016990106,0.000081892125],"category_scores_gemma":[0.000008841874,0.00022107821,0.0010044277,0.00023027806,0.00015442449,0.000022143442,0.000022073504,0.0002778258,0.00004237692],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090496475,0.0019220574,0.000066815,0.0152342925,0.02210627,0.000052626146,0.0009934179,0.000030774336,0.0012551789,0.000076538985,0.010432733,0.9469243],"study_design_scores_gemma":[0.0009702875,0.0007386061,0.000018557314,0.0011566012,0.026126118,0.000010943331,0.000030542116,0.00019016994,0.0009279829,0.00002245704,0.96964604,0.00016168812],"about_ca_topic_score_codex":0.0000065282647,"about_ca_topic_score_gemma":0.0000028389695,"teacher_disagreement_score":0.9592133,"about_ca_system_score_codex":0.00029883624,"about_ca_system_score_gemma":0.00075048103,"threshold_uncertainty_score":0.90153074},"labels":[],"label_agreement":null},{"id":"W4376638669","doi":"10.1016/j.pharmthera.2023.108437","title":"Measuring brain docosahexaenoic acid turnover as a marker of metabolic consumption","year":2023,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Fatty Acid Research and Health","field":"Nursing","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Docosahexaenoic acid; Polyunsaturated fatty acid; Biochemistry; Metabolism; Chemistry; Phospholipase A2; Phospholipid; Fatty acid; Metabolic pathway; Biology; Enzyme; Membrane","score_opus":0.2645997918398676,"score_gpt":0.46756971880878784,"score_spread":0.20296992696892024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376638669","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00034899169,0.9922946,0.000017194461,0.002053132,0.002741,0.0020145387,0.00012513118,0.00018846084,0.00021695382],"genre_scores_gemma":[0.00012229424,0.9950979,0.00012983747,0.0031481502,0.00058323285,0.00026942635,0.00008832768,0.00019127733,0.00036955735],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946653,0.0018729985,0.0011022775,0.0006365408,0.00061765086,0.0011052272],"domain_scores_gemma":[0.9971835,0.0012407935,0.0006622073,0.00046003758,0.00017719586,0.00027626214],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0016731578,0.00061847904,0.0022095693,0.0007381824,0.00022173897,0.00003938081,0.00072015077,0.0006389017,0.001053638],"category_scores_gemma":[0.000049957234,0.0005365384,0.00065585267,0.0007496665,0.00038789702,0.0001171765,0.00019397118,0.0017176496,0.0018891613],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049242616,0.00028155107,0.000044962188,0.029770792,0.0036102075,0.000049307688,0.0003150871,0.0000017446574,0.006284349,0.00012238024,0.005281709,0.9537455],"study_design_scores_gemma":[0.0010658259,0.00017170938,0.00006470396,0.0021416787,0.0041816374,0.00007219985,0.000010305609,0.00003169632,0.003497657,0.000120802164,0.98823196,0.00040984544],"about_ca_topic_score_codex":0.000043229586,"about_ca_topic_score_gemma":0.000031625914,"teacher_disagreement_score":0.9829502,"about_ca_system_score_codex":0.0002237879,"about_ca_system_score_gemma":0.0005507982,"threshold_uncertainty_score":0.9998595},"labels":[],"label_agreement":null},{"id":"W4377030824","doi":"10.1016/j.pharmthera.2023.108443","title":"Bacterial extracellular vesicles and their interplay with the immune system","year":2023,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Bacterial Infections and Vaccines","field":"Immunology and Microbiology","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval; Centre hospitalier universitaire de Québec","funders":"Fonds de Recherche du Québec - Santé; Natural Sciences and Engineering Research Council of Canada; Arthritis Society","keywords":"Extracellular vesicles; Immune system; Extracellular; Extracellular vesicle; Bacteria; Cell biology; Biology; Vesicle; Microvesicles; Microbiology; Immunology; Biochemistry; Genetics; Gene","score_opus":0.049985165018579435,"score_gpt":0.327771108224436,"score_spread":0.2777859432058566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377030824","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0036596397,0.99031705,0.0000270814,0.00021658913,0.004420736,0.00093901204,0.00013331907,0.00024710683,0.00003945993],"genre_scores_gemma":[0.0028725427,0.9949996,0.0000036411845,0.00006781861,0.00044461773,0.00029463053,0.00018396234,0.00010938242,0.0010238088],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976969,0.0008944779,0.0005291696,0.00041825496,0.000014082001,0.00044711516],"domain_scores_gemma":[0.9985538,0.00061946025,0.00040896866,0.0003341087,0.000060244478,0.000023413784],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039743033,0.0005710021,0.0013419312,0.00014303914,0.00043535724,0.000060231618,0.00042396173,0.00057051884,0.00027693788],"category_scores_gemma":[0.000001362053,0.00028592735,0.00024386842,0.00023516879,0.00037540033,0.00005606208,0.00019807415,0.00078250945,0.00036158194],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004072379,0.00020190032,0.000004068682,0.0056249984,0.0171595,0.000018205892,0.00083088083,4.81268e-7,0.19516584,0.000607975,0.0017380608,0.77824086],"study_design_scores_gemma":[0.0006708443,0.00018617584,0.0000043671444,0.0009025018,0.003762826,0.0005948901,0.00020430099,0.0000015433953,0.003370395,0.0000031051577,0.98998326,0.00031578328],"about_ca_topic_score_codex":0.0000247093,"about_ca_topic_score_gemma":0.000011528401,"teacher_disagreement_score":0.9882452,"about_ca_system_score_codex":0.000062775056,"about_ca_system_score_gemma":0.00012111169,"threshold_uncertainty_score":0.9999593},"labels":[],"label_agreement":null},{"id":"W4380149018","doi":"10.1016/j.pharmthera.2023.108476","title":"Immunotherapies in chronic pain through modulation of neuroimmune interactions","year":2023,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Pharmacological Effects of Natural Compounds","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"National Institute of Dental and Craniofacial Research; National Institutes of Health; Duke University; U.S. Department of Defense","keywords":"Immunotherapy; Immune system; Medicine; Chronic pain; Cytokine; Neuroscience; Inflammation; Immunology; Nociception; Biology; Receptor; Internal medicine","score_opus":0.398004805542641,"score_gpt":0.556434096332557,"score_spread":0.15842929078991602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149018","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012042008,0.9882845,0.00007667575,0.0005805478,0.00584593,0.0029695618,0.00017426975,0.00045337935,0.00041091384],"genre_scores_gemma":[0.005586764,0.98807937,0.00009178175,0.0034102262,0.00078766694,0.0008394573,0.00024564323,0.00025148125,0.0007075821],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.987724,0.007455977,0.0022362254,0.0009824453,0.0003511259,0.0012502193],"domain_scores_gemma":[0.989408,0.008292547,0.0014294345,0.0005234185,0.00019183695,0.00015473996],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.002695874,0.0011975411,0.0031203765,0.0009122873,0.00028106166,0.00003175938,0.0015705882,0.0014950809,0.001512645],"category_scores_gemma":[0.00006122755,0.0010767623,0.0010264631,0.002027052,0.0007732639,0.00035023302,0.0004445949,0.0054662568,0.00040099234],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049019465,0.0010054103,0.000023049342,0.009626177,0.005646679,0.00018879387,0.00048735054,0.0016113429,0.03318757,0.00017687188,0.003398258,0.9441583],"study_design_scores_gemma":[0.0021202804,0.0004954752,0.00004263398,0.0013368281,0.003933711,0.000043926,0.000026638856,0.005724211,0.00069894356,0.0005478984,0.9841788,0.0008506911],"about_ca_topic_score_codex":0.000042321157,"about_ca_topic_score_gemma":0.00004204976,"teacher_disagreement_score":0.9807805,"about_ca_system_score_codex":0.0013103951,"about_ca_system_score_gemma":0.00069737365,"threshold_uncertainty_score":0.99980116},"labels":[],"label_agreement":null},{"id":"W4386647306","doi":"10.1016/j.pharmthera.2023.108528","title":"Novel approaches to target fibroblast mechanotransduction in fibroproliferative diseases","year":2023,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Cellular Mechanics and Interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Ontario Ministry of Research and Innovation; Canadian Institutes of Health Research; Canada Foundation for Innovation; Ontario Research Foundation","keywords":"Mechanotransduction; Extracellular matrix; Fibroblast; Cell biology; Fibrosis; Wound healing; Focal adhesion; Extracellular; Biology; Chemistry; Cancer research; Pathology; Immunology; Medicine; Signal transduction; In vitro; Biochemistry","score_opus":0.24689485178412243,"score_gpt":0.3769661647893344,"score_spread":0.130071313005212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386647306","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000068007954,0.98480374,0.011093295,0.00038021238,0.0013112054,0.0016272265,0.0005754744,0.000057165926,0.00008365796],"genre_scores_gemma":[0.00014185335,0.9946165,0.00065640983,0.0006928064,0.000804699,0.00074596703,0.0011878458,0.00014695617,0.00100698],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980129,0.0001963762,0.00050161395,0.0007237497,0.0001267995,0.00043858445],"domain_scores_gemma":[0.9992995,0.000046929803,0.00017137089,0.00030103093,0.000047874884,0.00013326445],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014711602,0.00047795725,0.00076744996,0.00027508772,0.00009774498,0.00003260301,0.00035297687,0.00042272478,0.00008330856],"category_scores_gemma":[0.00000682029,0.000450415,0.00038113055,0.0004175527,0.00004421645,0.000006664251,0.00016998338,0.0004024007,0.00011144757],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008080424,0.0034803539,0.000006308858,0.013498916,0.011253812,0.0001112506,0.00088836404,0.002845144,0.44126326,0.0015388039,0.010122044,0.5141837],"study_design_scores_gemma":[0.00032493888,0.00025906097,5.6698167e-7,0.0004997431,0.0008483819,0.000050240164,0.0000356361,0.00035231534,0.0074097984,0.00007454707,0.98968816,0.00045662717],"about_ca_topic_score_codex":0.0000065062527,"about_ca_topic_score_gemma":0.00002024461,"teacher_disagreement_score":0.9795661,"about_ca_system_score_codex":0.00008753633,"about_ca_system_score_gemma":0.00024552696,"threshold_uncertainty_score":0.9997948},"labels":[],"label_agreement":null},{"id":"W4387521139","doi":"10.1016/j.pharmthera.2023.108546","title":"Neuropathic pain: From actual pharmacological treatments to new therapeutic horizons","year":2023,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Centre National de la Recherche Scientifique; Université de Strasbourg; Agence Nationale de la Recherche","keywords":"Neuropathic pain; Medicine; Tricyclic; Analgesic; Population; Intensive care medicine; Pharmacology","score_opus":0.20787814897411142,"score_gpt":0.4370841952021684,"score_spread":0.229206046228057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387521139","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019499619,0.98843646,0.0013937823,0.0013057999,0.002832352,0.004624354,0.00032797706,0.00077550096,0.000108796594],"genre_scores_gemma":[0.000082595485,0.9673337,0.00072162645,0.024098855,0.0018286052,0.00086677575,0.0005457005,0.00039160097,0.004130549],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9932223,0.0025030386,0.0010360538,0.0014314447,0.00055809395,0.0012490468],"domain_scores_gemma":[0.99555117,0.002307428,0.00040915623,0.00062242954,0.00009629118,0.001013516],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.00090651424,0.0014157426,0.0032500164,0.000499609,0.00025469932,0.000056418252,0.00066681724,0.0009177508,0.001520291],"category_scores_gemma":[0.000032304863,0.0010416323,0.0011040447,0.00096569565,0.00012039939,0.00006123483,0.00026014927,0.0013782834,0.0040323],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024817404,0.001061163,0.000018127752,0.00054209144,0.020113206,0.0014841569,0.000178444,8.180905e-7,0.00091672444,0.000016129743,0.0036012344,0.97181976],"study_design_scores_gemma":[0.0028019438,0.001942297,0.000018563369,0.0011715548,0.07045019,0.00008735681,0.000017831448,0.00006895222,0.00017647148,0.00026808062,0.92229944,0.0006973426],"about_ca_topic_score_codex":0.000050048628,"about_ca_topic_score_gemma":0.000003625426,"teacher_disagreement_score":0.9711224,"about_ca_system_score_codex":0.0006151491,"about_ca_system_score_gemma":0.0011079838,"threshold_uncertainty_score":0.9998593},"labels":[],"label_agreement":null},{"id":"W4389751531","doi":"10.1016/j.pharmthera.2023.108578","title":"Therapeutic strategies to target connective tissue growth factor in fibrotic lung diseases","year":2023,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Connective Tissue Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"CTGF; Growth factor; Idiopathic pulmonary fibrosis; Transdifferentiation; Fibrosis; Pulmonary fibrosis; Cancer research; Extracellular matrix; Connective tissue; Myofibroblast; CYR61; Lung; Signal transduction; Medicine; Transforming growth factor; Immunology; Biology; Pathology; Cell biology; Receptor; Internal medicine; Stem cell","score_opus":0.08750136862387767,"score_gpt":0.43991100946175543,"score_spread":0.35240964083787774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389751531","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012954039,0.99263287,0.00037695482,0.00022949309,0.0010039579,0.0035058917,0.0007142236,0.0001141157,0.00012712223],"genre_scores_gemma":[0.008341358,0.9875153,0.00004046862,0.0007587687,0.0008234341,0.0012380868,0.00043761797,0.0003045182,0.0005404822],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953176,0.0011561298,0.00072478515,0.0012930152,0.00034961168,0.0011588958],"domain_scores_gemma":[0.9980776,0.0005664137,0.00024467942,0.00055052113,0.0002443741,0.00031641766],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000259762,0.00093077595,0.0016105776,0.0006167132,0.00014248794,0.00010506118,0.001082065,0.0006600266,0.00027262158],"category_scores_gemma":[0.000045049488,0.0008642277,0.0003931454,0.0009445277,0.00023527084,0.000017561888,0.00054743566,0.00077772466,0.00031363292],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013482264,0.0020178459,0.0026148057,0.037274107,0.023674145,0.0014184626,0.00214591,0.00012269191,0.07864839,0.0007140098,0.0060545397,0.84396684],"study_design_scores_gemma":[0.0007882713,0.00067094155,0.00037419412,0.00064614206,0.001445234,0.00003789736,0.0001306246,0.000021463402,0.0031996598,0.00033275454,0.99121726,0.0011355483],"about_ca_topic_score_codex":0.00004150012,"about_ca_topic_score_gemma":0.000052215608,"teacher_disagreement_score":0.98516273,"about_ca_system_score_codex":0.00030895963,"about_ca_system_score_gemma":0.0010917945,"threshold_uncertainty_score":0.9993808},"labels":[],"label_agreement":null},{"id":"W4405695727","doi":"10.1016/j.pharmthera.2024.108788","title":"Non-canonical signaling initiated by hormone-responsive G protein-coupled receptors from subcellular compartments","year":2024,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Receptor Mechanisms and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Receptor; G protein-coupled receptor; Non canonical; Signal transduction; Cell biology; Hormone; Hormone receptor; Chemistry; Biology; Internal medicine; Endocrinology; Biochemistry; Medicine","score_opus":0.06249043893659233,"score_gpt":0.3633521660185275,"score_spread":0.30086172708193515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405695727","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012712998,0.98227763,0.00061193854,0.000058455793,0.001886299,0.0019147686,0.0004217976,0.00007336765,0.00004275051],"genre_scores_gemma":[0.0040860926,0.9877978,0.00030418864,0.0010081459,0.0010211882,0.0005836894,0.0041684653,0.0002787278,0.00075172447],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959895,0.0006164496,0.0010464458,0.0012366724,0.00032368486,0.00078726525],"domain_scores_gemma":[0.9985461,0.000102078186,0.00049341004,0.00045607434,0.00015016331,0.0002521801],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004414332,0.0010255635,0.001679624,0.00015760772,0.00019346905,0.00010197411,0.0007819941,0.0012276882,0.0006753606],"category_scores_gemma":[0.0000064698843,0.00088426186,0.00079722545,0.00030242966,0.00018554444,0.000007891978,0.00032970202,0.0010538716,0.00031629336],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024632932,0.00021711452,5.9835116e-7,0.0006234969,0.005518404,0.000059456564,0.00006260838,0.0000059127146,0.96618956,0.000004747932,0.008727739,0.018344054],"study_design_scores_gemma":[0.0007894279,0.00044545042,4.124688e-8,0.0006061526,0.005590693,0.000011469564,0.000022459157,0.00017085786,0.15960975,0.00003877677,0.8319422,0.0007726946],"about_ca_topic_score_codex":0.000021316288,"about_ca_topic_score_gemma":0.0000017002197,"teacher_disagreement_score":0.8232145,"about_ca_system_score_codex":0.00014108252,"about_ca_system_score_gemma":0.0006584847,"threshold_uncertainty_score":0.9993608},"labels":[],"label_agreement":null},{"id":"W4406715259","doi":"10.1016/j.pharmthera.2025.108800","title":"Semaphorin 3s signaling in the central nervous system: Mechanisms and therapeutic implication for brain diseases","year":2025,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Axon Guidance and Neuronal Signaling","field":"Neuroscience","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ministry of Education and Child Care","funders":"National Natural Science Foundation of China","keywords":"Semaphorin; Central nervous system; Neuroscience; Nervous system; Signal transduction; Biology; Medicine; Receptor; Cell biology; Internal medicine","score_opus":0.09154832386350707,"score_gpt":0.3908425451859244,"score_spread":0.2992942213224173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406715259","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000260913,0.99238855,0.0015713947,0.001014388,0.00080530945,0.003625395,0.00018476222,0.00011384303,0.0000354228],"genre_scores_gemma":[0.014777516,0.9707538,0.000045672976,0.012427237,0.0003081157,0.0015393912,0.000024544404,0.00006932929,0.000054387518],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962315,0.0013214524,0.00069284474,0.00080858415,0.00024189825,0.0007036998],"domain_scores_gemma":[0.9942142,0.00498245,0.00039084873,0.00029653986,0.00003534127,0.00008064713],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005104539,0.00052255346,0.0009966799,0.00022312194,0.0003658791,0.0000894976,0.0008327835,0.00025410592,0.000011141259],"category_scores_gemma":[0.000025754385,0.00037313372,0.00033155346,0.00054188294,0.00013657453,0.00006733719,0.000096612675,0.00051337393,0.0000057708353],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019071305,0.0003781181,0.000007750981,0.022866149,0.00036696444,0.000076656164,0.000602764,0.000060337836,0.09262893,0.02058603,0.00036318178,0.8618724],"study_design_scores_gemma":[0.0012158338,0.00030241135,0.000020153962,0.0030288002,0.0064156167,0.00017263214,0.00018973062,0.0007171124,0.008208074,0.002717966,0.97613156,0.00088012347],"about_ca_topic_score_codex":0.000004596796,"about_ca_topic_score_gemma":0.0000012750208,"teacher_disagreement_score":0.9757684,"about_ca_system_score_codex":0.00014997202,"about_ca_system_score_gemma":0.0002944306,"threshold_uncertainty_score":0.9998721},"labels":[],"label_agreement":null},{"id":"W4410109004","doi":"10.1016/j.pharmthera.2025.108875","title":"Management of drug-resistant hypertension as a heterogeneous disorder","year":2025,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Drug; Medicine; Pharmacology; Resistant hypertension; Internal medicine; Blood pressure","score_opus":0.06734096885332026,"score_gpt":0.38276244990995384,"score_spread":0.3154214810566336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410109004","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006329349,0.9949863,0.0000045616316,0.0007869777,0.0008123367,0.0014961108,0.000034105033,0.000074306394,0.0017419963],"genre_scores_gemma":[0.00023024328,0.98699427,0.00016731699,0.008404961,0.00011711858,0.00018285825,0.000042502244,0.000060212828,0.003800532],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979142,0.00021270914,0.0007252345,0.00050024036,0.00027708782,0.00037050818],"domain_scores_gemma":[0.998677,0.0002965003,0.00029081188,0.0004454655,0.00020518662,0.00008501818],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015700719,0.0005154411,0.0028921408,0.00025953367,0.00011278424,0.0000062772137,0.00024116774,0.0002727483,0.00018500941],"category_scores_gemma":[0.0000015801056,0.00037141863,0.0006700966,0.00034245325,0.00017338576,0.000015355274,0.00030079306,0.00043227882,0.000065999964],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000273,0.0008259519,0.0000050001186,0.04461497,0.027121084,0.0011201684,0.000069084424,7.9093394e-7,0.000078271136,0.000051482053,0.006123996,0.9197162],"study_design_scores_gemma":[0.0011242884,0.00014187781,0.00000422189,0.006435772,0.10952779,0.00017307852,0.000040397077,0.000003875424,0.000092379625,0.000023295665,0.88219684,0.00023619864],"about_ca_topic_score_codex":0.000021517486,"about_ca_topic_score_gemma":0.0000028276481,"teacher_disagreement_score":0.91948,"about_ca_system_score_codex":0.00002669899,"about_ca_system_score_gemma":0.00018844222,"threshold_uncertainty_score":0.99987376},"labels":[],"label_agreement":null},{"id":"W4414629045","doi":"10.1016/j.pharmthera.2025.108931","title":"Towards directed therapy for fusion-positive rhabdomyosarcoma","year":2025,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba","funders":"Cancer Moonshot; Hyundai Hope On Wheels; National Cancer Institute; National Institutes of Health","keywords":"Rhabdomyosarcoma; Soft tissue sarcoma; Sarcoma; Systemic therapy; Immune system; Standard of care; Genetic enhancement; Fusion gene","score_opus":0.08743973682005188,"score_gpt":0.43342422570900385,"score_spread":0.34598448888895195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414629045","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000036269714,0.9884775,0.000055972545,0.0018162762,0.0015106145,0.0064052735,0.00041835065,0.00026660063,0.0010130865],"genre_scores_gemma":[0.00002968088,0.98294926,0.00094130455,0.010029367,0.0005771627,0.0037484453,0.00070942653,0.00011935546,0.00089598063],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973845,0.0003496626,0.0006981962,0.0007313098,0.00022615133,0.0006101757],"domain_scores_gemma":[0.9971662,0.001635661,0.00032007764,0.00042152047,0.0002887296,0.00016778639],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002111249,0.0008047666,0.0026889108,0.00038139036,0.00020709242,0.000026001419,0.000308911,0.00058322697,0.000371134],"category_scores_gemma":[0.00000992498,0.00057346304,0.0013247615,0.0004946319,0.00014417023,0.000030549458,0.00009828922,0.00051731983,0.000045521527],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033768392,0.0017726374,0.000031599233,0.0035543283,0.008204263,0.00010390798,0.000070166505,5.0560427e-8,0.000026588146,0.00006106244,0.005252433,0.9805853],"study_design_scores_gemma":[0.0042208303,0.0006268797,0.00007740308,0.0032024535,0.021598857,0.00009393143,0.000007305895,0.000015656544,0.00047863115,0.0000810991,0.96919453,0.0004024039],"about_ca_topic_score_codex":0.000010402606,"about_ca_topic_score_gemma":0.0000013691026,"teacher_disagreement_score":0.9801829,"about_ca_system_score_codex":0.00037750995,"about_ca_system_score_gemma":0.0011770633,"threshold_uncertainty_score":0.9996717},"labels":[],"label_agreement":null}]}